≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Specific development disorders of speech and language

DOID EFO Endpoint Browser PheWeb

F5_SPEECH

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F80
  • Hospital discharge: ICD-9 — 3153
  • Hospital discharge: ICD-8 — 3060
  • Cause of death: ICD-10 — F80
  • Cause of death: ICD-9 — 3153
  • Cause of death: ICD-8 — 3060

2 out of 7 registries used, show all original rules.

2753

4. Check minimum number of events

None

2753

5. Include endpoints

2753

6. Filter based on genotype QC (FinnGen only)

2565

Control definitions (FinnGen only)

Control exclude
F5_PSYCHDEV

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
F80-F89
Name in latin
Perturbationes specificae progressus dictionis et linguae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 65508 19893 45590
Only index persons 49393 15358 34035
Unadjusted period prevalence (%)
Whole population 1.06 0.57 1.27
Only index persons 1.07 0.56 1.30
Median age at first event (years)
Whole population 5.39 5.72 5.22
Only index persons 5.75 6.18 5.55

-FinnGen-

Key figures

All Female Male
Number of individuals 2565 1218 1347
Unadjusted period prevalence (%) 0.53 0.43 0.62
Median age at first event (years) 8.89 11.71 6.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2718
Matched controls
26185
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F80.2
ICD-10 Finland
Receptive language disorder
849.3
307.7
562
8
F80.1
ICD-10 Finland
Expressive language disorder
2520.1
307.7
1457
12
F80.0
ICD-10 Finland
Specific speech articulation disorder
100.7
307.7
339
37
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
636.5
307.7
397
7
R62.0
ICD-10 Finland
Delayed milestone
19.9
305.7
247
131
F83
ICD-10 Finland
Mixed specific developmental disorders
482.1
273.2
272
6
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
423.2
241.6
242
6
F81.0
ICD-10 Finland
Specific reading disorder
53.8
234.6
138
26
XA800
NOMESCO Finland
Neuropsychological investigation
8.4
234.2
330
423
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
+∞
233.7
224
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
15.0
220.4
204
141
F82
ICD-10 Finland
Specific developmental disorder of motor function
306.8
201.3
205
7
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
49.5
197.2
118
24
R4130
NOMESCO Finland
Speech therapy
10.3
194.4
230
234
Z2445
NOMESCO Finland
Psychologist
4.8
147.7
367
817
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
+∞
147.3
142
*
Z50.5
ICD-10 Finland
Speech therapy
8.7
141.9
188
221
AA1AD
NOMESCO Finland
CT of head and brain
2.9
127.2
795
3249
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
38.0
114.8
73
19
F84.5
ICD-10 Finland
Asperger syndrome
23.8
113.9
84
35
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
14.9
109.2
100
67
Z3226
NOMESCO Finland
Physiotherapist
2.9
109.2
655
2593
Z2446
NOMESCO Finland
Social worker
3.5
107.8
426
1318
R47.0
ICD-10 Finland
Dysphasia and aphasia
17.0
107.6
92
54
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
4.9
105.4
252
539
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.1
104.0
314
806
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.5
103.1
273
634
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
177.0
100.5
106
6
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.9
94.6
553
2143
R4120
NOMESCO Finland
Occupational therapy
4.1
92.2
277
707
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
6.3
91.5
160
256
R1260
NOMESCO Finland
Evaluation of communicative skills
8.7
84.4
110
126
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
6.6
78.7
132
202
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.6
76.0
558
2403
N03AX14
ATC
levetiracetam; systemic
5.4
76.0
158
298
N03AG01
ATC
valproic acid; systemic, rectal
3.7
75.7
258
717
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
36.2
74.4
48
13
RL140, ,
NOMESCO Finland
20.8
73.2
57
27
F88
ICD-10 Finland
Other disorders of psychological development
40.1
71.6
45
11
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
71.3
432
1688
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.9
70.3
375
1369
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
118.7
66.1
72
6
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.9
65.6
338
1208
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.0
65.6
334
1186
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.5
64.4
163
363
N05AX08
ATC
risperidone; systemic
3.0
63.3
314
1098
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.4
62.7
245
743
N03AF02
ATC
oxcarbazepine; oral
4.4
61.6
164
380
Z2221
NOMESCO Finland
Medical doctor
2.1
61.6
767
4096
Z3231
NOMESCO Finland
Registered nurse
2.1
61.5
854
4749
R47.1
ICD-10 Finland
Dysarthria and anarthria
11.4
61.0
65
56
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
7.4
59.5
89
120
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.3
57.7
241
761
N19
ICPC
Speech disorder
4.6
57.7
144
317
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.4
57.6
221
662
PA6AD
NOMESCO Finland
CT of neck arteries
4.7
56.6
135
286
P24
ICPC
Specific learning problem
5.1
55.5
120
234
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.0
55.0
259
877
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.1
54.9
255
857
A28
ICPC
Limited function/disability NOS
2.5
54.6
412
1777
R4110
NOMESCO Finland
Physiotherapy
2.0
54.2
727
3961
ZY010
NOMESCO Finland
Hospital outpatient
2.8
53.6
289
1055
N05AH03
ATC
olanzapine; systemic
2.9
53.4
278
995
N05AX12
ATC
aripiprazole; systemic
3.1
53.3
236
771
RL130, ,
NOMESCO Finland
14.0
53.1
50
35
RT150, ,
NOMESCO Finland
11.0
53.0
58
52
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
3.7
52.5
176
482
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
74.0
52.3
60
8
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
52.3
433
1944
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
52.0
291
1083
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.8
51.6
119
245
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.5
51.5
186
535
IGV01
NOMESCO Finland
Psychiatric network contact
4.8
49.1
114
236
P85
ICPC
Mental retardation
9.3
48.2
59
62
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.9
48.2
252
903
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.2
47.4
131
312
DFF20
NOMESCO Finland
Audiometry for children
8.5
47.0
62
72
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
45.4
274
1057
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.8
44.9
240
869
EBA15
NOMESCO Finland
Extraction of multiple teeth
4.1
44.9
128
312
F84.0
ICD-10 Finland
Childhood autism
+∞
44.3
43
*
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.9
43.4
131
333
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.1
43.4
193
631
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
5.1
42.7
91
175
P22
ICPC
Child behaviour symptom/complaint
3.9
42.5
129
329
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.9
42.4
209
724
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.2
42.4
174
542
F84.8
ICD-10 Finland
Other pervasive developmental disorders
215.3
42.4
44
*
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.8
40.5
217
786
N05AH04
ATC
quetiapine; oral
2.0
40.2
578
3185
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.2
40.0
167
525
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
39.1
418
2067
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.7
38.7
125
333
F81.1
ICD-10 Finland
Specific spelling disorder
102.7
38.2
42
*
B01AC04
ATC
clopidogrel; oral
2.4
38.0
286
1223
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
37.9
489
2590
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.3
37.7
320
1441
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.8
37.7
199
715
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.7
37.4
216
813
F80
ICD-10 Finland
Specific developmental disorders of speech and language
130.3
37.2
40
*
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
+∞
37.1
36
*
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
10.3
35.9
41
39
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
35.2
857
5514
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.6
35.2
85
182
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.3
35.0
284
1253
30600
ICD-8 Finland
Special symptoms not elsewhere classified, Stammering and stuttering
+∞
35.0
34
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
34.9
276
1204
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
34.7
554
3143
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
34.0
517
2885
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
33.9
766
4816
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
9.1
33.8
42
45
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
33.8
406
2090
N05CD08
ATC
midazolam; nasal, systemic
4.0
33.7
97
238
R1250
NOMESCO Finland
Evaluation of functional capability
4.5
33.6
83
181
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.6
33.4
199
761
183
Kela drug reimbursment
Lamotrigin and topiramate
5.8
32.9
61
103
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
32.6
997
6784
WX892
NOMESCO Finland
Monitored bed care
2.5
32.5
220
894
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.7
32.5
105
280
WX882
NOMESCO Finland
High dependency care
2.8
32.4
166
586
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
31.7
311
1482
P99
ICPC
Psychological disorders other
3.0
31.3
145
484
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
7.4
31.2
46
61
XX4AW, ,
NOMESCO Finland
6.3
30.9
53
83
R5599
NOMESCO Finland
Other rehabilitation service
3.6
30.7
103
282
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
3.7
30.5
97
256
N03AX09
ATC
lamotrigine; oral
2.6
29.8
188
739
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
4.1
29.6
84
204
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.6
29.6
174
660
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.6
29.1
180
700
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
29.0
485
2776
IGP01
NOMESCO Finland
Psychiatric family contact
3.5
28.3
100
283
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
28.2
218
940
RS220, ,
NOMESCO Finland
4.6
28.1
67
142
N05BA09
ATC
clobazam; oral
5.3
28.1
57
105
N03AX18
ATC
lacosamide; systemic
6.4
28.0
47
72
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
2.8
27.9
145
516
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.1
27.8
122
395
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
3.9
27.8
82
205
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
27.6
498
2913
G40.10
ICD-10 Finland
Simple partial seizures
6.6
27.5
45
67
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
27.5
644
4054
K03.66
ICD-10 Finland
Tooth plaque
2.0
27.3
325
1661
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.3
27.1
103
306
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.4
26.9
199
841
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
26.8
293
1451
ZXE00
NOMESCO Finland
One hour or less
1.6
26.6
924
6408
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
5.6
26.6
51
89
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
26.6
473
2752
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.2
26.5
107
330
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
26.3
421
2371
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.2
26.3
70
162
N05AH02
ATC
clozapine; systemic
3.8
26.0
82
215
R41.0
ICD-10 Finland
Disorientation, unspecified
3.7
25.9
83
220
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
2.8
25.8
135
482
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
58.4
25.6
30
5
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
3.8
24.5
76
197
R55
ICD-10 Finland
Syncope and collapse
2.1
24.3
263
1297
K59.09
ICD-10 Finland
Constipation, unspecified
2.3
24.0
182
777
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.0
23.5
108
359
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.9
23.5
71
181
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
65.6
23.4
27
*
K89
ICPC
Transient cerebral ischaemia
7.7
23.2
33
42
IEV99
NOMESCO Finland
Other psychiatric network intervention
4.0
23.2
66
161
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
5.8
22.7
42
71
N06AB04
ATC
citalopram; systemic
1.8
22.6
372
2108
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
4.5
22.5
55
119
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
4.9
22.5
50
100
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
4.8
22.4
51
104
R42
ICD-10 Finland
Dizziness and giddiness
1.7
22.3
474
2888
RS211, ,
NOMESCO Finland
5.9
22.1
40
66
IEP03
NOMESCO Finland
Focused parental counselling
4.2
22.1
60
141
N18
ICPC
Paralysis/weakness
4.7
22.1
52
109
F20.9
ICD-10 Finland
Schizophrenia, unspecified
3.6
22.1
73
198
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
4.1
22.0
61
146
ZYC01
NOMESCO Finland
Remote contact by phone
2.2
22.0
195
890
N05AD01
ATC
haloperidol; systemic
3.6
21.9
73
199
Z31.5
ICD-10 Finland
Genetic counselling
2.2
21.8
182
810
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.4
21.7
78
224
N05BA01
ATC
diazepam; systemic, rectal
1.9
21.5
272
1416
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
5.2
21.4
44
82
L28
ICPC
Limited function/disability (L)
1.8
21.2
351
1991
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.2
21.2
177
788
F05.9
ICD-10 Finland
Delirium, unspecified
4.2
21.0
56
130
K90
ICPC
Stroke/cerebrovascular accident
3.9
20.8
61
152
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
18.3
20.8
32
17
N06BA04
ATC
methylphenidate; oral
2.0
20.7
248
1266
RT160, ,
NOMESCO Finland
6.7
20.6
33
48
N04AA02
ATC
biperiden; systemic
4.4
20.5
52
116
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
3.3
20.5
80
242
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
3.6
20.4
69
190
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
16.4
20.0
32
19
R51.80
ICD-10 Finland
Headache
1.6
19.9
490
3097
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
19.8
239
1224
H01AC01
ATC
somatropin; parenteral
3.8
19.7
60
154
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
19.6
334
1908
F80.3
ICD-10 Finland
Acquired aphasia with epilepsy [Landau-Kleffner]
+∞
19.5
19
*
N05BA06
ATC
lorazepam; systemic, sublingual
2.7
19.4
109
404
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
2.4
19.3
132
538
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.5
19.3
124
491
F89
ICD-10 Finland
Unspecified disorder of psychological development
28.1
19.3
26
9
IEY01
NOMESCO Finland
Psychoeducation, individual
3.9
19.2
56
139
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
3.7
19.2
60
157
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
3.5
19.1
67
189
IEP99
NOMESCO Finland
Other psychiatric family intervention
4.0
19.1
54
131
RS140, ,
NOMESCO Finland
6.2
19.1
33
52
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
5.4
19.1
38
69
N28
ICPC
Limited function/disability (N)
4.2
19.0
50
115
RS222, ,
NOMESCO Finland
4.2
18.8
51
120
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.0
18.8
213
1066
TAB00
NOMESCO Finland
Lumbar puncture
2.4
18.6
130
536
R25.1
ICD-10 Finland
Tremor, unspecified
3.2
18.5
75
232
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.0
18.5
210
1051
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
18.3
200
987
WX730
NOMESCO Finland
Conventional respirator
4.4
18.3
46
102
R13
ICD-10 Finland
Dysphagia
2.3
18.0
138
593
H53.0
ICD-10 Finland
Amblyopia ex anopsia
3.4
17.9
66
193
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
4.0
17.8
51
125
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.3
17.8
140
608
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.6
17.6
107
413
AA5PD
NOMESCO Finland
CT examination of brain pefusion
6.0
17.6
31
50
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.7
17.6
97
357
PA7BD
NOMESCO Finland
CT angiography of neck and brain
4.6
17.5
41
86
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
3.4
17.3
64
187
H50.31
ICD-10 Finland
Intermittent exotropia
3.5
17.3
61
173
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.2
17.1
69
213
Z02.7
ICD-10 Finland
Issue of medical certificate
2.0
17.1
207
1060
D12
ICPC
Constipation
2.6
17.1
104
402
WX402
NOMESCO Finland
General anaesthesia
1.6
17.0
535
3569
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
3.7
17.0
54
143
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
3.6
16.8
56
153
N06AX11
ATC
mirtazapine; oral
1.5
16.7
709
5034
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
16.7
692
4891
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
5.3
16.7
34
63
SPAT1389
SPAT
Visit based on need for special support
2.0
16.7
200
1021
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.7
16.6
38
78
ZXA10
NOMESCO Finland
Bilateral
1.6
16.6
400
2504
N03AE01
ATC
clonazepam; systemic
2.4
16.4
110
445
FM2CE, ,
NOMESCO Finland
2.7
16.4
91
336
N05AA02
ATC
levomepromazine; systemic
2.7
16.4
87
314
602
Kela drug reimbursment
Children's severe malnutrition
3.4
16.4
59
170
3141A
ICD-9 Finland
Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay
87.3
16.3
18
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
16.2
512
3415
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.1
16.2
166
801
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
16.2
1946
16632
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
4.6
16.1
38
80
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.0
16.1
187
944
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
1.8
16.0
236
1289
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
5.2
16.0
33
62
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.1
15.9
148
688
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
3.3
15.9
60
178
N05AN01
ATC
lithium; oral
2.9
15.9
74
249
Z71.8
ICD-10 Finland
Other specified counselling
1.4
15.8
933
7036
Z13.4
ICD-10 Finland
Special screening examination for certain developmental disorders in childhood
46.0
15.7
19
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
15.7
518
3486
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
4.6
15.7
37
78
N17
ICPC
Vertigo/dizziness
1.7
15.5
299
1765
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.0
15.5
162
788
Q38.1
ICD-10 Finland
Ankyloglossia
3.5
15.4
53
148
3150A
ICD-9 Finland
Specific delays in development, Specific reading disorder
+∞
15.4
15
*
K08.3
ICD-10 Finland
Retained dental root
2.1
15.4
140
646
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
15.3
122
533
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.6
15.3
456
3000
N05AF05
ATC
zuclopenthixol; systemic
5.8
15.3
28
47
WX002
NOMESCO Finland
Sedation and analgesia
1.7
15.2
339
2080
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.4
15.1
109
456
A97
ICPC
No disease
1.5
15.1
611
4286
C10AA05
ATC
atorvastatin; oral
1.5
15.1
535
3653
P29
ICPC
Psychological sympt/compl other
1.7
15.1
334
2045
A06AD11
ATC
lactulose; oral
1.8
14.9
259
1484
P07.2
ICD-10 Finland
Extreme immaturity
27.7
14.9
20
7
F93.89
ICD-10 Finland
Other childhood emotional disorders
2.8
14.9
76
269
S18
ICPC
Laceration/cut
1.4
14.8
1001
7711
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.6
14.8
85
320
L17
ICPC
Foot/toe symptom/complaint
1.4
14.7
738
5389
N05BA04
ATC
oxazepam; oral
1.5
14.7
524
3579
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.8
14.7
250
1425
SPAT1307
SPAT
Psychosocial counselling and guidance
1.7
14.6
297
1778
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.5
14.6
49
135
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
3.9
14.5
42
104
RT420, ,
NOMESCO Finland
12.0
14.5
26
21
SPAT1216
SPAT
Assessment of functional ability
1.7
14.4
283
1677
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.4
14.4
104
435
XA820, ,
NOMESCO Finland
6.6
14.2
23
34
XX4BW, ,
NOMESCO Finland
6.6
14.2
23
34
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
3.0
14.1
61
197
H66.9
ICD-10 Finland
Otitis media, unspecified
1.6
14.1
372
2377
C08CA01
ATC
amlodipine; oral
1.5
14.0
503
3437
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
5.3
14.0
28
51
RD210, ,
NOMESCO Finland
2.4
14.0
94
381
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
4.0
14.0
39
94
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
14.0
177
920
N05AF03
ATC
chlorprothixene; systemic
3.0
14.0
61
198
N88
ICPC
Epilepsy
4.3
13.9
36
82
TJD20
NOMESCO Finland
Change of gastrostomy tube
5.1
13.9
29
55
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
1.9
13.9
176
915
DFF00
NOMESCO Finland
Pure tone audiometry
1.9
13.9
188
999
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
3.7
13.9
43
112
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
2.8
13.8
69
242
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
5.6
13.7
26
45
DFF10
NOMESCO Finland
Measurement of acoustic impedance (tympanometry and reflex testing)
5.6
13.7
26
45
SCA02
NOMESCO Finland
Preventive oral health care
1.5
13.7
542
3779
ZX199
NOMESCO Finland
Other rote
5.8
13.6
25
42
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
13.6
921
7068
WX872
NOMESCO Finland
Intensive care
2.5
13.6
87
345
XF404
NOMESCO Finland
Ambulatory ECG
1.9
13.6
166
853
OAA43, ,
SPAT
2.1
13.4
126
589
H81
ICPC
Excessive ear wax
1.6
13.4
329
2065
3154A
ICD-9 Finland
Specific delays in development, Coördination disorder
+∞
13.4
13
*
U07
ICPC
Urine symptom/complaint other
1.9
13.3
176
928
ZY000
NOMESCO Finland
Hospital inpatient
2.8
13.3
64
220
R5110, ,
SPAT
2.0
13.2
142
698
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
3.2
13.2
52
159
UDC00
NOMESCO Finland
Ear microscopy
1.8
13.2
205
1138
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.3
13.1
48
140
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.0
13.1
59
195
WX110, ,
SPAT
1.9
13.1
172
905
ICB06, ,
NOMESCO Finland
3.1
13.0
53
165
RS120, ,
NOMESCO Finland
6.3
13.0
22
34
RK320, ,
NOMESCO Finland
5.5
13.0
25
44
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
0.6
12.9
229
3528
WX704
NOMESCO Finland
Intubation
1.9
12.8
165
862
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.6
12.8
328
2077
P20
ICPC
Memory disturbance
1.8
12.8
199
1103
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.3
12.8
48
142
N05AB03
ATC
perphenazine; systemic, rectal
2.6
12.8
75
285
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
4.3
12.8
33
75
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
12.8
1210
9764
ZXD05
NOMESCO Finland
Urgent procedure
1.4
12.7
617
4465
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.5
12.6
43
120
XA400
NOMESCO Finland
EEG
5.2
12.6
26
49
H52.2
ICD-10 Finland
Astigmatism
2.4
12.5
85
347
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
4.9
12.5
27
53
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
12.5
255
1528
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.0
12.4
55
180
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.8
12.4
62
217
OAA68, ,
SPAT
3.0
12.4
53
170
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
12.4
80
319
F99
ICD-10 Finland
Mental disorder, not otherwise specified
2.6
12.4
72
273
4212
FHL
Maxillapremmaxilla opening septum resection and reconstruction
11.9
12.3
22
18
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
3.7
12.3
38
99
N06AX16
ATC
venlafaxine; oral
1.6
12.3
314
1989
OAB43, ,
SPAT
0.7
12.2
622
7720
P72
ICPC
Schizophrenia
2.8
12.2
59
203
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
12.2
187
1033
A04
ICPC
Weakness/tiredness general
1.5
12.2
475
3294
N29
ICPC
Neurological sympt/complt other
3.1
12.1
49
152
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
5.6
12.1
23
40
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
2.9
12.1
55
183
P28
ICPC
Limited function/disability (P)
3.9
12.1
35
87
N99
ICPC
Neurological disease other
4.0
12.0
34
83
A29
ICPC
General symptom/complaint other
1.6
12.0
299
1882
R4140
NOMESCO Finland
Psychotherapy
4.1
12.0
33
79
RT490, ,
NOMESCO Finland
13.9
12.0
20
14
N03AX23
ATC
brivaracetam; systemic
5.8
12.0
22
37
N06AA04
ATC
clomipramine; systemic
3.8
12.0
36
92
N03AX11
ATC
topiramate; oral
2.6
12.0
68
255
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
11.9
164
876
EMB30
NOMESCO Finland
Adenotomy
1.6
11.9
261
1592
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
6.0
11.9
21
34
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
5.1
11.8
25
48
Z07
ICPC
Education problem
2.6
11.8
67
251
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
17.4
11.8
18
10
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
4.9
11.8
26
52
R41.3
ICD-10 Finland
Other amnesia
2.9
11.8
55
186
SAA04
NOMESCO Finland
Special examination of mouth
1.7
11.7
206
1185
G40.89
ICD-10 Finland
Other epilepsy
5.2
11.7
24
45
A99
ICPC
Disease/condition unspecnature/site
1.7
11.6
248
1501
H01
ICPC
Ear pain/earache
1.5
11.6
430
2948
C03CA01
ATC
furosemide; systemic
1.5
11.6
400
2705
G45.8
ICD-10 Finland
Other transient cerebral ischaemic attacks and related syndromes
5.8
11.5
21
35
EB1WA, ,
NOMESCO Finland
4.8
11.5
26
53
H53.1
ICD-10 Finland
Subjective visual disturbances
1.9
11.4
150
790
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.5
11.4
39
109
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
15.9
11.4
18
11
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
5.1
11.4
24
46
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.6
11.4
309
1983
R4120, ,
SPAT
3.7
11.4
35
91
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
11.3
264
1634
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
11.3
320
2072
3152A
ICD-9 Finland
Specific delays in development, Other specific learning difficulties
+∞
11.3
11
*
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.0
11.3
50
164
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
11.3
202
1167
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
3.6
11.3
36
96
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
11.3
994
7891
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
4.3
11.3
29
66
ZXA00
NOMESCO Finland
Right side
1.5
11.2
420
2885
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
11.2
155
830
F94.0
ICD-10 Finland
Elective mutism
13.2
11.2
19
14
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
11.1
180
1010
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
2.4
11.1
78
323
D21
ICPC
Swallowing problem
3.4
11.1
40
116
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
11.1
1141
9258
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.7
11.1
58
209
R32
ICD-10 Finland
Unspecified urinary incontinence
2.7
11.1
58
209
SPAT1229
SPAT
Assessment of need for aid
2.0
11.0
117
574
R5120
NOMESCO Finland
Preparation of an aid
2.7
11.0
56
199
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
3.7
11.0
34
89
F91.9
ICD-10 Finland
Conduct disorder, unspecified
5.1
10.9
23
44
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
5.1
10.9
23
44
K02.1
ICD-10 Finland
Caries of dentine
1.3
10.8
1632
13942
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
4.7
10.8
25
52
U04
ICPC
Incontinence urine
2.1
10.8
101
472
G41.9
ICD-10 Finland
Status epilepticus, unspecified
5.7
10.8
20
34
R4190
NOMESCO Finland
Nutritional therapy
1.8
10.7
167
927
G12.2
ICD-10 Finland
Motor neuron disease
9.7
10.7
21
21
N06AB10
ATC
escitalopram; oral
1.4
10.7
539
3912
IGY02, ,
SPAT
2.5
10.7
64
247
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.5
10.6
302
1958
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
4.2
10.6
28
65
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.0
10.6
112
548
IEY03
NOMESCO Finland
Vocational rehabilitation
4.6
10.6
25
53
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.0
10.5
112
549
L12
ICPC
Hand/finger symptom/complaint
1.4
10.5
484
3454
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.2
10.5
86
381
Q93.5
ICD-10 Finland
Other deletions of part of a chromosome
27.1
10.5
14
5
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.3
10.5
79
338
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.1
10.5
42
130
RS314, ,
NOMESCO Finland
10.2
10.5
20
19
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
10.2
10.5
20
19
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.7
10.5
56
204
7834D
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[LAPSEN NORMAALIN KEHITTYMISEN HIDASTUMINEN]
20.7
10.5
15
7
V628A
ICD-9 Finland
Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified
58.0
10.4
12
*
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
2.1
10.4
98
459
R11
ICD-10 Finland
Nausea and vomiting
1.6
10.4
266
1683
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
12.5
10.4
18
14
N06AB03
ATC
fluoxetine; oral
1.6
10.4
251
1568
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.0
10.4
114
566
ZXA05
NOMESCO Finland
Left side
1.5
10.3
383
2626
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.6
10.3
34
93
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
2.5
10.3
62
240
C07AB02
ATC
metoprolol; systemic
1.6
10.2
266
1689
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.1
10.2
43
137
101
Kela drug reimbursment
Anterior pituitary hypofunction
3.2
10.2
40
122
ZXY03
NOMESCO Finland
Occupational therapist
5.0
10.2
22
43
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
10.2
180
1036
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.9
10.2
126
651
UGC02
NOMESCO Finland
Rigid bronchoscopy
4.6
10.1
24
51
WYA30, ,
SPAT
3.8
10.1
30
76
K07.24
ICD-10 Finland
Open bite
2.4
10.1
70
289
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
3.4
10.0
36
104
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
10.0
164
925
SPAT1301
SPAT
No procedures
1.3
10.0
741
5714
F60.8
ICD-10 Finland
Other specific personality disorders
4.3
9.9
25
56
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.4
9.9
585
4353
N06AB06
ATC
sertraline; oral
1.5
9.9
304
2004
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
5.2
9.9
20
37
N06AX21
ATC
duloxetine; oral
1.6
9.9
215
1309
P76
ICPC
Depressive disorder
1.6
9.8
219
1340
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.9
9.8
46
156
P74
ICPC
Anxiety disorder/anxiety state
1.7
9.8
184
1077
SBB10
NOMESCO Finland
Dental impressions
1.5
9.8
362
2477
IAZ98
NOMESCO Finland
Other internal psychiatric consultation
4.0
9.8
27
65
H02AB09
ATC
hydrocortisone; systemic
2.2
9.8
83
374
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
4.1
9.7
26
61
ZXY60
NOMESCO Finland
2-person team, nurses
3.6
9.7
31
83
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
9.7
131
697
S21
ICPC
Skin texture symptom/complaint
1.5
9.6
354
2420
W19
ICD-10 Finland
Unspecified fall
1.6
9.6
258
1650
F70
ICD-10 Finland
Mild mental retardation
25.2
9.6
13
5
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
3.7
9.6
30
79
SPAT1395
SPAT
Health check-up of persons outside student and working life
2.7
9.6
52
191
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
9.6
557
4132
D01
ICPC
Abdominal pain/cramps general
1.4
9.6
400
2803
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.0
9.5
99
482
R27.0
ICD-10 Finland
Ataxia, unspecified
8.4
9.5
20
23
3140B
ICD-9 Finland
Hyperkinetic syndrome of childhood, Attention deficit disorder
53.2
9.5
11
*
K59.0
ICD-10 Finland
Constipation
1.8
9.5
133
716
RK220, ,
NOMESCO Finland
4.6
9.5
22
46
N05AA01
ATC
chlorpromazine; systemic, rectal
4.3
9.5
24
54
A11
ICPC
Chest pain NOS
1.7
9.5
158
896
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
3.3
9.4
35
104
J35.2
ICD-10 Finland
Hypertrophy of adenoids
1.7
9.4
190
1136
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
3.0
9.4
40
129
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.8
9.3
46
161
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
14.5
9.3
15
10
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
4.1
9.3
25
59
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.0
9.3
101
500
RS214, ,
NOMESCO Finland
4.7
9.3
21
43
Q87.06
ICD-10 Finland
Velocardiofacial syndrome
96.7
9.3
10
*
F98.5
ICD-10 Finland
Stuttering [stammering]
8.8
9.3
19
21
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
9.2
427
3045
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
9.2
466
3374
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.9
9.2
111
569
N30.0
ICD-10 Finland
Acute cystitis
1.4
9.2
368
2556
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
16.9
9.2
14
8
F39
ICD-10 Finland
Unspecified mood [affective] disorder
2.2
9.2
74
327
SJB00
NOMESCO Finland
Fitting of removable appliance incl. patient instructions
1.6
9.2
194
1173
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
5.1
9.1
19
36
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
2.1
9.1
82
378
RS122, ,
NOMESCO Finland
7.3
9.1
21
28
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
3.3
9.1
34
101
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
9.1
444
3198
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.4
9.0
496
3641
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
9.0
409
2905
B01AF02
ATC
apixaban; oral
1.7
9.0
173
1019
H50.0
ICD-10 Finland
Convergent concomitant strabismus
2.8
9.0
44
153
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
9.2
9.0
18
19
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
4.4
9.0
22
48
OAA46, ,
SPAT
2.7
9.0
48
175
P27
ICPC
Fear of mental disorder
2.4
9.0
60
244
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.3
9.0
33
97
R49.2
ICD-10 Finland
Hypernasality and hyponasality
13.2
9.0
15
11
S29
ICPC
Skin symptom/complaint other
1.4
8.9
479
3502
N03AF01
ATC
carbamazepine; oral, rectal
2.2
8.9
76
343
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
8.9
193
1173
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
4.0
8.9
25
61
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.8
8.9
126
681
SPAT1303
SPAT
Counselling and guidance related to growth and development
1.8
8.9
125
674
3199A
ICD-9 Finland
Unspecified mental retardation[MUU ÄLYLLINEN KEHITYSVAMMAISUUS,EI KÄYTTÄYTYMIHÄIRI]
35.5
8.9
11
*
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
8.8
1935
17123
RT190, ,
NOMESCO Finland
11.1
8.8
16
14
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
3.5
8.8
30
84
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.8
8.8
124
669
ICB03, ,
SPAT
4.5
8.8
21
45
R53
ICD-10 Finland
Malaise and fatigue
1.3
8.8
585
4426
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
18.0
8.7
13
7
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
3.9
8.7
25
62
SPAT1234
SPAT
Support of social functional capacity
1.9
8.7
99
498
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
8.7
178
1067
A03
ICPC
Fever
1.3
8.7
634
4861
H03AA01
ATC
levothyroxine sodium; systemic
1.4
8.7
357
2491
SFA20
NOMESCO Finland
Two-surface restoration
1.3
8.7
1377
11688
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
2.5
8.7
54
213
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
2.4
8.6
59
243
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
7.7
8.6
19
24
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
7.7
8.6
19
24
EJC20
NOMESCO Finland
Operation on frenulum of tongue
3.1
8.6
35
110
T82
ICPC
Obesity
2.0
8.6
92
454
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.6
8.6
187
1140
R33
ICD-10 Finland
Retention of urine
1.9
8.5
109
570
M79.6
ICD-10 Finland
Pain in limb
1.3
8.5
895
7209
N03AD01
ATC
ethosuximide; oral
9.1
8.5
17
18
3170A
ICD-9 Finland
Mild mental retardation[LIEVÄ ÄLYLL.KEHITYSVAMMAISUUS,EI KÄYTÄYTYM.HÄIRIÖTÄ]
48.3
8.5
10
*
301
Kela drug reimbursment
Growth hormone
3.8
8.5
25
63
SPF10
NOMESCO Finland
Demanding reparation of dental prosthesis
3.8
8.5
25
63
G81.1
ICD-10 Finland
Spastic hemiplegia
13.5
8.5
14
10
A02BC02
ATC
pantoprazole; systemic
1.3
8.5
1190
9940
SPA60
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 1 to 3 units
3.7
8.4
26
68
D09
ICPC
Nausea
1.6
8.4
212
1337
F20
ICD-10 Finland
Schizophrenia
4.1
8.4
23
55
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.8
8.4
113
601
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.4
8.4
491
3639
F21
ICD-10 Finland
Schizotypal disorder
4.2
8.4
22
51
H61.2
ICD-10 Finland
Impacted cerumen
1.7
8.4
142
810
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
4.3
8.4
21
47
ZXY02
NOMESCO Finland
Neuropsychologist
4.5
8.4
20
43
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
3.2
8.3
32
97
IER01
NOMESCO Finland
Psychoeducation, group
2.7
8.3
42
149
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.0
8.3
85
412
SPAT1254
SPAT
Administration of medicine
1.4
8.3
429
3115
D10
ICPC
Vomiting
1.5
8.3
255
1680
R50.9
ICD-10 Finland
Fever, unspecified
1.4
8.3
423
3065
N05AE04
ATC
ziprasidone; systemic
3.9
8.3
24
60
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
3.7
8.3
26
69
78151
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Aphasia
+∞
8.2
8
*
30610
ICD-8 Finland
Special symptoms not elsewhere classified, Specific learning disturbance
+∞
8.2
8
*
F92.0
ICD-10 Finland
Depressive conduct disorder
3.2
8.2
31
93
S06.0
ICD-10 Finland
Concussion
1.5
8.2
314
2162
RT250, ,
NOMESCO Finland
4.8
8.2
18
36
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.4
8.2
55
225
E34.35
ICD-10 Finland
Abnormal growth retardation
2.5
8.2
49
190
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
3.4
8.1
28
79
R4130, ,
SPAT
4.6
8.1
19
40
IEP02
NOMESCO Finland
Child-centred family therapy
2.6
8.1
44
162
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
3.0
8.1
34
109
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
9.1
8.1
16
17
DFE00
NOMESCO Finland
Insertion of cochlear implant
9.1
8.1
16
17
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
8.0
159
945
Z08
ICPC
Social welfare problem
2.9
8.0
37
125
KMAK, ,
NOMESCO Finland
1.3
8.0
1046
8643
N05AX13
ATC
paliperidone; systemic
3.7
8.0
25
66
WYA20
NOMESCO Finland
Home visit
2.6
8.0
43
158
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.1
8.0
73
340
H52.0
ICD-10 Finland
Hypermetropia
2.1
8.0
77
366
E34.31
ICD-10 Finland
Short stature, prenatal disorder
4.7
7.9
18
37
SFA30
NOMESCO Finland
Three-surface restoration
1.3
7.9
733
5799
R52.9
ICD-10 Finland
Pain, unspecified
1.5
7.9
221
1427
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
3.4
7.9
27
76
SPAT1240
SPAT
Therapeutic discussion
1.4
7.9
327
2285
N06AX26
ATC
vortioxetine; oral
1.5
7.9
222
1436
J21.90
ICD-10 Finland
Acute obstructive bronchitis in children
2.2
7.9
66
297
B01AA03
ATC
warfarin; systemic
1.5
7.8
228
1486
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
6.6
7.8
19
28
A98
ICPC
Health maint/preventive medicine
2.0
7.8
2643
24806
N03AX16
ATC
[U] pregabalin
1.4
7.8
322
2249
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
7.8
458
3395
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
4.1
7.7
21
50
Z00.1
ICD-10 Finland
Routine child health examination
1.4
7.7
475
3544
A11CC03
ATC
alfacalcidol; systemic
2.4
7.7
51
207
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
2.9
7.7
34
112
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.0
7.7
76
364
ICB01, ,
SPAT
2.8
7.7
37
128
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
4.2
7.7
20
46
OAA40, ,
SPAT
1.5
7.7
251
1675
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.2
7.7
59
256
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.5
7.7
214
1381
G04BD12
ATC
mirabegron; oral
1.7
7.7
153
912
R20.2
ICD-10 Finland
Paraesthesia of skin
1.7
7.6
140
816
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
10.4
7.6
14
13
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
8.2
7.6
16
19
RS312, ,
NOMESCO Finland
9.1
7.6
15
16
N05CF01
ATC
zopiclone; oral
1.4
7.6
464
3460
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
4.0
7.5
21
51
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
7.5
159
962
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
7.5
738
5877
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
2.0
7.5
81
401
N01
ICPC
Headache
1.3
7.5
508
3845
N07BB01
ATC
disulfiram; oral
2.1
7.5
72
342
ZXD20
NOMESCO Finland
Day surgery
1.5
7.4
223
1462
RS221, ,
NOMESCO Finland
2.4
7.4
48
193
N05AX15
ATC
cariprazine; oral
3.6
7.4
24
65
OAA62, ,
SPAT
0.6
7.4
158
2343
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.9
7.4
92
478
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
2.5
7.4
45
176
R06.0
ICD-10 Finland
Dyspnoea
1.3
7.4
477
3585
D06
ICPC
Abdominal pain localized other
1.5
7.4
229
1513
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
3.9
7.4
21
52
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
3.9
7.4
21
52
P06
ICPC
Sleep disturbance
1.4
7.4
314
2205
F90.8
ICD-10 Finland
Other hyperkinetic disorders
6.5
7.4
18
27
3459X
ICD-9 Finland
Epilepsy, unspecified
9.7
7.3
14
14
OAA52, ,
SPAT
9.7
7.3
14
14
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
9.7
7.3
14
14
H50.2
ICD-10 Finland
Vertical strabismus
3.7
7.3
23
61
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
3.7
7.3
23
61
SPAT1360
SPAT
Extensive global examination
1.7
7.3
125
715
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
7.3
1983
17759
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
3.3
7.3
27
80
3430A
ICD-9 Finland
Infantile cerebral palsy, Diplegic
77.4
7.3
8
*
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
4.0
7.3
20
48
H13
ICPC
Plugged feeling ear
1.4
7.3
355
2550
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
5.9
7.3
19
31
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
7.2
398
2916
SPAT1243
SPAT
Psychiatric/psychological examination
1.8
7.2
110
609
4122
FHL
Tympanostomy (tympanic tube)
1.9
7.2
93
489
H35.1
ICD-10 Finland
Retinopathy of prematurity
12.9
7.2
12
9
H53.4
ICD-10 Finland
Visual field defects
2.8
7.2
35
122
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.7
7.2
37
133
L04AA01
ATC
[U] ciclosporin
3.3
7.2
26
76
U08
ICPC
Urinary retention
3.0
7.2
31
101
C07AB07
ATC
bisoprolol; oral
1.3
7.2
642
5046
RT120, ,
NOMESCO Finland
6.2
7.2
18
28
J01DB01
ATC
cefalexin; oral
1.3
7.2
1974
17684
G40
ICD-10 Finland
Epilepsy
3.1
7.2
29
91
P03
ICPC
Feeling depressed
1.4
7.2
382
2786
EBA00
NOMESCO Finland
Extraction of tooth
1.3
7.2
1048
8745
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
1.8
7.1
103
561
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
4.0
7.1
20
49
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.2
7.1
1203
10200
7505
FHL
Funicular lysis and orchidopexy
3.7
7.1
22
58
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
3.7
7.1
22
58
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
15.2
7.1
11
7
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
15.2
7.1
11
7
R02
ICPC
Shortness of breath/dyspnoea
1.4
7.1
270
1858
P01
ICPC
Feeling anxious/nervous/tense
1.3
7.0
547
4219
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.8
7.0
102
557
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
7.0
176
1110
B03XA01
ATC
erythropoietin; parenteral
3.5
7.0
23
63
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.5
7.0
23
63
RK110, ,
NOMESCO Finland
3.5
7.0
23
63
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
3.8
7.0
21
54
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
3.8
7.0
21
54
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
19.3
7.0
10
5
E86
ICD-10 Finland
Volume depletion
2.4
7.0
46
187
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
1.9
7.0
78
392
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
3.3
6.9
25
73
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
6.9
1051
8795
P11
ICPC
Eating problem in child
3.9
6.9
20
50
SPA47
NOMESCO Finland
Precision impression for denture
2.6
6.9
39
147
Z25
ICPC
Assault/harmful event problem
2.6
6.9
39
147
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
3.6
6.9
22
59
K06.18
ICD-10 Finland
Another gingival hyperplasia
3.6
6.9
22
59
G81.9
ICD-10 Finland
Hemiplegia, unspecified
3.6
6.9
22
59
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
7.6
6.9
15
19
XKC03
NOMESCO Finland
Water cystometry
2.4
6.9
47
194
N05AE03
ATC
sertindole; oral
6.3
6.9
17
26
SJD40
NOMESCO Finland
Placement of prefabricated palatal or lingual arch
1.5
6.9
182
1162
RS230, ,
NOMESCO Finland
4.0
6.9
19
46
H29
ICPC
Ear symptom/complaint other
1.4
6.8
263
1812
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
3.7
6.8
21
55
127
Kela drug reimbursment
Transplant complication
2.4
6.8
46
189
H50.1
ICD-10 Finland
Divergent concomitant strabismus
2.9
6.8
30
99
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.3
6.8
47
195
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.7
6.8
111
627
ZXY49
NOMESCO Finland
Other health care provider
3.4
6.8
24
69
A10BJ05
ATC
dulaglutide; parenteral
3.0
6.8
29
94
XF606
NOMESCO Finland
Ortostatic test
4.3
6.8
17
38
N03AX22
ATC
perampanel; oral
6.7
6.8
16
23
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.8
6.8
107
599
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
2.8
6.8
32
110
F98.02
ICD-10 Finland
Non-organic nocturnal and diurnal enuresis
3.6
6.8
22
60
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
3.8
6.7
20
51
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
6.7
389
2871
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
6.7
324
2323
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
6.7
190
1231
RT130, ,
NOMESCO Finland
6.1
6.7
17
27
SPAT1262
SPAT
Handing over of treatment supplies
1.4
6.7
253
1737
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
2.7
6.7
35
127
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
6.7
139
839
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
3.1
6.7
27
85
RL720, ,
NOMESCO Finland
38.6
6.6
8
*
Q98.5
ICD-10 Finland
Karyotype 47,XYY
38.6
6.6
8
*
Z00.8
ICD-10 Finland
Other general examinations
1.5
6.6
209
1385
ZXY84
NOMESCO Finland
Occupational therapist in multidisciplinary team
8.0
6.6
14
17
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
4.1
6.6
18
43
SPAT1016
SPAT
Examination of vision
1.5
6.6
241
1644
ZXY54
NOMESCO Finland
2-person team, doctor-occupational therapist
16.1
6.6
10
6
F71.1
ICD-10 Finland
Moderate mental retardation, significant impairment of behaviour requiring attention or treatment
16.1
6.6
10
6
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
6.6
147
903
P15
ICPC
Chronic alcohol abuse
2.0
6.6
67
326
WZB00, ,
SPAT
0.7
6.6
258
3391
F34.1
ICD-10 Finland
Dysthymia
1.8
6.5
86
456
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
5.4
6.5
18
32
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
3.0
6.5
27
86
XKD00
NOMESCO Finland
Uroflowmetry
1.5
6.5
191
1247
N06AX22
ATC
agomelatine; oral
2.0
6.5
64
307
ZX121
NOMESCO Finland
Central venous catheter
3.6
6.5
21
57
G04BD11
ATC
fesoterodine; oral
2.7
6.5
34
124
KAY40, ,
NOMESCO Finland
0.5
6.5
76
1312
G47.3
ICD-10 Finland
Sleep apnoea
1.4
6.4
320
2306
RS210, ,
NOMESCO Finland
3.7
6.4
20
53
ZXC95
NOMESCO Finland
Use of surgical navigator
3.2
6.4
24
72
Z72.8
ICD-10 Finland
Other problems related to lifestyle
3.1
6.4
25
77
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.8
6.4
30
103
BC00A, ,
NOMESCO Finland
9.7
6.4
12
12
WX290, ,
SPAT
1.7
6.4
101
567
Z94.0
ICD-10 Finland
Kidney transplant status
2.6
6.4
34
125
R49.08
ICD-10 Finland
Other specified dysphonia
2.5
6.4
37
142
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.0
6.4
64
310
N03AX12
ATC
[U] gabapentin; oral
1.5
6.3
220
1487
Z01.2
ICD-10 Finland
Dental examination
1.2
6.3
1314
11335
P07.3
ICD-10 Finland
Other preterm infants
2.1
6.3
54
246
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
3.4
6.3
22
63
C09CA01
ATC
losartan; oral
1.4
6.3
301
2155
WX212
NOMESCO Finland
Femoral plexus blockade
2.3
6.3
44
184
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.4
6.3
42
172
E66.9
ICD-10 Finland
Obesity, unspecified
1.9
6.3
78
406
207
Kela drug reimbursment
Chronic arrhythmias
1.5
6.3
186
1217
K29
ICPC
Cardiovascular sympt/complt other
2.1
6.3
60
285
SPE02
NOMESCO Finland
Metal-framed partial denture
3.1
6.3
25
78
H65.2
ICD-10 Finland
Chronic serous otitis media
2.2
6.3
52
234
E66.01
ICD-10 Finland
Obesity due to excess calories
1.5
6.3
193
1274
Q93.8
ICD-10 Finland
Other deletions from the autosomes
13.8
6.3
10
7
WX702
NOMESCO Finland
Supraglottic ventilation device
1.7
6.2
100
563
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.2
6.2
51
228
B01AB05
ATC
enoxaparin; parenteral
1.3
6.2
430
3257
F61.0
ICD-10 Finland
Mixed personality disorders
2.4
6.2
39
155
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
6.2
423
3197
RS110, ,
NOMESCO Finland
5.5
6.2
17
30
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.5
6.2
202
1347
R2110
NOMESCO Finland
Giving the first information
1.7
6.2
108
622
XF402
NOMESCO Finland
ECG with work load test
1.6
6.2
137
839
Q21.10
ICD-10 Finland
Persistent ostium secundum
2.5
6.2
37
144
SDA03
NOMESCO Finland
Periodontal treatment
1.2
6.2
902
7493
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.6
6.2
34
127
SPAT1172
SPAT
Guidance concerning hydration
2.6
6.2
34
127
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
2.9
6.2
27
89
R05
ICPC
Cough
1.3
6.2
617
4908
F84.11
ICD-10 Finland
Autism with atypical symptoms
+∞
6.2
6
*
SFA10
NOMESCO Finland
One-surface restoration
1.2
6.2
1426
12424
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.3
6.2
22
64
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
3.3
6.2
22
64
UKC02
NOMESCO Finland
Cystoscopy
1.5
6.1
203
1359
A01
ICPC
Pain general/multiple sites
1.5
6.1
194
1287
S10
ICPC
Boil/carbuncle
1.6
6.1
127
766
IEP01
NOMESCO Finland
Psychoeducation, family
3.1
6.1
24
74
E87.5
ICD-10 Finland
Hyperkalaemia
2.8
6.1
29
100
RS121, ,
NOMESCO Finland
2.8
6.1
29
100
H53.2
ICD-10 Finland
Diplopia
2.1
6.1
56
262
DFF15
NOMESCO Finland
Speech audiometry
2.0
6.1
66
328
34408
ICD-8 Finland
Other cerebral paralysis, Alia definita
25.8
6.1
8
*
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
1.7
6.1
97
545
R07.3
ICD-10 Finland
Other chest pain
1.5
6.1
182
1194
N03AG04
ATC
vigabatrin; oral
5.3
6.1
17
31
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
5.3
6.1
17
31
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.3
6.1
42
175
S20.2
ICD-10 Finland
Contusion of thorax
1.7
6.1
100
568
WX725
NOMESCO Finland
Noninvasive ventilation
1.7
6.0
98
554
C03DA01
ATC
spironolactone; oral
1.5
6.0
169
1094
W10
ICD-10 Finland
Fall on and from stairs and steps
1.7
6.0
102
584
EB1AA, ,
SPAT
1.6
6.0
133
816

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Speech therapy
R4130 [2001310235]
2.0e+00
2.3e+00
2.9e+00
1.0e+50
3.9e+00
2.9e+00
2.7e+00
cases:1.69%
controls:0.23%
cases:1.56%
controls:0.17%
cases:0.54%
controls:0.03%
cases:1.50%
controls:0.00%
cases:1.35%
controls:0.03%
cases:3.28%
controls:0.18%
cases:5.52%
controls:0.37%
31
39
1806
17190
29
29
1832
17404
10
5
1851
17428
28
0
1833
17433
25
5
1831
17387
58
30
1708
16827
80
52
1370
13903
Delayed milestone
R62.0 [45597195]
1.7e+00
2.8e+00
3.7e+00
—
—
3.4e+00
3.2e+00
cases:3.59%
controls:0.70%
cases:3.39%
controls:0.22%
cases:1.13%
controls:0.03%
—
—
—
—
cases:1.59%
controls:0.05%
cases:1.24%
controls:0.05%
66
121
1771
17108
63
38
1798
17395
21
5
1840
17428
—
—
28
9
1738
16848
18
7
1432
13948
Transient cerebral ischaemic attack, unspecified
G45.9 [45542892]
1.3e+00
2.1e+00
3.1e+00
—
3.8e+00
2.1e+00
1.3e+00
cases:2.94%
controls:0.82%
cases:1.93%
controls:0.25%
cases:0.97%
controls:0.05%
—
—
cases:1.83%
controls:0.04%
cases:2.72%
controls:0.33%
cases:2.34%
controls:0.67%
54
141
1783
17088
36
43
1825
17390
18
8
1843
17425
—
34
7
1822
17385
48
56
1718
16801
34
94
1416
13861
Psychologist
Z2445 [2001311558]
8.8e-01
1.6e+00
2.9e+00
1.0e+50
2.8e+00
2.2e+00
2.9e+00
cases:1.91%
controls:0.80%
cases:1.24%
controls:0.25%
cases:0.86%
controls:0.05%
cases:0.59%
controls:0.00%
cases:0.65%
controls:0.04%
cases:1.81%
controls:0.20%
cases:4.14%
controls:0.23%
35
138
1802
17091
23
44
1838
17389
16
8
1845
17425
11
0
1850
17433
12
7
1844
17385
32
34
1734
16823
60
32
1390
13923
Cerebral infarction, unspecified
I63.9 [45596216]
1.1e+00
1.9e+00
2.9e+00
—
4.0e+00
2.1e+00
1.2e+00
cases:3.27%
controls:1.09%
cases:2.26%
controls:0.36%
cases:0.86%
controls:0.05%
—
—
cases:2.10%
controls:0.04%
cases:2.66%
controls:0.34%
cases:2.97%
controls:0.90%
60
187
1777
17042
42
63
1819
17370
16
8
1845
17425
—
39
7
1817
17385
47
57
1719
16800
43
126
1407
13829
Paediatric neurology
421 [44777781]
1.1e+00
1.6e+00
2.6e+00
—
3.2e+00
2.3e+00
2.1e+00
cases:8.87%
controls:3.29%
cases:8.76%
controls:1.99%
cases:3.92%
controls:0.31%
—
—
cases:8.08%
controls:0.37%
cases:14.10%
controls:1.58%
cases:20.48%
controls:2.95%
163
566
1674
16663
163
347
1698
17086
73
54
1788
17379
—
150
65
1706
17327
249
267
1517
16590
297
411
1153
13544
Physiotherapist
Z3226 [2001311560]
8.4e-01
1.2e+00
2.3e+00
—
2.6e+00
2.4e+00
2.1e+00
cases:6.97%
controls:3.14%
cases:2.74%
controls:0.85%
cases:1.02%
controls:0.10%
—
—
cases:1.45%
controls:0.11%
cases:4.25%
controls:0.39%
cases:5.31%
controls:0.67%
128
541
1709
16688
51
149
1810
17284
19
18
1842
17415
—
27
19
1829
17373
75
65
1691
16792
77
94
1373
13861
Emergency Room Visit
ER [9203]
2.2e-01
6.2e-01
1.3e+00
6.4e+00
1.8e+00
6.0e-01
4.5e-01
cases:40.45%
controls:35.20%
cases:20.10%
controls:11.93%
cases:5.32%
controls:1.44%
cases:17.84%
controls:0.03%
cases:7.00%
controls:1.27%
cases:16.99%
controls:10.10%
cases:33.72%
controls:24.49%
743
6065
1094
11164
374
2079
1487
15354
99
251
1762
17182
332
6
1529
17427
130
221
1726
17171
300
1703
1466
15154
489
3418
961
10537
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
3.4e-01
7.1e-01
1.3e+00
5.9e+00
2.1e+00
7.5e-01
2.5e-01
cases:22.48%
controls:17.05%
cases:14.99%
controls:7.95%
cases:4.62%
controls:1.27%
cases:17.68%
controls:0.06%
cases:9.11%
controls:1.20%
cases:13.87%
controls:7.10%
cases:19.17%
controls:15.54%
413
2937
1424
14292
279
1386
1582
16047
86
221
1775
17212
329
10
1532
17423
169
209
1687
17183
245
1197
1521
15660
278
2168
1172
11787
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
3.2e-01
7.1e-01
1.4e+00
5.1e+00
2.5e+00
8.7e-01
3.7e-01
cases:10.07%
controls:7.51%
cases:7.15%
controls:3.65%
cases:2.36%
controls:0.62%
cases:6.13%
controls:0.04%
cases:6.47%
controls:0.55%
cases:6.46%
controls:2.81%
cases:8.97%
controls:6.36%
185
1294
1652
15935
133
637
1728
16796
44
108
1817
17325
114
7
1747
17426
120
95
1736
17297
114
474
1652
16383
130
888
1320
13067
Evaluation of communicative skills
R1260 [2001310179]
2.0e+00
2.5e+00
1.0e+50
1.0e+50
—
3.3e+00
3.3e+00
cases:1.09%
controls:0.15%
cases:0.70%
controls:0.06%
cases:0.27%
controls:0.00%
cases:0.43%
controls:0.00%
—
—
cases:0.79%
controls:0.03%
cases:1.17%
controls:0.04%
20
25
1817
17204
13
10
1848
17423
5
0
1856
17433
8
0
1853
17433
—
14
5
1752
16852
17
6
1433
13949
Disturbance of activity and attention
F90.0 [45542870]
1.2e+00
1.7e+00
1.6e+00
—
2.6e+00
2.1e+00
1.8e+00
cases:0.93%
controls:0.28%
cases:1.34%
controls:0.26%
cases:0.43%
controls:0.09%
—
—
cases:1.35%
controls:0.10%
cases:2.72%
controls:0.36%
cases:6.28%
controls:1.10%
17
49
1820
17180
25
45
1836
17388
8
15
1853
17418
—
25
17
1831
17375
48
60
1718
16797
91
153
1359
13802
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.1e+00
1.4e+00
2.9e+00
—
2.4e+00
1.5e+00
1.4e+00
cases:3.05%
controls:0.99%
cases:1.24%
controls:0.32%
cases:0.64%
controls:0.03%
—
—
cases:0.65%
controls:0.06%
cases:1.42%
controls:0.31%
cases:3.03%
controls:0.74%
56
170
1781
17059
23
56
1838
17377
12
6
1849
17427
—
12
10
1844
17382
25
53
1741
16804
44
103
1406
13852
Neurology
13 [38004458]
8.3e-01
1.5e+00
2.2e+00
—
3.0e+00
2.0e+00
1.1e+00
cases:15.13%
controls:7.22%
cases:11.66%
controls:2.93%
cases:5.16%
controls:0.58%
—
—
cases:12.77%
controls:0.71%
cases:19.37%
controls:3.11%
cases:16.41%
controls:6.23%
278
1244
1559
15985
217
511
1644
16922
96
101
1765
17332
—
237
123
1619
17269
342
524
1424
16333
238
870
1212
13085
levetiracetam; oral, parenteral
N03AX14 [21604436]
1.0e+00
1.5e+00
1.7e+00
—
2.5e+00
2.0e+00
1.9e+00
cases:1.31%
controls:0.46%
cases:1.45%
controls:0.33%
cases:0.75%
controls:0.14%
—
—
cases:1.51%
controls:0.13%
cases:2.77%
controls:0.39%
cases:2.69%
controls:0.40%
24
80
1813
17149
27
58
1834
17375
14
24
1847
17409
—
28
22
1828
17370
49
65
1717
16792
39
56
1411
13899
Child behaviour symptom/complaint
P22 [2002000817]
1.6e+00
2.2e+00
2.8e+00
—
2.9e+00
1.2e+00
5.3e-01
cases:2.34%
controls:0.47%
cases:2.74%
controls:0.33%
cases:1.07%
controls:0.07%
—
—
cases:0.70%
controls:0.04%
cases:1.47%
controls:0.46%
cases:1.79%
controls:1.06%
43
81
1794
17148
51
57
1810
17376
20
12
1841
17421
—
13
7
1843
17385
26
77
1740
16780
26
148
1424
13807
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.29 [2000502142]
1.3e+00
1.5e+00
—
1.0e+50
3.2e+00
2.4e+00
2.1e+00
cases:0.76%
controls:0.21%
cases:0.64%
controls:0.14%
—
—
cases:0.38%
controls:0.00%
cases:0.86%
controls:0.03%
cases:1.30%
controls:0.12%
cases:1.72%
controls:0.21%
14
36
1823
17193
12
25
1849
17408
—
7
0
1854
17433
16
6
1840
17386
23
20
1743
16837
25
29
1425
13926
Social worker
Z2446 [2001311559]
8.8e-01
1.0e+00
1.8e+00
1.0e+50
2.4e+00
2.0e+00
2.4e+00
cases:4.19%
controls:1.79%
cases:1.34%
controls:0.49%
cases:0.54%
controls:0.09%
cases:0.38%
controls:0.00%
cases:0.43%
controls:0.04%
cases:1.36%
controls:0.18%
cases:2.97%
controls:0.28%
77
308
1760
16921
25
86
1836
17347
10
15
1851
17418
7
0
1854
17433
8
7
1848
17385
24
31
1742
16826
43
39
1407
13916
Emergency Medicine
93 [38004510]
1.7e-01
6.3e-01
1.5e+00
6.3e+00
1.3e+00
6.6e-01
1.9e-01
cases:19.98%
controls:17.34%
cases:16.50%
controls:9.50%
cases:5.91%
controls:1.39%
cases:21.82%
controls:0.05%
cases:5.17%
controls:1.49%
cases:17.10%
controls:9.63%
cases:25.86%
controls:22.41%
367
2987
1470
14242
307
1657
1554
15776
110
242
1751
17191
406
9
1455
17424
96
260
1760
17132
302
1624
1464
15233
375
3127
1075
10828
oxcarbazepine; oral
N03AF02 [21604418]
1.5e+00
1.4e+00
1.9e+00
—
2.0e+00
1.7e+00
1.7e+00
cases:1.58%
controls:0.37%
cases:1.24%
controls:0.30%
cases:0.54%
controls:0.08%
—
—
cases:0.75%
controls:0.10%
cases:2.04%
controls:0.36%
cases:2.76%
controls:0.49%
29
63
1808
17166
23
53
1838
17380
10
14
1851
17419
—
14
18
1842
17374
36
61
1730
16796
40
69
1410
13886
Sequelae of cerebral infarction
I69.3 [45533476]
1.3e+00
1.3e+00
1.5e+00
—
2.8e+00
1.9e+00
1.4e+00
cases:2.99%
controls:0.85%
cases:2.15%
controls:0.57%
cases:0.59%
controls:0.13%
—
—
cases:1.99%
controls:0.13%
cases:3.62%
controls:0.58%
cases:4.48%
controls:1.13%
55
147
1782
17082
40
99
1821
17334
11
22
1850
17411
—
37
22
1819
17370
64
98
1702
16759
65
157
1385
13798
Otolaryngology
4 [38004449]
3.2e-01
5.6e-01
9.7e-01
5.1e+00
1.6e+00
9.0e-01
7.0e-01
cases:20.52%
controls:15.78%
cases:9.51%
controls:5.64%
cases:2.42%
controls:0.94%
cases:4.51%
controls:0.03%
cases:5.06%
controls:1.06%
cases:12.00%
controls:5.25%
cases:21.31%
controls:11.82%
377
2718
1460
14511
177
984
1684
16449
45
163
1816
17270
84
5
1777
17428
94
184
1762
17208
212
885
1554
15972
309
1650
1141
12305
INR in Blood by Coagulation assay
34714-6 [3032080]
4.1e-01
7.1e-01
1.0e+00
5.2e+00
1.4e+00
7.7e-01
2.8e-01
cases:18.24%
controls:12.90%
cases:12.57%
controls:6.61%
cases:5.53%
controls:2.12%
cases:16.23%
controls:0.11%
cases:7.60%
controls:1.99%
cases:12.06%
controls:5.99%
cases:14.14%
controls:11.05%
335
2222
1502
15007
234
1153
1627
16280
103
369
1758
17064
302
19
1559
17414
141
346
1715
17046
213
1009
1553
15848
205
1542
1245
12413
Occupational therapy
R4120 [2001310234]
1.2e+00
1.6e+00
2.5e+00
1.0e+50
—
2.4e+00
2.0e+00
cases:2.23%
controls:0.71%
cases:1.67%
controls:0.33%
cases:0.64%
controls:0.05%
cases:1.29%
controls:0.00%
—
—
cases:2.21%
controls:0.21%
cases:4.62%
controls:0.67%
41
122
1796
17107
31
57
1830
17376
12
9
1849
17424
24
0
1837
17433
—
39
35
1727
16822
67
93
1383
13862
Internal Medicine
11 [38004456]
3.0e-01
6.6e-01
1.5e+00
5.2e+00
1.4e+00
5.8e-01
1.4e-01
cases:19.11%
controls:14.83%
cases:10.37%
controls:5.66%
cases:3.33%
controls:0.78%
cases:7.74%
controls:0.05%
cases:3.72%
controls:0.93%
cases:9.51%
controls:5.55%
cases:14.28%
controls:12.60%
351
2555
1486
14674
193
986
1668
16447
62
136
1799
17297
144
8
1717
17425
69
161
1787
17231
168
936
1598
15921
207
1759
1243
12196
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
6.4e-01
1.1e+00
2.3e+00
—
3.6e+00
1.2e+00
5.5e-01
cases:11.81%
controls:6.61%
cases:7.52%
controls:2.56%
cases:3.22%
controls:0.33%
—
—
cases:9.11%
controls:0.26%
cases:7.25%
controls:2.29%
cases:10.21%
controls:6.17%
217
1138
1620
16091
140
447
1721
16986
60
57
1801
17376
—
169
46
1687
17346
128
386
1638
16471
148
861
1302
13094
Psychiatry
26 [38004469]
1.1e+00
1.6e+00
1.7e+00
—
2.0e+00
1.7e+00
1.4e+00
cases:8.60%
controls:3.04%
cases:6.72%
controls:1.43%
cases:2.74%
controls:0.52%
—
—
cases:3.56%
controls:0.51%
cases:7.19%
controls:1.43%
cases:9.86%
controls:2.74%
158
523
1679
16706
125
249
1736
17184
51
91
1810
17342
—
66
89
1790
17303
127
241
1639
16616
143
382
1307
13573
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
5.6e-01
1.0e+00
1.9e+00
—
3.4e+00
1.4e+00
8.9e-01
cases:3.16%
controls:1.83%
cases:1.40%
controls:0.52%
cases:0.54%
controls:0.08%
—
—
cases:1.02%
controls:0.03%
cases:1.76%
controls:0.44%
cases:2.00%
controls:0.83%
58
316
1779
16913
26
90
1835
17343
10
14
1851
17419
—
19
6
1837
17386
31
75
1735
16782
29
116
1421
13839
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.2e+00
1.6e+00
1.9e+00
—
1.7e+00
1.5e+00
1.2e+00
cases:3.48%
controls:1.09%
cases:2.53%
controls:0.53%
cases:0.91%
controls:0.13%
—
—
cases:0.54%
controls:0.10%
cases:2.43%
controls:0.53%
cases:5.45%
controls:1.79%
64
188
1773
17041
47
92
1814
17341
17
23
1844
17410
—
10
17
1846
17375
43
89
1723
16768
79
250
1371
13705
Neuropsychological investigation
XA800 [2001300412]
1.6e+00
2.0e+00
—
1.0e+50
—
2.7e+00
2.8e+00
cases:1.91%
controls:0.41%
cases:1.18%
controls:0.16%
—
—
cases:0.43%
controls:0.00%
—
—
cases:2.72%
controls:0.20%
cases:5.24%
controls:0.33%
35
70
1802
17159
22
28
1839
17405
—
8
0
1853
17433
—
48
33
1718
16824
76
46
1374
13909
Audiology
64 [38004489]
4.6e-01
8.5e-01
1.2e+00
—
2.9e+00
2.0e+00
1.5e+00
cases:5.77%
controls:3.74%
cases:4.03%
controls:1.77%
cases:1.02%
controls:0.30%
—
—
cases:5.17%
controls:0.29%
cases:11.27%
controls:1.74%
cases:13.93%
controls:3.45%
106
644
1731
16585
75
308
1786
17125
19
52
1842
17381
—
96
51
1760
17341
199
293
1567
16564
202
482
1248
13473
Osmolality of Urine
2695-5 [3026782]
3.2e-01
6.3e-01
1.5e+00
3.9e+00
1.9e+00
6.1e-01
3.3e-01
cases:8.76%
controls:6.54%
cases:4.62%
controls:2.52%
cases:1.34%
controls:0.30%
cases:1.45%
controls:0.03%
cases:1.94%
controls:0.29%
cases:3.51%
controls:1.93%
cases:5.24%
controls:3.81%
161
1126
1676
16103
86
440
1775
16993
25
52
1836
17381
27
5
1834
17428
36
51
1820
17341
62
326
1704
16531
76
532
1374
13423
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
7.7e-01
9.0e-01
2.2e+00
1.0e+50
2.6e+00
1.6e+00
8.0e-01
cases:2.61%
controls:1.22%
cases:1.24%
controls:0.50%
cases:0.59%
controls:0.06%
cases:1.07%
controls:0.00%
cases:0.59%
controls:0.05%
cases:2.32%
controls:0.48%
cases:3.17%
controls:1.45%
48
211
1789
17018
23
88
1838
17345
11
11
1850
17422
20
0
1841
17433
11
8
1845
17384
41
81
1725
16776
46
203
1404
13752
methylphenidate; oral
N06BA04 [21604757]
1.1e+00
1.1e+00
1.7e+00
—
1.7e+00
1.6e+00
1.6e+00
cases:0.82%
controls:0.28%
cases:0.86%
controls:0.29%
cases:0.64%
controls:0.11%
—
—
cases:0.75%
controls:0.13%
cases:1.76%
controls:0.36%
cases:4.97%
controls:1.00%
15
49
1822
17180
16
51
1845
17382
12
20
1849
17413
—
14
23
1842
17369
31
61
1735
16796
72
139
1378
13816
Speech therapy
Z50.5 [45547321]
2.1e+00
2.4e+00
—
1.0e+50
—
2.5e+00
1.7e+00
cases:1.96%
controls:0.24%
cases:2.15%
controls:0.19%
—
—
cases:0.32%
controls:0.00%
—
—
cases:1.76%
controls:0.14%
cases:1.86%
controls:0.35%
36
42
1801
17187
40
33
1821
17400
—
6
0
1855
17433
—
31
24
1735
16833
27
49
1423
13906
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
7.6e-01
1.4e+00
1.8e+00
—
2.0e+00
1.6e+00
1.2e+00
cases:4.19%
controls:2.01%
cases:4.46%
controls:1.14%
cases:2.04%
controls:0.36%
—
—
cases:2.42%
controls:0.34%
cases:6.12%
controls:1.28%
cases:10.62%
controls:3.48%
77
347
1760
16882
83
198
1778
17235
38
62
1823
17371
—
45
59
1811
17333
108
216
1658
16641
154
486
1296
13469
Inpatient Hospital
21 [8717]
1.6e-01
3.1e-01
9.1e-01
4.6e+00
1.7e+00
7.4e-01
3.6e-01
cases:38.27%
controls:34.56%
cases:14.02%
controls:10.65%
cases:3.49%
controls:1.43%
cases:9.08%
controls:0.10%
cases:7.76%
controls:1.45%
cases:15.40%
controls:7.96%
cases:24.62%
controls:18.56%
703
5954
1134
11275
261
1856
1600
15577
65
250
1796
17183
169
17
1692
17416
144
253
1712
17139
272
1342
1494
15515
357
2590
1093
11365
Bacteria identified in Urine by Culture
630-4 [3026008]
3.4e-01
5.3e-01
1.4e+00
3.9e+00
1.6e+00
5.3e-01
3.9e-01
cases:10.83%
controls:7.97%
cases:6.02%
controls:3.64%
cases:2.04%
controls:0.50%
cases:1.61%
controls:0.03%
cases:2.69%
controls:0.57%
cases:6.63%
controls:3.99%
cases:11.93%
controls:8.41%
199
1374
1638
15855
112
634
1749
16799
38
87
1823
17346
30
6
1831
17427
50
100
1806
17292
117
673
1649
16184
173
1174
1277
12781
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.2e-01
3.8e-01
1.1e+00
4.9e+00
1.8e+00
4.3e-01
7.0e-02
cases:38.27%
controls:35.41%
cases:28.96%
controls:21.79%
cases:11.88%
controls:4.35%
cases:28.10%
controls:0.29%
cases:21.66%
controls:4.35%
cases:27.86%
controls:20.13%
cases:35.24%
controls:33.67%
703
6100
1134
11129
539
3799
1322
13634
221
758
1640
16675
523
51
1338
17382
402
756
1454
16636
492
3393
1274
13464
511
4698
939
9257
Neurosurgery
14 [38004459]
9.1e-01
1.1e+00
1.5e+00
—
2.7e+00
1.5e+00
9.2e-01
cases:4.52%
controls:1.87%
cases:2.15%
controls:0.75%
cases:0.75%
controls:0.17%
—
—
cases:1.78%
controls:0.13%
cases:3.34%
controls:0.74%
cases:3.45%
controls:1.40%
83
322
1754
16907
40
130
1821
17303
14
30
1847
17403
—
33
22
1823
17370
59
124
1707
16733
50
195
1400
13760
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
5.1e-01
8.7e-01
1.4e+00
3.8e+00
2.1e+00
4.8e-01
3.6e-01
cases:3.97%
controls:2.42%
cases:2.74%
controls:1.17%
cases:0.75%
controls:0.20%
cases:1.50%
controls:0.03%
cases:1.24%
controls:0.16%
cases:2.10%
controls:1.31%
cases:5.03%
controls:3.56%
73
417
1764
16812
51
204
1810
17229
14
34
1847
17399
28
6
1833
17427
23
28
1833
17364
37
221
1729
16636
73
497
1377
13458
Carotid artery syndrome (hemispheric)
G45.1 [45576586]
1.7e+00
2.1e+00
—
1.0e+50
—
2.9e+00
1.9e+00
cases:1.69%
controls:0.31%
cases:0.86%
controls:0.10%
—
—
cases:2.10%
controls:0.00%
—
—
cases:1.36%
controls:0.08%
cases:1.45%
controls:0.23%
31
54
1806
17175
16
18
1845
17415
—
39
0
1822
17433
—
24
13
1742
16844
21
32
1429
13923
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2.7e-01
5.8e-01
9.0e-01
3.8e+00
2.5e+00
5.2e-01
1.1e-01
cases:18.40%
controls:14.63%
cases:11.18%
controls:6.60%
cases:2.15%
controls:0.88%
cases:1.72%
controls:0.04%
cases:8.73%
controls:0.80%
cases:9.85%
controls:6.12%
cases:15.93%
controls:14.51%
338
2521
1499
14708
208
1150
1653
16283
40
154
1821
17279
32
7
1829
17426
162
140
1694
17252
174
1031
1592
15826
231
2025
1219
11930
Hospital outpatient
ZY010 [2001311599]
6.3e-01
1.1e+00
1.8e+00
1.0e+50
1.7e+00
1.6e+00
1.8e+00
cases:1.91%
controls:1.02%
cases:1.13%
controls:0.38%
cases:0.54%
controls:0.09%
cases:0.43%
controls:0.00%
cases:0.48%
controls:0.09%
cases:1.13%
controls:0.24%
cases:1.93%
controls:0.34%
35
176
1802
17053
21
66
1840
17367
10
16
1851
17417
8
0
1853
17433
9
16
1847
17376
20
40
1746
16817
28
47
1422
13908
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
6.7e-01
1.6e+00
2.8e+00
1.0e+50
2.7e+00
1.4e+00
7.5e-01
cases:1.20%
controls:0.62%
cases:1.07%
controls:0.23%
cases:0.48%
controls:0.03%
cases:0.54%
controls:0.00%
cases:0.59%
controls:0.04%
cases:1.02%
controls:0.26%
cases:1.59%
controls:0.75%
22
106
1815
17123
20
40
1841
17393
9
5
1852
17428
10
0
1851
17433
11
7
1845
17385
18
43
1748
16814
23
105
1427
13850
Valproate [Moles/volume] in Serum or Plasma
14946-8 [3009466]
9.5e-01
1.3e+00
—
—
3.3e+00
1.5e+00
1.4e+00
cases:1.25%
controls:0.49%
cases:0.97%
controls:0.28%
—
—
—
—
cases:0.81%
controls:0.03%
cases:1.25%
controls:0.28%
cases:1.86%
controls:0.47%
23
84
1814
17145
18
48
1843
17385
—
—
15
5
1841
17387
22
48
1744
16809
27
65
1423
13890
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
9.1e-01
1.4e+00
2.0e+00
1.0e+50
1.7e+00
1.6e+00
9.2e-01
cases:1.20%
controls:0.49%
cases:0.86%
controls:0.22%
cases:0.48%
controls:0.07%
cases:0.38%
controls:0.00%
cases:0.48%
controls:0.09%
cases:1.08%
controls:0.23%
cases:1.79%
controls:0.72%
22
84
1815
17145
16
39
1845
17394
9
12
1852
17421
7
0
1854
17433
9
15
1847
17377
19
38
1747
16819
26
101
1424
13854
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
3.5e-01
5.9e-01
8.5e-01
3.8e+00
1.6e+00
6.1e-01
2.7e-01
cases:21.34%
controls:16.07%
cases:14.40%
controls:8.52%
cases:3.65%
controls:1.59%
cases:3.76%
controls:0.09%
cases:6.68%
controls:1.36%
cases:13.19%
controls:7.64%
cases:18.76%
controls:14.96%
392
2769
1445
14460
268
1485
1593
15948
68
277
1793
17156
70
15
1791
17418
124
237
1732
17155
233
1288
1533
15569
272
2088
1178
11867
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
2.1e-01
4.3e-01
1.1e+00
4.1e+00
1.4e+00
5.7e-01
2.8e-01
cases:23.52%
controls:19.91%
cases:14.56%
controls:9.99%
cases:4.41%
controls:1.50%
cases:4.73%
controls:0.08%
cases:5.55%
controls:1.45%
cases:15.12%
controls:9.15%
cases:22.28%
controls:17.78%
432
3431
1405
13798
271
1742
1590
15691
82
262
1779
17171
88
14
1773
17419
103
252
1753
17140
267
1542
1499
15315
323
2481
1127
11474
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
1.6e+00
2.7e+00
—
—
—
1.8e+00
1.9e+00
cases:1.25%
controls:0.24%
cases:1.24%
controls:0.08%
—
—
—
—
—
—
cases:0.57%
controls:0.09%
cases:1.59%
controls:0.24%
23
42
1814
17187
23
14
1838
17419
—
—
—
10
16
1756
16841
23
34
1427
13921
Atrial fibrillation and flutter
I48 [45596206]
3.3e-01
4.5e-01
9.0e-01
3.9e+00
1.5e+00
6.0e-01
3.9e-01
cases:7.62%
controls:5.62%
cases:4.67%
controls:3.02%
cases:1.50%
controls:0.62%
cases:1.93%
controls:0.04%
cases:2.42%
controls:0.55%
cases:4.81%
controls:2.69%
cases:6.76%
controls:4.69%
140
969
1697
16260
87
527
1774
16906
28
108
1833
17325
36
7
1825
17426
45
96
1811
17296
85
454
1681
16403
98
655
1352
13300
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.0e-01
2.8e-01
9.3e-01
4.7e+00
1.7e+00
3.4e-01
-1.5e-02
cases:39.90%
controls:37.43%
cases:33.69%
controls:27.65%
cases:13.22%
controls:5.66%
cases:28.48%
controls:0.34%
cases:23.71%
controls:5.45%
cases:33.30%
controls:26.29%
cases:35.66%
controls:36.01%
733
6449
1104
10780
627
4820
1234
12613
246
986
1615
16447
530
60
1331
17373
440
948
1416
16444
588
4431
1178
12426
517
5025
933
8930
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
5.8e-01
1.3e+00
2.4e+00
—
3.5e+00
7.8e-01
6.7e-01
cases:1.25%
controls:0.71%
cases:1.24%
controls:0.33%
cases:0.64%
controls:0.06%
—
—
cases:1.13%
controls:0.03%
cases:1.02%
controls:0.47%
cases:2.41%
controls:1.25%
23
122
1814
17107
23
57
1838
17376
12
10
1849
17423
—
21
6
1835
17386
18
79
1748
16778
35
175
1415
13780
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
1.9e+00
1.8e+00
—
1.0e+50
—
2.3e+00
2.0e+00
cases:0.38%
controls:0.06%
cases:0.38%
controls:0.06%
—
—
cases:0.27%
controls:0.00%
—
—
cases:0.51%
controls:0.05%
cases:0.83%
controls:0.11%
7
10
1830
17219
7
11
1854
17422
—
5
0
1856
17433
—
9
9
1757
16848
12
16
1438
13939
CT of cerebral ischaemia
AA5BD [2001300158]
1.5e+00
2.8e+00
—
1.0e+50
—
2.1e+00
1.5e+00
cases:0.71%
controls:0.16%
cases:0.75%
controls:0.05%
—
—
cases:1.72%
controls:0.00%
—
—
cases:0.45%
controls:0.05%
cases:0.76%
controls:0.17%
13
28
1824
17201
14
8
1847
17425
—
32
0
1829
17433
—
8
9
1758
16848
11
24
1439
13931
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.1e-01
2.8e-01
9.2e-01
4.7e+00
1.7e+00
3.2e-01
-2.2e-02
cases:40.12%
controls:37.60%
cases:33.91%
controls:27.86%
cases:13.33%
controls:5.75%
cases:27.67%
controls:0.34%
cases:23.60%
controls:5.52%
cases:33.24%
controls:26.60%
cases:35.66%
controls:36.16%
737
6478
1100
10751
631
4856
1230
12577
248
1003
1613
16430
515
60
1346
17373
438
960
1418
16432
587
4484
1179
12373
517
5046
933
8909
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
3.2e-01
4.7e-01
1.0e+00
4.0e+00
1.4e+00
4.7e-01
2.3e-01
cases:26.08%
controls:20.34%
cases:15.64%
controls:10.34%
cases:4.25%
controls:1.55%
cases:4.03%
controls:0.08%
cases:5.93%
controls:1.52%
cases:14.72%
controls:9.74%
cases:22.00%
controls:18.30%
479
3504
1358
13725
291
1802
1570
15631
79
270
1782
17163
75
14
1786
17419
110
265
1746
17127
260
1642
1506
15215
319
2554
1131
11401
General evaluation of the need for rehabilitation
R1100 [2001310172]
1.1e+00
2.3e+00
—
—
—
2.5e+00
2.0e+00
cases:1.14%
controls:0.39%
cases:0.64%
controls:0.06%
—
—
—
—
—
—
cases:0.51%
controls:0.04%
cases:1.79%
controls:0.26%
21
67
1816
17162
12
11
1849
17422
—
—
—
9
7
1757
16850
26
36
1424
13919
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
1.1e+00
1.6e+00
—
1.0e+50
3.1e+00
2.1e+00
7.7e-01
cases:2.40%
controls:0.83%
cases:1.13%
controls:0.24%
—
—
cases:0.43%
controls:0.00%
cases:0.75%
controls:0.03%
cases:1.42%
controls:0.17%
cases:1.10%
controls:0.52%
44
143
1793
17086
21
41
1840
17392
—
8
0
1853
17433
14
6
1842
17386
25
29
1741
16828
16
72
1434
13883
aripiprazole; oral, parenteral
N05AX12 [21604562]
1.6e+00
1.4e+00
1.0e+00
—
1.7e+00
1.4e+00
1.7e+00
cases:1.47%
controls:0.31%
cases:1.02%
controls:0.25%
cases:0.32%
controls:0.11%
—
—
cases:0.59%
controls:0.10%
cases:1.02%
controls:0.24%
cases:1.72%
controls:0.33%
27
54
1810
17175
19
43
1842
17390
6
20
1855
17413
—
11
18
1845
17374
18
41
1748
16816
25
46
1425
13909
Functional capacity evaluation
443351003 [40481051]
6.6e-01
8.4e-01
1.0e+00
2.8e+00
1.5e+00
9.3e-01
4.1e-01
cases:5.82%
controls:3.09%
cases:3.28%
controls:1.44%
cases:0.97%
controls:0.36%
cases:0.59%
controls:0.03%
cases:1.67%
controls:0.37%
cases:3.34%
controls:1.35%
cases:3.79%
controls:2.54%
107
533
1730
16696
61
251
1800
17182
18
62
1843
17371
11
6
1850
17427
31
65
1825
17327
59
227
1707
16630
55
355
1395
13600
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
7.1e-01
1.1e+00
1.8e+00
—
2.4e+00
1.1e+00
6.4e-01
cases:8.71%
controls:4.49%
cases:5.70%
controls:1.98%
cases:1.93%
controls:0.33%
—
—
cases:2.64%
controls:0.25%
cases:4.08%
controls:1.41%
cases:6.41%
controls:3.48%
160
773
1677
16456
106
345
1755
17088
36
57
1825
17376
—
49
43
1807
17349
72
237
1694
16620
93
486
1357
13469
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
3.7e-01
6.3e-01
1.2e+00
3.5e+00
1.5e+00
5.9e-01
2.3e-01
cases:6.75%
controls:4.75%
cases:5.53%
controls:3.02%
cases:1.50%
controls:0.48%
cases:0.91%
controls:0.03%
cases:1.89%
controls:0.43%
cases:5.72%
controls:3.26%
cases:10.97%
controls:8.89%
124
818
1713
16411
103
527
1758
16906
28
83
1833
17350
17
5
1844
17428
35
75
1821
17317
101
549
1665
16308
159
1240
1291
12715
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
2.8e-01
4.2e-01
8.1e-01
3.6e+00
1.6e+00
6.5e-01
3.8e-01
cases:10.29%
controls:7.96%
cases:6.66%
controls:4.47%
cases:1.67%
controls:0.75%
cases:1.61%
controls:0.05%
cases:2.75%
controls:0.58%
cases:7.42%
controls:4.00%
cases:12.14%
controls:8.66%
189
1371
1648
15858
124
779
1737
16654
31
130
1830
17303
30
8
1831
17425
51
101
1805
17291
131
674
1635
16183
176
1209
1274
12746
Bipolar disorder Depressive episode without somatic syndrome
F31.30 [2000501976]
1.8e+00
2.1e+00
—
—
—
2.0e+00
1.7e+00
cases:0.60%
controls:0.10%
cases:0.54%
controls:0.06%
—
—
—
—
—
—
cases:0.45%
controls:0.06%
cases:0.76%
controls:0.14%
11
17
1826
17212
10
11
1851
17422
—
—
—
8
10
1758
16847
11
20
1439
13935
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
2.3e-01
5.1e-01
9.2e-01
4.0e+00
1.5e+00
7.1e-01
2.1e-01
cases:13.66%
controls:11.22%
cases:7.25%
controls:4.47%
cases:1.34%
controls:0.54%
cases:2.42%
controls:0.05%
cases:2.26%
controls:0.52%
cases:6.91%
controls:3.53%
cases:10.97%
controls:9.05%
251
1933
1586
15296
135
780
1726
16653
25
94
1836
17339
45
8
1816
17425
42
91
1814
17301
122
595
1644
16262
159
1263
1291
12692
Essential (primary) hypertension
I10 [45591453]
1.9e-01
4.2e-01
8.5e-01
4.5e+00
1.3e+00
4.9e-01
1.1e-01
cases:18.51%
controls:15.83%
cases:11.39%
controls:7.80%
cases:3.65%
controls:1.60%
cases:7.20%
controls:0.09%
cases:5.44%
controls:1.49%
cases:12.91%
controls:8.35%
cases:16.69%
controls:15.23%
340
2727
1497
14502
212
1359
1649
16074
68
279
1793
17154
134
15
1727
17418
101
259
1755
17133
228
1407
1538
15450
242
2125
1208
11830
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
2.8e-01
5.4e-01
7.9e-01
3.4e+00
1.5e+00
6.1e-01
3.1e-01
cases:18.84%
controls:14.92%
cases:12.63%
controls:7.80%
cases:3.12%
controls:1.44%
cases:2.58%
controls:0.09%
cases:5.39%
controls:1.23%
cases:11.78%
controls:6.73%
cases:16.76%
controls:12.90%
346
2571
1491
14658
235
1360
1626
16073
58
251
1803
17182
48
15
1813
17418
100
214
1756
17178
208
1135
1558
15722
243
1800
1207
12155
Neuropsychological evaluation of need and possibilities to rehabilitation
R1230 [2001310176]
1.2e+00
2.1e+00
1.0e+50
1.0e+50
—
2.6e+00
2.7e+00
cases:0.44%
controls:0.13%
cases:0.81%
controls:0.10%
cases:0.27%
controls:0.00%
cases:0.38%
controls:0.00%
—
—
cases:1.36%
controls:0.10%
cases:4.55%
controls:0.32%
8
22
1829
17207
15
18
1846
17415
5
0
1856
17433
7
0
1854
17433
—
24
17
1742
16840
66
45
1384
13910
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
5.0e-02
2.1e-01
8.7e-01
4.5e+00
1.5e+00
2.3e-01
-4.8e-02
cases:40.12%
controls:38.92%
cases:35.20%
controls:30.64%
cases:14.88%
controls:6.84%
cases:28.59%
controls:0.42%
cases:24.30%
controls:6.66%
cases:34.54%
controls:29.55%
cases:37.31%
controls:38.45%
737
6706
1100
10523
655
5341
1206
12092
277
1193
1584
16240
532
74
1329
17359
451
1159
1405
16233
610
4981
1156
11876
541
5365
909
8590
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
1.1e+00
1.2e+00
1.5e+00
1.0e+50
3.2e+00
1.9e+00
5.3e-01
cases:1.80%
controls:0.60%
cases:0.75%
controls:0.24%
cases:0.32%
controls:0.07%
cases:0.75%
controls:0.00%
cases:1.08%
controls:0.05%
cases:1.08%
controls:0.16%
cases:0.62%
controls:0.37%
33
104
1804
17125
14
41
1847
17392
6
13
1855
17420
14
0
1847
17433
20
8
1836
17384
19
27
1747
16830
9
51
1441
13904
pH of Urine
2756-5 [3015736]
2.2e-01
5.6e-01
1.1e+00
3.9e+00
1.3e+00
4.9e-01
1.9e-01
cases:11.16%
controls:9.17%
cases:8.11%
controls:4.81%
cases:2.20%
controls:0.71%
cases:1.61%
controls:0.03%
cases:2.42%
controls:0.68%
cases:7.64%
controls:4.84%
cases:14.07%
controls:11.95%
205
1580
1632
15649
151
838
1710
16595
41
124
1820
17309
30
6
1831
17427
45
118
1811
17274
135
816
1631
16041
204
1667
1246
12288
Cerebral infarction due to thrombosis of cerebral arteries
I63.3 [45562366]
1.2e+00
2.3e+00
—
1.0e+50
—
2.3e+00
1.5e+00
cases:0.82%
controls:0.24%
cases:0.70%
controls:0.07%
—
—
cases:0.64%
controls:0.00%
—
—
cases:0.79%
controls:0.08%
cases:0.83%
controls:0.18%
15
42
1822
17187
13
12
1848
17421
—
12
0
1849
17433
—
14
14
1752
16843
12
25
1438
13930
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
2.6e-01
3.7e-01
8.6e-01
3.6e+00
1.4e+00
5.5e-01
2.9e-01
cases:11.43%
controls:9.04%
cases:6.93%
controls:4.90%
cases:1.93%
controls:0.83%
cases:1.77%
controls:0.05%
cases:2.86%
controls:0.69%
cases:7.70%
controls:4.60%
cases:12.90%
controls:9.96%
210
1557
1627
15672
129
854
1732
16579
36
145
1825
17288
33
9
1828
17424
53
120
1803
17272
136
775
1630
16082
187
1390
1263
12565
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
1.0e+00
1.1e+00
1.5e+00
1.0e+50
3.3e+00
1.8e+00
3.7e-01
cases:1.85%
controls:0.66%
cases:0.81%
controls:0.26%
cases:0.32%
controls:0.07%
cases:0.75%
controls:0.00%
cases:1.29%
controls:0.05%
cases:1.02%
controls:0.17%
cases:0.62%
controls:0.43%
34
114
1803
17115
15
45
1846
17388
6
13
1855
17420
14
0
1847
17433
24
8
1832
17384
18
29
1748
16828
9
60
1441
13895
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
3.1e-01
5.0e-01
1.3e+00
4.1e+00
1.5e+00
4.0e-01
3.5e-01
cases:5.61%
controls:4.17%
cases:3.60%
controls:2.23%
cases:1.24%
controls:0.35%
cases:2.26%
controls:0.04%
cases:1.45%
controls:0.33%
cases:2.66%
controls:1.80%
cases:5.52%
controls:3.95%
103
718
1734
16511
67
388
1794
17045
23
61
1838
17372
42
7
1819
17426
27
57
1829
17335
47
304
1719
16553
80
551
1370
13404
CBC panel - Blood by Automated count
58410-2 [40761511]
9.1e-02
1.8e-01
8.1e-01
4.7e+00
1.5e+00
2.5e-01
-4.3e-02
cases:38.98%
controls:36.83%
cases:26.65%
controls:23.24%
cases:9.24%
controls:4.34%
cases:20.04%
controls:0.22%
cases:16.92%
controls:4.26%
cases:25.03%
controls:20.70%
cases:30.28%
controls:31.19%
716
6346
1121
10883
496
4052
1365
13381
172
757
1689
16676
373
38
1488
17395
314
741
1542
16651
442
3490
1324
13367
439
4352
1011
9603
Lactate [Moles/volume] in Venous blood
2519-7 [3008037]
7.5e-01
1.4e+00
2.8e+00
—
3.1e+00
8.7e-01
3.1e-01
cases:1.09%
controls:0.52%
cases:1.13%
controls:0.27%
cases:0.54%
controls:0.03%
—
—
cases:0.75%
controls:0.03%
cases:0.74%
controls:0.31%
cases:1.24%
controls:0.92%
20
89
1817
17140
21
47
1840
17386
10
6
1851
17427
—
14
6
1842
17386
13
52
1753
16805
18
128
1432
13827
clopidogrel; oral
B01AC04 [21600989]
6.0e-01
8.9e-01
1.1e+00
—
2.2e+00
1.5e+00
9.4e-01
cases:4.74%
controls:2.65%
cases:4.46%
controls:1.88%
cases:1.61%
controls:0.52%
—
—
cases:4.74%
controls:0.53%
cases:7.53%
controls:1.86%
cases:6.00%
controls:2.42%
87
457
1750
16772
83
327
1778
17106
30
90
1831
17343
—
88
92
1768
17300
133
313
1633
16544
87
338
1363
13617
Bacteria [Presence] in Urine
87829-8 [36304419]
2.5e-01
3.9e-01
8.3e-01
3.5e+00
1.6e+00
6.5e-01
3.6e-01
cases:9.85%
controls:7.83%
cases:6.23%
controls:4.32%
cases:1.67%
controls:0.73%
cases:1.45%
controls:0.05%
cases:2.64%
controls:0.55%
cases:7.02%
controls:3.79%
cases:11.45%
controls:8.27%
181
1349
1656
15880
116
753
1745
16680
31
128
1830
17305
27
8
1834
17425
49
96
1807
17296
124
639
1642
16218
166
1154
1284
12801
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
5.5e-01
1.1e+00
2.0e+00
1.0e+50
1.9e+00
1.1e+00
6.2e-01
cases:5.17%
controls:3.05%
cases:2.15%
controls:0.70%
cases:0.54%
controls:0.07%
cases:0.91%
controls:0.00%
cases:0.38%
controls:0.06%
cases:1.59%
controls:0.56%
cases:3.45%
controls:1.88%
95
526
1742
16703
40
122
1821
17311
10
13
1851
17420
17
0
1844
17433
7
10
1849
17382
28
94
1738
16763
50
262
1400
13693
Cerebral infarction due to embolism of cerebral arteries
I63.4 [45591475]
1.5e+00
1.9e+00
—
1.0e+50
—
2.3e+00
1.6e+00
cases:0.93%
controls:0.21%
cases:0.59%
controls:0.09%
—
—
cases:0.59%
controls:0.00%
—
—
cases:0.74%
controls:0.08%
cases:1.03%
controls:0.21%
17
36
1820
17193
11
16
1850
17417
—
11
0
1850
17433
—
13
13
1753
16844
15
30
1435
13925
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
1.1e+00
1.1e+00
1.5e+00
1.0e+50
3.3e+00
1.7e+00
2.8e-01
cases:1.74%
controls:0.61%
cases:0.75%
controls:0.25%
cases:0.32%
controls:0.07%
cases:0.75%
controls:0.00%
cases:1.24%
controls:0.05%
cases:0.91%
controls:0.16%
cases:0.55%
controls:0.42%
32
105
1805
17124
14
44
1847
17389
6
12
1855
17421
14
0
1847
17433
23
8
1833
17384
16
27
1750
16830
8
58
1442
13897
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
2.2e-01
4.0e-01
8.1e-01
3.6e+00
1.4e+00
6.2e-01
3.6e-01
cases:12.63%
controls:10.43%
cases:7.47%
controls:5.15%
cases:1.88%
controls:0.85%
cases:1.88%
controls:0.05%
cases:2.91%
controls:0.72%
cases:8.32%
controls:4.66%
cases:13.86%
controls:10.14%
232
1797
1605
15432
139
898
1722
16535
35
148
1826
17285
35
9
1826
17424
54
126
1802
17266
147
786
1619
16071
201
1415
1249
12540
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.5e-01
2.4e-01
8.4e-01
4.3e+00
1.5e+00
3.2e-01
9.4e-02
cases:33.81%
controls:30.45%
cases:29.02%
controls:24.39%
cases:12.09%
controls:5.58%
cases:21.82%
controls:0.37%
cases:19.29%
controls:5.25%
cases:29.16%
controls:23.08%
cases:34.00%
controls:31.93%
621
5246
1216
11983
540
4252
1321
13181
225
973
1636
16460
406
64
1455
17369
358
913
1498
16479
515
3890
1251
12967
493
4456
957
9499
olanzapine; oral, parenteral
N05AH03 [21604543]
1.2e+00
1.3e+00
1.4e+00
—
9.1e-01
1.6e+00
1.6e+00
cases:2.07%
controls:0.60%
cases:1.61%
controls:0.44%
cases:0.59%
controls:0.14%
—
—
cases:0.48%
controls:0.20%
cases:2.04%
controls:0.44%
cases:3.10%
controls:0.64%
38
104
1799
17125
30
76
1831
17357
11
25
1850
17408
—
9
34
1847
17358
36
74
1730
16783
45
89
1405
13866
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
9.3e-02
2.3e-01
8.2e-01
4.6e+00
1.5e+00
1.8e-01
-1.2e-01
cases:27.16%
controls:25.36%
cases:24.66%
controls:20.64%
cases:10.16%
controls:4.74%
cases:19.61%
controls:0.24%
cases:17.24%
controls:4.55%
cases:24.24%
controls:21.12%
cases:26.21%
controls:28.51%
499
4370
1338
12859
459
3599
1402
13834
189
826
1672
16607
365
42
1496
17391
320
791
1536
16601
428
3560
1338
13297
380
3979
1070
9976
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
5.2e-02
2.1e-01
8.3e-01
4.3e+00
1.5e+00
3.1e-01
7.1e-02
cases:34.68%
controls:33.50%
cases:29.34%
controls:25.18%
cases:11.71%
controls:5.45%
cases:20.10%
controls:0.33%
cases:18.53%
controls:5.07%
cases:29.39%
controls:23.46%
cases:34.07%
controls:32.49%
637
5772
1200
11457
546
4389
1315
13044
218
950
1643
16483
374
57
1487
17376
344
881
1512
16511
519
3954
1247
12903
494
4534
956
9421
Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]
1.1e+00
8.2e-01
—
1.0e+50
2.1e+00
2.3e+00
1.5e+00
cases:0.71%
controls:0.23%
cases:0.38%
controls:0.17%
—
—
cases:0.43%
controls:0.00%
cases:0.43%
controls:0.05%
cases:1.47%
controls:0.15%
cases:1.38%
controls:0.30%
13
39
1824
17190
7
29
1854
17404
—
8
0
1853
17433
8
9
1848
17383
26
25
1740
16832
20
42
1430
13913
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
4.9e-01
7.5e-01
1.9e+00
—
2.4e+00
9.7e-01
6.1e-01
cases:7.73%
controls:4.86%
cases:4.89%
controls:2.38%
cases:2.26%
controls:0.34%
—
—
cases:3.13%
controls:0.30%
cases:4.98%
controls:1.94%
cases:8.55%
controls:4.84%
142
838
1695
16391
91
415
1770
17018
42
60
1819
17373
—
58
52
1798
17340
88
327
1678
16530
124
675
1326
13280
Diagnostic and symptom-mapping evaluation
IBA01 [2001304043]
1.7e+00
1.8e+00
—
—
—
1.9e+00
1.7e+00
cases:0.44%
controls:0.08%
cases:0.43%
controls:0.07%
—
—
—
—
—
—
cases:0.45%
controls:0.07%
cases:1.66%
controls:0.30%
8
14
1829
17215
8
13
1853
17420
—
—
—
8
11
1758
16846
24
42
1426
13913
Speech disorder
N19 [2002000730]
1.2e+00
1.8e+00
—
1.0e+50
2.6e+00
1.5e+00
2.5e-01
cases:1.52%
controls:0.45%
cases:1.77%
controls:0.31%
—
—
cases:0.70%
controls:0.00%
cases:0.92%
controls:0.07%
cases:1.98%
controls:0.46%
cases:1.31%
controls:1.02%
28
77
1809
17152
33
54
1828
17379
—
13
0
1848
17433
17
12
1839
17380
35
77
1731
16780
19
143
1431
13812
fluoxetine; oral
N06AB03 [21604711]
1.2e+00
1.5e+00
—
—
2.1e+00
1.2e+00
1.0e+00
cases:1.52%
controls:0.49%
cases:1.07%
controls:0.24%
—
—
—
—
cases:0.43%
controls:0.05%
cases:0.91%
controls:0.27%
cases:1.59%
controls:0.59%
28
84
1809
17145
20
42
1841
17391
—
—
8
9
1848
17383
16
46
1750
16811
23
82
1427
13873
Leukocytes [#/volume] in Urine
30405-5 [3018095]
2.6e-01
3.4e-01
8.3e-01
3.6e+00
1.4e+00
5.4e-01
2.5e-01
cases:12.41%
controls:9.86%
cases:7.85%
controls:5.71%
cases:2.04%
controls:0.90%
cases:1.83%
controls:0.05%
cases:3.29%
controls:0.81%
cases:8.66%
controls:5.26%
cases:14.34%
controls:11.57%
228
1698
1609
15531
146
995
1715
16438
38
157
1823
17276
34
9
1827
17424
61
141
1795
17251
153
887
1613
15970
208
1614
1242
12341
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
8.0e-02
4.0e-01
1.3e+00
4.2e+00
1.1e+00
1.7e-01
-3.9e-02
cases:10.51%
controls:9.77%
cases:6.88%
controls:4.71%
cases:2.15%
controls:0.62%
cases:1.83%
controls:0.03%
cases:2.10%
controls:0.70%
cases:5.72%
controls:4.86%
cases:9.93%
controls:10.28%
193
1684
1644
15545
128
821
1733
16612
40
108
1821
17325
34
5
1827
17428
39
121
1817
17271
101
819
1665
16038
144
1435
1306
12520
Platelets [#/volume] in Blood
26515-7 [3007461]
5.5e-03
1.3e-01
7.8e-01
4.5e+00
1.4e+00
2.0e-01
-8.4e-02
cases:43.88%
controls:43.74%
cases:38.64%
controls:35.61%
cases:16.01%
controls:8.07%
cases:29.02%
controls:0.45%
cases:25.97%
controls:7.61%
cases:38.45%
controls:33.94%
cases:41.72%
controls:43.79%
806
7536
1031
9693
719
6208
1142
11225
298
1407
1563
16026
540
79
1321
17354
482
1323
1374
16069
679
5721
1087
11136
605
6111
845
7844
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
4.2e-03
1.3e-01
7.7e-01
4.5e+00
1.5e+00
1.9e-01
-8.6e-02
cases:43.93%
controls:43.83%
cases:38.69%
controls:35.67%
cases:16.01%
controls:8.11%
cases:29.02%
controls:0.45%
cases:26.08%
controls:7.62%
cases:38.51%
controls:34.02%
cases:41.72%
controls:43.82%
807
7551
1030
9678
720
6219
1141
11214
298
1413
1563
16020
540
79
1321
17354
484
1326
1372
16066
680
5735
1086
11122
605
6115
845
7840
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
2.4e-03
1.3e-01
7.7e-01
4.5e+00
1.4e+00
2.0e-01
-8.4e-02
cases:43.88%
controls:43.82%
cases:38.69%
controls:35.64%
cases:16.01%
controls:8.09%
cases:29.02%
controls:0.45%
cases:25.97%
controls:7.62%
cases:38.51%
controls:33.97%
cases:41.72%
controls:43.78%
806
7549
1031
9680
720
6213
1141
11220
298
1411
1563
16022
540
79
1321
17354
482
1325
1374
16067
680
5727
1086
11130
605
6109
845
7846
MCH [Entitic mass]
28539-5 [3035941]
2.4e-04
1.3e-01
7.7e-01
4.5e+00
1.4e+00
2.0e-01
-8.5e-02
cases:43.82%
controls:43.82%
cases:38.69%
controls:35.62%
cases:16.01%
controls:8.10%
cases:29.02%
controls:0.45%
cases:25.97%
controls:7.62%
cases:38.51%
controls:33.97%
cases:41.72%
controls:43.81%
805
7549
1032
9680
720
6210
1141
11223
298
1412
1563
16021
540
79
1321
17354
482
1325
1374
16067
680
5727
1086
11130
605
6114
845
7841
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
2.2e-03
1.3e-01
7.7e-01
4.5e+00
1.4e+00
1.9e-01
-8.6e-02
cases:43.88%
controls:43.82%
cases:38.69%
controls:35.66%
cases:16.01%
controls:8.10%
cases:29.02%
controls:0.45%
cases:26.02%
controls:7.63%
cases:38.51%
controls:34.02%
cases:41.72%
controls:43.82%
806
7550
1031
9679
720
6216
1141
11217
298
1412
1563
16021
540
79
1321
17354
483
1327
1373
16065
680
5735
1086
11122
605
6115
845
7840
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
-3.8e-04
1.3e-01
7.7e-01
4.5e+00
1.4e+00
1.9e-01
-8.7e-02
cases:43.88%
controls:43.89%
cases:38.69%
controls:35.70%
cases:16.01%
controls:8.11%
cases:29.07%
controls:0.45%
cases:26.02%
controls:7.64%
cases:38.51%
controls:34.05%
cases:41.72%
controls:43.86%
806
7561
1031
9668
720
6223
1141
11210
298
1414
1563
16019
541
79
1320
17354
483
1328
1373
16064
680
5740
1086
11117
605
6120
845
7835
Leukocytes [#/volume] in Blood
26464-8 [3010813]
4.0e-03
1.3e-01
7.7e-01
4.5e+00
1.4e+00
2.0e-01
-9.0e-02
cases:43.98%
controls:43.89%
cases:38.74%
controls:35.70%
cases:15.96%
controls:8.11%
cases:29.02%
controls:0.45%
cases:26.02%
controls:7.66%
cases:38.67%
controls:34.08%
cases:41.72%
controls:43.92%
808
7561
1029
9668
721
6224
1140
11209
297
1414
1564
16019
540
79
1321
17354
483
1332
1373
16060
683
5745
1083
11112
605
6129
845
7826
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2.8e-01
4.4e-01
1.1e+00
3.9e+00
1.4e+00
4.3e-01
3.5e-01
cases:5.88%
controls:4.50%
cases:3.87%
controls:2.54%
cases:1.29%
controls:0.42%
cases:2.31%
controls:0.05%
cases:1.51%
controls:0.38%
cases:3.23%
controls:2.13%
cases:6.41%
controls:4.59%
108
775
1729
16454
72
442
1789
16991
24
73
1837
17360
43
8
1818
17425
28
66
1828
17326
57
359
1709
16498
93
641
1357
13314
Dizziness and giddiness
R42 [45568132]
5.6e-01
1.1e+00
1.5e+00
1.0e+50
2.0e+00
1.1e+00
7.1e-01
cases:5.06%
controls:2.94%
cases:3.17%
controls:1.11%
cases:0.59%
controls:0.14%
cases:1.02%
controls:0.00%
cases:0.81%
controls:0.11%
cases:2.32%
controls:0.77%
cases:5.59%
controls:2.82%
93
507
1744
16722
59
194
1802
17239
11
24
1850
17409
19
0
1842
17433
15
20
1841
17372
41
129
1725
16728
81
393
1369
13562
pH of Venous blood
2746-6 [3012544]
2.9e-01
4.4e-01
1.2e+00
3.8e+00
1.4e+00
4.5e-01
3.2e-01
cases:5.99%
controls:4.54%
cases:3.87%
controls:2.54%
cases:1.40%
controls:0.41%
cases:2.36%
controls:0.05%
cases:1.45%
controls:0.38%
cases:3.34%
controls:2.15%
cases:6.28%
controls:4.64%
110
783
1727
16446
72
442
1789
16991
26
71
1835
17362
44
9
1817
17424
27
66
1829
17326
59
363
1707
16494
91
648
1359
13307
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
1.2e-01
4.4e-01
1.1e+00
3.8e+00
1.2e+00
3.2e-01
9.5e-02
cases:12.96%
controls:11.65%
cases:9.89%
controls:6.60%
cases:2.74%
controls:0.94%
cases:1.99%
controls:0.05%
cases:3.29%
controls:0.98%
cases:9.46%
controls:7.04%
cases:17.31%
controls:15.99%
238
2007
1599
15222
184
1150
1677
16283
51
164
1810
17269
37
8
1824
17425
61
170
1795
17222
167
1187
1599
15670
251
2231
1199
11724
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
1.2e-01
4.3e-01
1.1e+00
3.8e+00
1.2e+00
3.0e-01
1.0e-01
cases:13.06%
controls:11.76%
cases:9.83%
controls:6.64%
cases:2.74%
controls:0.94%
cases:1.99%
controls:0.05%
cases:3.29%
controls:0.98%
cases:9.34%
controls:7.07%
cases:17.45%
controls:15.99%
240
2026
1597
15203
183
1158
1678
16275
51
163
1810
17270
37
8
1824
17425
61
170
1795
17222
165
1191
1601
15666
253
2232
1197
11723
Outpatient Visit
OP [9202]
5.8e-02
1.6e-01
4.2e-01
4.3e+00
1.2e+00
5.9e-01
3.3e-01
cases:72.89%
controls:71.72%
cases:60.61%
controls:56.66%
cases:18.27%
controls:12.85%
cases:34.01%
controls:0.69%
cases:31.79%
controls:12.32%
cases:69.14%
controls:55.39%
cases:80.48%
controls:74.86%
1339
12357
498
4872
1128
9877
733
7556
340
2241
1521
15192
633
120
1228
17313
590
2142
1266
15250
1221
9337
545
7520
1167
10447
283
3508
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
1.3e-01
4.1e-01
1.1e+00
3.8e+00
1.3e+00
3.3e-01
8.7e-02
cases:12.79%
controls:11.44%
cases:9.56%
controls:6.55%
cases:2.69%
controls:0.93%
cases:1.93%
controls:0.05%
cases:3.34%
controls:0.97%
cases:9.40%
controls:6.96%
cases:17.03%
controls:15.84%
235
1971
1602
15258
178
1142
1683
16291
50
162
1811
17271
36
8
1825
17425
62
169
1794
17223
166
1174
1600
15683
247
2210
1203
11745
clozapine; oral, parenteral
N05AH02 [21604542]
1.5e+00
1.6e+00
1.2e+00
—
1.1e+00
1.7e+00
2.0e+00
cases:0.71%
controls:0.16%
cases:0.75%
controls:0.15%
cases:0.48%
controls:0.14%
—
—
cases:0.38%
controls:0.12%
cases:0.79%
controls:0.14%
cases:1.10%
controls:0.15%
13
28
1824
17201
14
26
1847
17407
9
25
1852
17408
—
7
21
1849
17371
14
24
1752
16833
16
21
1434
13934
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
3.1e-01
6.1e-01
1.1e+00
2.2e+00
1.7e+00
7.7e-01
4.5e-01
cases:5.61%
controls:4.17%
cases:3.76%
controls:2.08%
cases:1.24%
controls:0.43%
cases:0.59%
controls:0.06%
cases:2.21%
controls:0.43%
cases:3.57%
controls:1.68%
cases:5.45%
controls:3.55%
103
719
1734
16510
70
363
1791
17070
23
75
1838
17358
11
11
1850
17422
41
75
1815
17317
63
284
1703
16573
79
496
1371
13459
Other healthcare associate professional
Z3229 [2001311561]
6.0e-01
9.9e-01
2.2e+00
1.0e+50
—
1.6e+00
1.3e+00
cases:2.72%
controls:1.51%
cases:0.97%
controls:0.36%
cases:0.32%
controls:0.03%
cases:0.43%
controls:0.00%
—
—
cases:1.19%
controls:0.23%
cases:2.34%
controls:0.65%
50
261
1787
16968
18
63
1843
17370
6
6
1855
17427
8
0
1853
17433
—
21
39
1745
16818
34
91
1416
13864
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
9.2e-01
1.0e+00
—
1.0e+50
3.1e+00
1.7e+00
4.4e-01
cases:1.52%
controls:0.62%
cases:0.75%
controls:0.27%
—
—
cases:0.54%
controls:0.00%
cases:0.97%
controls:0.05%
cases:0.96%
controls:0.17%
cases:0.62%
controls:0.40%
28
106
1809
17123
14
47
1847
17386
—
10
0
1851
17433
18
8
1838
17384
17
29
1749
16828
9
56
1441
13899
General Surgery
2 [38004447]
2.8e-01
5.4e-01
9.4e-01
3.2e+00
1.2e+00
5.5e-01
2.1e-01
cases:13.34%
controls:10.43%
cases:5.27%
controls:3.14%
cases:0.97%
controls:0.38%
cases:0.70%
controls:0.03%
cases:1.08%
controls:0.33%
cases:5.27%
controls:3.10%
cases:10.07%
controls:8.30%
245
1797
1592
15432
98
548
1763
16885
18
66
1843
17367
13
5
1848
17428
20
58
1836
17334
93
522
1673
16335
146
1158
1304
12797
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
7.3e-01
1.2e+00
2.2e+00
—
2.4e+00
7.0e-01
1.6e-01
cases:2.07%
controls:1.00%
cases:1.56%
controls:0.45%
cases:0.64%
controls:0.07%
—
—
cases:0.92%
controls:0.08%
cases:1.02%
controls:0.51%
cases:1.86%
controls:1.59%
38
173
1799
17056
29
79
1832
17354
12
12
1849
17421
—
17
14
1839
17378
18
86
1748
16771
27
222
1423
13733
Poisoning by systemic antibiotics
T36 [45756588]
1.3e+00
1.9e+00
—
—
—
1.9e+00
1.5e+00
cases:1.09%
controls:0.31%
cases:0.38%
controls:0.06%
—
—
—
—
—
—
cases:0.62%
controls:0.09%
cases:0.90%
controls:0.19%
20
53
1817
17176
7
10
1854
17423
—
—
—
11
16
1755
16841
13
27
1437
13928
Other and unspecified speech disturbances
R47.8 [45592422]
3.1e+00
—
1.0e+50
1.0e+50
1.0e+50
—
3.5e+00
cases:0.76%
controls:0.03%
—
—
cases:0.32%
controls:0.00%
cases:0.91%
controls:0.00%
cases:0.65%
controls:0.00%
—
—
cases:1.59%
controls:0.05%
14
6
1823
17223
—
6
0
1855
17433
17
0
1844
17433
12
0
1844
17392
—
23
7
1427
13948
Outpatient Hospital
22 [8756]
1.8e-01
1.9e-01
3.9e-01
4.0e+00
1.4e+00
6.4e-01
4.6e-01
cases:29.67%
controls:26.13%
cases:8.87%
controls:7.45%
cases:1.72%
controls:1.18%
cases:3.76%
controls:0.07%
cases:4.31%
controls:1.11%
cases:9.23%
controls:5.09%
cases:16.62%
controls:11.14%
545
4502
1292
12727
165
1298
1696
16135
32
205
1829
17228
70
12
1791
17421
80
193
1776
17199
163
858
1603
15999
241
1555
1209
12400
Epilepsy, unspecified
G40.9 [45562083]
9.8e-01
1.5e+00
—
1.0e+50
—
1.9e+00
2.2e+00
cases:1.25%
controls:0.48%
cases:0.81%
controls:0.18%
—
—
cases:0.27%
controls:0.00%
—
—
cases:1.30%
controls:0.20%
cases:2.34%
controls:0.27%
23
82
1814
17147
15
32
1846
17401
—
5
0
1856
17433
—
23
34
1743
16823
34
38
1416
13917
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
1.5e-01
4.1e-01
6.6e-01
3.0e+00
2.1e+00
3.5e-01
8.8e-03
cases:24.71%
controls:21.97%
cases:15.37%
controls:10.72%
cases:2.90%
controls:1.51%
cases:0.91%
controls:0.05%
cases:9.97%
controls:1.38%
cases:13.25%
controls:9.73%
cases:20.07%
controls:19.93%
454
3785
1383
13444
286
1868
1575
15565
54
264
1807
17169
17
8
1844
17425
185
240
1671
17152
234
1641
1532
15216
291
2781
1159
11174
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
1.8e-01
3.7e-01
6.8e-01
2.9e+00
2.1e+00
2.6e-01
2.4e-02
cases:32.12%
controls:28.34%
cases:21.82%
controls:16.14%
cases:3.87%
controls:2.00%
cases:1.29%
controls:0.07%
cases:13.52%
controls:1.87%
cases:19.76%
controls:16.02%
cases:29.79%
controls:29.29%
590
4883
1247
12346
406
2813
1455
14620
72
348
1789
17085
24
13
1837
17420
251
326
1605
17066
349
2700
1417
14157
432
4087
1018
9868
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
2.1e-01
4.6e-01
7.8e-01
3.5e+00
1.3e+00
6.7e-01
4.4e-01
cases:4.95%
controls:4.04%
cases:4.08%
controls:2.61%
cases:1.02%
controls:0.47%
cases:0.97%
controls:0.03%
cases:1.51%
controls:0.40%
cases:5.10%
controls:2.69%
cases:9.03%
controls:6.03%
91
696
1746
16533
76
455
1785
16978
19
82
1842
17351
18
5
1843
17428
28
69
1828
17323
90
453
1676
16404
131
842
1319
13113
Base excess in Venous blood by calculation
1927-3 [3002032]
2.8e-01
4.2e-01
1.2e+00
3.8e+00
1.3e+00
4.6e-01
3.6e-01
cases:5.82%
controls:4.49%
cases:3.82%
controls:2.54%
cases:1.40%
controls:0.42%
cases:2.31%
controls:0.05%
cases:1.40%
controls:0.37%
cases:3.34%
controls:2.13%
cases:6.34%
controls:4.51%
107
773
1730
16456
71
442
1790
16991
26
73
1835
17360
43
9
1818
17424
26
64
1830
17328
59
359
1707
16498
92
629
1358
13326
Emergency Room and Inpatient Visit
ERIP [262]
4.2e-01
8.9e-01
1.6e+00
—
2.2e+00
8.7e-01
3.4e-01
cases:9.58%
controls:6.48%
cases:8.92%
controls:3.87%
cases:2.85%
controls:0.57%
—
—
cases:4.90%
controls:0.57%
cases:9.34%
controls:4.12%
cases:14.34%
controls:10.66%
176
1117
1661
16112
166
675
1695
16758
53
99
1808
17334
—
91
99
1765
17293
165
695
1601
16162
208
1488
1242
12467
12 lead EKG panel
34534-8 [3044889]
2.0e-01
2.9e-01
7.1e-01
3.5e+00
1.7e+00
2.6e-01
3.1e-02
cases:22.43%
controls:19.12%
cases:12.09%
controls:9.36%
cases:2.15%
controls:1.07%
cases:1.07%
controls:0.03%
cases:5.50%
controls:1.06%
cases:11.16%
controls:8.83%
cases:18.00%
controls:17.55%
412
3295
1425
13934
225
1632
1636
15801
40
186
1821
17247
20
6
1841
17427
102
184
1754
17208
197
1488
1569
15369
261
2449
1189
11506
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
2.0e-01
4.3e-01
8.1e-01
3.3e+00
1.5e+00
6.5e-01
4.2e-01
cases:4.63%
controls:3.82%
cases:4.03%
controls:2.65%
cases:1.07%
controls:0.48%
cases:0.91%
controls:0.03%
cases:1.67%
controls:0.37%
cases:5.15%
controls:2.75%
cases:9.66%
controls:6.57%
85
658
1752
16571
75
462
1786
16971
20
84
1841
17349
17
6
1844
17427
31
65
1825
17327
91
463
1675
16394
140
917
1310
13038
quetiapine; oral
N05AH04 [21604544]
9.9e-01
1.1e+00
1.2e+00
—
9.6e-01
1.0e+00
9.7e-01
cases:6.10%
controls:2.35%
cases:4.51%
controls:1.59%
cases:1.77%
controls:0.53%
—
—
cases:1.62%
controls:0.63%
cases:4.42%
controls:1.63%
cases:6.69%
controls:2.64%
112
405
1725
16824
84
278
1777
17155
33
92
1828
17341
—
30
109
1826
17283
78
275
1688
16582
97
369
1353
13586
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.3e-01
2.9e-01
7.6e-01
3.3e+00
1.6e+00
2.6e-01
1.9e-03
cases:39.36%
controls:36.30%
cases:31.81%
controls:25.93%
cases:9.83%
controls:4.86%
cases:5.37%
controls:0.20%
cases:18.48%
controls:4.55%
cases:31.09%
controls:25.73%
cases:36.48%
controls:36.44%
723
6254
1114
10975
592
4521
1269
12912
183
848
1678
16585
100
35
1761
17398
343
791
1513
16601
549
4338
1217
12519
529
5085
921
8870
Bacteria [#/volume] in Urine by Culture
100906-7 [1761482]
5.6e-01
1.3e+00
2.2e+00
—
2.6e+00
9.1e-01
1.8e-01
cases:1.25%
controls:0.72%
cases:1.07%
controls:0.31%
cases:0.43%
controls:0.05%
—
—
cases:0.48%
controls:0.03%
cases:0.91%
controls:0.37%
cases:1.03%
controls:0.87%
23
124
1814
17105
20
54
1841
17379
8
8
1853
17425
—
9
6
1847
17386
16
62
1750
16795
15
121
1435
13834
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
2.0e-01
3.4e-01
9.8e-01
3.4e+00
1.7e+00
4.0e-01
9.3e-02
cases:7.57%
controls:6.26%
cases:3.55%
controls:2.55%
cases:0.91%
controls:0.34%
cases:0.86%
controls:0.03%
cases:1.67%
controls:0.30%
cases:3.17%
controls:2.15%
cases:5.17%
controls:4.74%
139
1078
1698
16151
66
445
1795
16988
17
60
1844
17373
16
5
1845
17428
31
53
1825
17339
56
363
1710
16494
75
661
1375
13294
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
2.7e-01
5.5e-01
8.5e-01
2.8e+00
1.1e+00
5.8e-01
1.2e-01
cases:16.82%
controls:13.38%
cases:10.64%
controls:6.42%
cases:3.39%
controls:1.47%
cases:1.07%
controls:0.07%
cases:3.50%
controls:1.25%
cases:10.42%
controls:6.13%
cases:13.79%
controls:12.48%
309
2306
1528
14923
198
1119
1663
16314
63
256
1798
17177
20
12
1841
17421
65
218
1791
17174
184
1034
1582
15823
200
1741
1250
12214
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
2.1e-01
4.7e-01
8.7e-01
3.2e+00
1.6e+00
8.1e-01
2.7e-01
cases:10.13%
controls:8.38%
cases:5.21%
controls:3.33%
cases:0.97%
controls:0.41%
cases:0.86%
controls:0.03%
cases:1.72%
controls:0.37%
cases:5.44%
controls:2.50%
cases:7.86%
controls:6.11%
186
1443
1651
15786
97
580
1764
16853
18
71
1843
17362
16
6
1845
17427
32
64
1824
17328
96
422
1670
16435
114
853
1336
13102
Supplier / Service Provider
OMOP5117446 [33004]
-3.8e-01
-3.4e-01
-4.3e-01
-1.0e+50
2.6e+00
2.1e+00
1.7e+00
cases:16.93%
controls:22.91%
cases:5.59%
controls:7.68%
cases:0.54%
controls:0.82%
cases:0.00%
controls:0.03%
cases:1.24%
controls:0.09%
cases:4.64%
controls:0.61%
cases:9.93%
controls:1.89%
311
3947
1526
13282
104
1339
1757
16094
10
143
1851
17290
0
6
1861
17427
23
16
1833
17376
82
103
1684
16754
144
264
1306
13691
Dysarthria and anarthria
R47.1 [45558471]
2.2e+00
—
—
1.0e+50
1.0e+50
3.8e+00
1.0e+50
cases:0.71%
controls:0.08%
—
—
—
—
cases:0.75%
controls:0.00%
cases:0.48%
controls:0.00%
cases:1.30%
controls:0.03%
cases:0.69%
controls:0.00%
13
13
1824
17216
—
—
14
0
1847
17433
9
0
1847
17392
23
5
1743
16852
10
0
1440
13955
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]
4.5e-02
7.8e-02
5.9e-01
3.1e+00
2.3e+00
5.8e-02
-1.7e-01
cases:27.93%
controls:27.02%
cases:13.97%
controls:13.06%
cases:2.53%
controls:1.42%
cases:1.24%
controls:0.06%
cases:11.37%
controls:1.22%
cases:12.91%
controls:12.27%
cases:19.93%
controls:22.77%
513
4656
1324
12573
260
2276
1601
15157
47
248
1814
17185
23
10
1838
17423
211
212
1645
17180
228
2069
1538
14788
289
3177
1161
10778
Participation in compiling a psychiatric treatment plan
ICZ03 [2001304119]
1.4e+00
1.4e+00
—
1.0e+50
—
1.6e+00
1.5e+00
cases:0.87%
controls:0.21%
cases:0.86%
controls:0.21%
—
—
cases:0.43%
controls:0.00%
—
—
cases:1.13%
controls:0.23%
cases:2.41%
controls:0.52%
16
37
1821
17192
16
37
1845
17396
—
8
0
1853
17433
—
20
38
1746
16819
35
73
1415
13882
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
7.6e-01
1.4e+00
2.4e+00
—
—
1.4e+00
7.8e-01
cases:1.85%
controls:0.88%
cases:0.91%
controls:0.24%
cases:0.32%
controls:0.03%
—
—
—
—
cases:0.79%
controls:0.19%
cases:1.24%
controls:0.57%
34
151
1803
17078
17
41
1844
17392
6
5
1855
17428
—
—
14
32
1752
16825
18
80
1432
13875
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
3.4e-02
1.5e-01
7.0e-01
3.0e+00
2.3e+00
1.5e-01
-1.5e-01
cases:28.74%
controls:28.06%
cases:17.52%
controls:15.51%
cases:3.39%
controls:1.71%
cases:1.34%
controls:0.07%
cases:13.31%
controls:1.53%
cases:17.21%
controls:15.23%
cases:25.24%
controls:28.22%
528
4834
1309
12395
326
2704
1535
14729
63
298
1798
17135
25
12
1836
17421
247
266
1609
17126
304
2567
1462
14290
366
3938
1084
10017
lacosamide; oral, parenteral
N03AX18 [21604440]
1.4e+00
2.0e+00
—
—
—
2.1e+00
1.9e+00
cases:0.27%
controls:0.07%
cases:0.38%
controls:0.05%
—
—
—
—
—
—
cases:0.74%
controls:0.09%
cases:0.69%
controls:0.11%
5
12
1832
17217
7
9
1854
17424
—
—
—
13
15
1753
16842
10
15
1440
13940
Dysphasia and aphasia
R47.0 [45592421]
2.9e+00
3.0e+00
—
1.0e+50
—
—
—
cases:0.65%
controls:0.03%
cases:0.91%
controls:0.05%
—
—
cases:0.54%
controls:0.00%
—
—
—
—
—
—
12
6
1825
17223
17
8
1844
17425
—
10
0
1851
17433
—
—
—
Other psychiatric treatment contact
IGY99 [2001304323]
1.1e+00
1.4e+00
—
—
—
1.7e+00
1.8e+00
cases:0.82%
controls:0.28%
cases:0.59%
controls:0.15%
—
—
—
—
—
—
cases:1.13%
controls:0.21%
cases:2.21%
controls:0.37%
15
49
1822
17180
11
26
1850
17407
—
—
—
20
36
1746
16821
32
51
1418
13904
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
2.7e-01
5.3e-01
8.3e-01
2.1e+00
1.6e+00
5.9e-01
2.6e-01
cases:14.92%
controls:11.75%
cases:9.89%
controls:6.09%
cases:2.90%
controls:1.29%
cases:0.54%
controls:0.07%
cases:4.96%
controls:1.00%
cases:10.14%
controls:5.90%
cases:14.21%
controls:11.37%
274
2025
1563
15204
184
1062
1677
16371
54
225
1807
17208
10
12
1851
17421
92
174
1764
17218
179
994
1587
15863
206
1586
1244
12369
Office Visit
OMOP4822458 [581477]
7.1e-02
1.2e-01
7.5e-01
3.7e+00
1.5e+00
2.9e-01
-1.5e-01
cases:12.57%
controls:11.82%
cases:5.59%
controls:4.98%
cases:1.34%
controls:0.64%
cases:1.77%
controls:0.05%
cases:3.45%
controls:0.80%
cases:6.06%
controls:4.59%
cases:8.34%
controls:9.61%
231
2036
1606
15193
104
868
1757
16565
25
111
1836
17322
33
8
1828
17425
64
139
1792
17253
107
773
1659
16084
121
1341
1329
12614
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
4.0e-02
1.7e-01
6.9e-01
2.9e+00
2.3e+00
1.4e-01
-1.7e-01
cases:29.34%
controls:28.52%
cases:18.48%
controls:16.10%
cases:3.55%
controls:1.81%
cases:1.29%
controls:0.07%
cases:13.52%
controls:1.58%
cases:17.89%
controls:15.92%
cases:25.52%
controls:28.80%
539
4914
1298
12315
344
2807
1517
14626
66
316
1795
17117
24
12
1837
17421
251
275
1605
17117
316
2683
1450
14174
370
4019
1080
9936
Migraine, unspecified
G43.9 [45595943]
1.3e+00
1.9e+00
—
1.0e+50
—
1.5e+00
1.2e+00
cases:1.42%
controls:0.39%
cases:0.70%
controls:0.11%
—
—
cases:0.48%
controls:0.00%
—
—
cases:0.68%
controls:0.15%
cases:1.45%
controls:0.44%
26
67
1811
17162
13
19
1848
17414
—
9
0
1852
17433
—
12
25
1754
16832
21
61
1429
13894
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
8.2e-01
7.5e-01
8.3e-01
—
1.5e+00
1.2e+00
1.6e+00
cases:2.72%
controls:1.22%
cases:2.20%
controls:1.05%
cases:0.97%
controls:0.42%
—
—
cases:1.78%
controls:0.39%
cases:3.28%
controls:1.03%
cases:5.03%
controls:1.07%
50
210
1787
17019
41
183
1820
17250
18
74
1843
17359
—
33
68
1823
17324
58
174
1708
16683
73
149
1377
13806
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
7.0e-02
2.0e-01
6.6e-01
2.9e+00
2.1e+00
1.2e-01
-1.1e-01
cases:31.46%
controls:29.97%
cases:21.39%
controls:18.20%
cases:4.03%
controls:2.12%
cases:1.29%
controls:0.07%
cases:13.63%
controls:1.97%
cases:20.22%
controls:18.37%
cases:28.34%
controls:30.68%
578
5163
1259
12066
398
3172
1463
14261
75
369
1786
17064
24
12
1837
17421
253
343
1603
17049
357
3096
1409
13761
411
4281
1039
9674
Stroke/cerebrovascular accident
K90 [2002000617]
4.5e-01
1.7e+00
—
—
—
2.2e+00
1.9e+00
cases:0.49%
controls:0.31%
cases:0.59%
controls:0.10%
—
—
—
—
—
—
cases:1.13%
controls:0.12%
cases:1.45%
controls:0.22%
9
54
1828
17175
11
18
1850
17415
—
—
—
20
21
1746
16836
21
31
1429
13924
Spastic hemiplegic cerebral palsy
G80.2 [45571826]
—
1.8e+00
—
—
—
2.3e+00
1.8e+00
—
—
cases:0.38%
controls:0.06%
—
—
—
—
—
—
cases:0.51%
controls:0.05%
cases:0.62%
controls:0.11%
—
7
11
1854
17422
—
—
—
9
9
1757
16848
9
15
1441
13940
Profession-specific psychiatric evaluation
IBZ01 [2001304075]
1.3e+00
2.2e+00
—
1.0e+50
2.2e+00
2.0e+00
1.6e+00
cases:0.44%
controls:0.12%
cases:0.70%
controls:0.08%
—
—
cases:0.32%
controls:0.00%
cases:0.27%
controls:0.03%
cases:0.91%
controls:0.12%
cases:1.93%
controls:0.41%
8
20
1829
17209
13
14
1848
17419
—
6
0
1855
17433
5
5
1851
17387
16
20
1750
16837
28
57
1422
13898
Laboratory Visit
OMOP4822461 [32036]
-3.1e-02
2.1e-02
5.9e-01
4.0e+00
1.2e+00
9.4e-02
-1.6e-01
cases:47.09%
controls:47.87%
cases:44.22%
controls:43.70%
cases:22.62%
controls:13.96%
cases:30.74%
controls:0.84%
cases:33.57%
controls:13.14%
cases:44.79%
controls:42.47%
cases:45.52%
controls:49.47%
865
8247
972
8982
823
7619
1038
9814
421
2434
1440
14999
572
146
1289
17287
623
2286
1233
15106
791
7159
975
9698
660
6903
790
7052
Mixed personality disorders
F61.0 [2000502024]
1.7e+00
2.0e+00
—
—
—
1.9e+00
2.1e+00
cases:0.54%
controls:0.10%
cases:0.32%
controls:0.05%
—
—
—
—
—
—
cases:0.40%
controls:0.06%
cases:0.48%
controls:0.06%
10
17
1827
17212
6
8
1855
17425
—
—
—
7
10
1759
16847
7
8
1443
13947
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
6.9e-01
9.9e-01
—
—
2.4e+00
1.0e+00
6.7e-01
cases:3.32%
controls:1.70%
cases:1.61%
controls:0.60%
—
—
—
—
cases:0.43%
controls:0.04%
cases:1.53%
controls:0.56%
cases:3.10%
controls:1.61%
61
293
1776
16936
30
105
1831
17328
—
—
8
7
1848
17385
27
95
1739
16762
45
225
1405
13730
Counselling and guidance which enhance independent living
R2130 [2001310196]
3.8e-01
5.6e-01
1.8e+00
—
1.5e+00
1.2e+00
1.1e+00
cases:2.34%
controls:1.62%
cases:1.07%
controls:0.61%
cases:0.54%
controls:0.09%
—
—
cases:0.54%
controls:0.11%
cases:1.64%
controls:0.50%
cases:4.00%
controls:1.30%
43
279
1794
16950
20
107
1841
17326
10
15
1851
17418
—
10
20
1846
17372
29
85
1737
16772
58
182
1392
13773
Other specified special examinations
Z01.8 [45581003]
5.4e-01
8.4e-01
1.6e+00
—
1.9e+00
8.1e-01
4.2e-01
cases:5.23%
controls:3.11%
cases:2.90%
controls:1.28%
cases:0.70%
controls:0.14%
—
—
cases:0.81%
controls:0.12%
cases:2.27%
controls:1.02%
cases:4.83%
controls:3.22%
96
536
1741
16693
54
223
1807
17210
13
24
1848
17409
—
15
21
1841
17371
40
172
1726
16685
70
450
1380
13505
Severe psychotic and other severe mental disorders
112 [2001600112]
1.6e+00
—
—
—
—
2.1e+00
2.0e+00
cases:0.93%
controls:0.19%
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.05%
cases:0.97%
controls:0.14%
17
32
1820
17197
—
—
—
—
8
9
1758
16848
14
19
1436
13936
CT of neck arteries
PA6AD [2001308692]
1.6e+00
2.4e+00
—
1.0e+50
—
1.7e+00
7.7e-01
cases:0.65%
controls:0.13%
cases:0.64%
controls:0.06%
—
—
cases:2.79%
controls:0.00%
—
—
cases:0.45%
controls:0.08%
cases:1.10%
controls:0.52%
12
23
1825
17206
12
10
1849
17423
—
52
0
1809
17433
—
8
14
1758
16843
16
72
1434
13883
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
4.3e-01
7.3e-01
1.4e+00
—
2.4e+00
7.3e-01
3.6e-02
cases:12.96%
controls:8.81%
cases:7.74%
controls:3.87%
cases:2.36%
controls:0.62%
—
—
cases:5.55%
controls:0.51%
cases:7.47%
controls:3.74%
cases:8.55%
controls:8.28%
238
1518
1599
15711
144
674
1717
16759
44
108
1817
17325
—
103
88
1753
17304
132
630
1634
16227
124
1155
1326
12800
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
1.2e+00
1.3e+00
—
1.0e+50
2.6e+00
1.9e+00
1.0e+00
cases:0.76%
controls:0.23%
cases:0.48%
controls:0.13%
—
—
cases:0.38%
controls:0.00%
cases:0.38%
controls:0.03%
cases:0.74%
controls:0.11%
cases:0.69%
controls:0.24%
14
39
1823
17190
9
22
1852
17411
—
7
0
1854
17433
7
5
1849
17387
13
19
1753
16838
10
34
1440
13921
Malaise and fatigue
R53 [45553741]
5.9e-01
9.9e-01
1.4e+00
—
1.2e+00
9.7e-01
4.3e-01
cases:5.01%
controls:2.84%
cases:3.44%
controls:1.31%
cases:0.64%
controls:0.15%
—
—
cases:0.65%
controls:0.19%
cases:3.68%
controls:1.42%
cases:6.97%
controls:4.65%
92
490
1745
16739
64
228
1797
17205
12
27
1849
17406
—
12
33
1844
17359
65
240
1701
16617
101
649
1349
13306
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
1.6e+00
2.2e+00
—
—
—
1.6e+00
1.8e+00
cases:0.65%
controls:0.13%
cases:0.32%
controls:0.03%
—
—
—
—
—
—
cases:0.34%
controls:0.07%
cases:0.69%
controls:0.11%
12
23
1825
17206
6
6
1855
17427
—
—
—
6
12
1760
16845
10
16
1440
13939
Chronic alcohol abuse
P15 [2002000811]
1.7e+00
2.1e+00
—
—
—
1.6e+00
1.8e+00
cases:0.82%
controls:0.16%
cases:0.38%
controls:0.05%
—
—
—
—
—
—
cases:0.45%
controls:0.09%
cases:0.83%
controls:0.14%
15
27
1822
17202
7
8
1854
17425
—
—
—
8
16
1758
16841
12
19
1438
13936
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
9.1e-01
9.6e-01
—
1.0e+50
2.9e+00
1.7e+00
4.4e-01
cases:1.52%
controls:0.62%
cases:0.70%
controls:0.27%
—
—
cases:0.54%
controls:0.00%
cases:0.86%
controls:0.05%
cases:0.96%
controls:0.17%
cases:0.62%
controls:0.40%
28
107
1809
17122
13
47
1848
17386
—
10
0
1851
17433
16
8
1840
17384
17
29
1749
16828
9
56
1441
13899
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
1.2e-01
1.8e-01
5.4e-01
3.1e+00
1.9e+00
4.1e-02
-1.2e-01
cases:28.03%
controls:25.58%
cases:19.61%
controls:16.91%
cases:3.82%
controls:2.26%
cases:1.18%
controls:0.05%
cases:11.48%
controls:1.96%
cases:17.78%
controls:17.19%
cases:26.69%
controls:29.07%
515
4408
1322
12821
365
2948
1496
14485
71
394
1790
17039
22
9
1839
17424
213
341
1643
17051
314
2897
1452
13960
387
4057
1063
9898
Bacteria identified in Isolate by Culture
43409-2 [3042936]
4.5e-01
7.8e-01
1.8e+00
—
1.7e+00
8.0e-01
3.3e-01
cases:4.84%
controls:3.16%
cases:2.31%
controls:1.07%
cases:0.64%
controls:0.10%
—
—
cases:0.65%
controls:0.12%
cases:2.04%
controls:0.93%
cases:3.24%
controls:2.34%
89
544
1748
16685
43
187
1818
17246
12
18
1849
17415
—
12
21
1844
17371
36
156
1730
16701
47
327
1403
13628
Migraine with aura [classical migraine]
G43.1 [45562086]
9.9e-01
1.6e+00
—
1.0e+50
—
1.8e+00
1.2e+00
cases:1.52%
controls:0.57%
cases:1.18%
controls:0.25%
—
—
cases:1.40%
controls:0.00%
—
—
cases:1.47%
controls:0.24%
cases:2.28%
controls:0.73%
28
99
1809
17130
22
44
1839
17389
—
26
0
1835
17433
—
26
41
1740
16816
33
102
1417
13853
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
8.3e-01
7.8e-01
9.4e-01
—
1.4e+00
1.3e+00
1.1e+00
cases:4.63%
controls:2.07%
cases:2.04%
controls:0.95%
cases:0.48%
controls:0.19%
—
—
cases:0.70%
controls:0.17%
cases:2.66%
controls:0.71%
cases:4.21%
controls:1.43%
85
356
1752
16873
38
165
1823
17268
9
33
1852
17400
—
13
30
1843
17362
47
120
1719
16737
61
199
1389
13756
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
2.0e-01
4.1e-01
7.7e-01
2.6e+00
1.0e+00
4.1e-01
1.1e-01
cases:25.75%
controls:22.15%
cases:17.73%
controls:12.53%
cases:5.21%
controls:2.47%
cases:1.18%
controls:0.09%
cases:6.41%
controls:2.39%
cases:17.10%
controls:12.01%
cases:22.41%
controls:20.62%
473
3816
1364
13413
330
2185
1531
15248
97
431
1764
17002
22
15
1839
17418
119
415
1737
16977
302
2025
1464
14832
325
2877
1125
11078
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
9.3e-01
1.8e+00
—
1.0e+50
—
1.6e+00
1.1e+00
cases:3.05%
controls:1.23%
cases:1.77%
controls:0.30%
—
—
cases:3.12%
controls:0.00%
—
—
cases:1.76%
controls:0.35%
cases:2.34%
controls:0.79%
56
212
1781
17017
33
53
1828
17380
—
58
0
1803
17433
—
31
59
1735
16798
34
110
1416
13845
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
9.0e-01
8.8e-01
1.5e+00
—
3.2e-01
1.1e+00
1.1e+00
cases:1.47%
controls:0.60%
cases:1.18%
controls:0.49%
cases:0.59%
controls:0.14%
—
—
cases:0.27%
controls:0.20%
cases:1.59%
controls:0.54%
cases:2.07%
controls:0.70%
27
104
1810
17125
22
86
1839
17347
11
24
1850
17409
—
5
34
1851
17358
28
91
1738
16766
30
97
1420
13858
haloperidol; oral, parenteral
N05AD01 [21604516]
1.7e+00
—
—
—
—
2.0e+00
1.7e+00
cases:0.60%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.09%
cases:0.90%
controls:0.16%
11
19
1826
17210
—
—
—
—
12
16
1754
16841
13
22
1437
13933
Social phobias
F40.1 [45595907]
1.5e+00
1.9e+00
—
—
—
2.0e+00
8.8e-01
cases:0.49%
controls:0.11%
cases:0.43%
controls:0.06%
—
—
—
—
—
—
cases:0.74%
controls:0.10%
cases:0.34%
controls:0.14%
9
19
1828
17210
8
11
1853
17422
—
—
—
13
17
1753
16840
5
20
1445
13935
General Practice
1 [38004446]
3.7e-01
6.7e-01
1.1e+00
—
2.1e+00
7.4e-01
3.7e-01
cases:19.49%
controls:14.27%
cases:9.73%
controls:5.21%
cases:2.42%
controls:0.81%
—
—
cases:5.71%
controls:0.71%
cases:11.04%
controls:5.61%
cases:17.10%
controls:12.43%
358
2458
1479
14771
181
909
1680
16524
45
141
1816
17292
—
106
124
1750
17268
195
946
1571
15911
248
1735
1202
12220
Receptive language disorder
F80.2 [45576561]
—
—
—
1.0e+50
1.0e+50
—
5.4e+00
—
—
—
—
—
—
cases:9.78%
controls:0.00%
cases:5.23%
controls:0.00%
—
—
cases:9.93%
controls:0.05%
—
—
—
182
0
1679
17433
97
0
1759
17392
—
144
7
1306
13948
Bipolar affective disorder, unspecified
F31.9 [45571758]
1.4e+00
9.4e-01
—
—
—
2.0e+00
2.0e+00
cases:0.76%
controls:0.19%
cases:0.32%
controls:0.13%
—
—
—
—
—
—
cases:0.74%
controls:0.10%
cases:1.10%
controls:0.16%
14
33
1823
17196
6
22
1855
17411
—
—
—
13
17
1753
16840
16
22
1434
13933
Implementation of speech therapy rehabilitation plan
SPAT1224 [2001700325]
1.3e+00
2.1e+00
—
—
—
2.0e+00
1.0e+00
cases:1.25%
controls:0.34%
cases:1.02%
controls:0.13%
—
—
—
—
—
—
cases:1.13%
controls:0.16%
cases:0.69%
controls:0.24%
23
59
1814
17170
19
23
1842
17410
—
—
—
20
27
1746
16830
10
34
1440
13921
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
1.1e-01
2.4e-01
5.4e-01
2.8e+00
1.7e+00
1.2e-01
-3.7e-02
cases:31.19%
controls:28.82%
cases:19.72%
controls:16.17%
cases:3.12%
controls:1.84%
cases:0.59%
controls:0.03%
cases:7.97%
controls:1.57%
cases:17.33%
controls:15.72%
cases:26.83%
controls:27.57%
573
4965
1264
12264
367
2819
1494
14614
58
320
1803
17113
11
6
1850
17427
148
273
1708
17119
306
2650
1460
14207
389
3847
1061
10108
lamotrigine; oral
N03AX09 [21604431]
1.1e+00
1.1e+00
9.9e-01
—
—
1.4e+00
1.7e+00
cases:1.80%
controls:0.59%
cases:1.07%
controls:0.38%
cases:0.32%
controls:0.12%
—
—
—
—
cases:1.53%
controls:0.37%
cases:2.00%
controls:0.37%
33
101
1804
17128
20
66
1841
17367
6
21
1855
17412
—
—
27
62
1739
16795
29
52
1421
13903
Depressive episode, unspecified
F32.9 [45571760]
8.5e-01
1.6e+00
1.6e+00
—
2.0e+00
4.2e-01
8.9e-01
cases:2.56%
controls:1.11%
cases:1.67%
controls:0.36%
cases:0.38%
controls:0.07%
—
—
cases:0.43%
controls:0.06%
cases:0.85%
controls:0.56%
cases:2.90%
controls:1.21%
47
191
1790
17038
31
62
1830
17371
7
13
1854
17420
—
8
10
1848
17382
15
94
1751
16763
42
169
1408
13786
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
3.6e-01
1.0e+00
2.2e+00
—
2.1e+00
6.7e-01
2.7e-01
cases:1.63%
controls:1.14%
cases:1.45%
controls:0.53%
cases:0.64%
controls:0.07%
—
—
cases:0.81%
controls:0.10%
cases:1.08%
controls:0.55%
cases:2.07%
controls:1.59%
30
197
1807
17032
27
92
1834
17341
12
13
1849
17420
—
15
17
1841
17375
19
93
1747
16764
30
222
1420
13733
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
3.4e-01
7.9e-01
1.4e+00
—
1.6e+00
9.4e-01
5.5e-01
cases:3.48%
controls:2.51%
cases:2.53%
controls:1.16%
cases:0.64%
controls:0.16%
—
—
cases:0.70%
controls:0.14%
cases:3.00%
controls:1.20%
cases:6.41%
controls:3.82%
64
433
1773
16796
47
203
1814
17230
12
28
1849
17405
—
13
25
1843
17367
53
202
1713
16655
93
533
1357
13422
Supine thorax X-ray examination
GD1QA [2001303648]
7.3e-01
1.2e+00
1.7e+00
—
1.3e+00
8.6e-01
7.1e-01
cases:4.74%
controls:2.33%
cases:2.85%
controls:0.88%
cases:0.86%
controls:0.15%
—
—
cases:0.48%
controls:0.14%
cases:2.21%
controls:0.95%
cases:5.72%
controls:2.90%
87
402
1750
16827
53
154
1808
17279
16
27
1845
17406
—
9
24
1847
17368
39
160
1727
16697
83
404
1367
13551
Normoblasts [#/volume] in Blood
715-3 [3021589]
6.1e-02
3.2e-02
6.0e-01
3.5e+00
1.1e+00
2.1e-01
8.7e-02
cases:14.10%
controls:13.38%
cases:10.42%
controls:10.13%
cases:4.25%
controls:2.37%
cases:4.41%
controls:0.14%
cases:6.09%
controls:2.06%
cases:11.66%
controls:9.66%
cases:16.34%
controls:15.19%
259
2305
1578
14924
194
1766
1667
15667
79
414
1782
17019
82
25
1779
17408
113
358
1743
17034
206
1629
1560
15228
237
2120
1213
11835
Telehealth
OMOP5556618 [722455]
1.4e-01
2.7e-01
6.9e-01
2.2e+00
9.5e-01
5.7e-01
4.4e-01
cases:31.36%
controls:28.34%
cases:12.74%
controls:9.99%
cases:3.06%
controls:1.55%
cases:0.54%
controls:0.06%
cases:3.93%
controls:1.55%
cases:12.51%
controls:7.46%
cases:19.59%
controls:13.52%
576
4883
1261
12346
237
1742
1624
15691
57
271
1804
17162
10
10
1851
17423
73
270
1783
17122
221
1257
1545
15600
284
1887
1166
12068
Inpatient Visit
IP [9201]
2.8e-01
5.8e-01
1.1e+00
—
2.1e+00
7.4e-01
3.1e-01
cases:11.27%
controls:8.78%
cases:6.82%
controls:3.94%
cases:1.50%
controls:0.50%
—
—
cases:3.99%
controls:0.48%
cases:7.98%
controls:3.96%
cases:12.41%
controls:9.38%
207
1513
1630
15716
127
686
1734
16747
28
87
1833
17346
—
74
84
1782
17308
141
668
1625
16189
180
1309
1270
12646
Physiotherapy
R4110 [2001310233]
5.1e-01
7.4e-01
9.2e-01
—
2.0e+00
9.9e-01
9.0e-01
cases:9.53%
controls:5.96%
cases:4.67%
controls:2.29%
cases:0.86%
controls:0.34%
—
—
cases:1.72%
controls:0.23%
cases:4.70%
controls:1.79%
cases:9.17%
controls:3.93%
175
1027
1662
16202
87
399
1774
17034
16
60
1845
17373
—
32
40
1824
17352
83
302
1683
16555
133
549
1317
13406
Other function in accordance with speech therapy nomenclature
SPAT1297 [2001700398]
1.8e+00
2.0e+00
—
—
—
1.4e+00
—
cases:0.71%
controls:0.12%
cases:0.64%
controls:0.09%
—
—
—
—
—
—
cases:0.57%
controls:0.14%
—
—
13
21
1824
17208
12
16
1849
17417
—
—
—
10
23
1756
16834
—
pregabalin; oral
N02BF02 [955152]
6.2e-01
8.7e-01
1.1e+00
-1.0e+50
1.0e+00
8.4e-01
6.7e-01
cases:5.39%
controls:2.98%
cases:3.28%
controls:1.41%
cases:1.40%
controls:0.46%
cases:0.00%
controls:0.03%
cases:1.35%
controls:0.49%
cases:3.06%
controls:1.35%
cases:4.28%
controls:2.23%
99
513
1738
16716
61
245
1800
17188
26
80
1835
17353
0
6
1861
17427
25
85
1831
17307
54
227
1712
16630
62
311
1388
13644
Psychological disorders other
P99 [2002000880]
1.3e+00
2.2e+00
—
—
—
1.7e+00
1.5e+00
cases:0.60%
controls:0.16%
cases:0.38%
controls:0.04%
—
—
—
—
—
—
cases:0.28%
controls:0.05%
cases:1.03%
controls:0.23%
11
27
1826
17202
7
7
1854
17426
—
—
—
5
9
1761
16848
15
32
1435
13923
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
5.9e-01
9.2e-01
—
1.0e+50
2.5e+00
9.8e-01
6.9e-01
cases:1.63%
controls:0.91%
cases:1.13%
controls:0.45%
—
—
cases:0.64%
controls:0.00%
cases:0.54%
controls:0.05%
cases:1.13%
controls:0.43%
cases:2.83%
controls:1.44%
30
157
1807
17072
21
79
1840
17354
—
12
0
1849
17433
10
8
1846
17384
20
72
1746
16785
41
201
1409
13754
Post-traumatic stress disorder
F43.1 [45595909]
1.7e+00
1.6e+00
—
—
—
1.7e+00
1.2e+00
cases:0.71%
controls:0.13%
cases:0.48%
controls:0.10%
—
—
—
—
—
—
cases:0.62%
controls:0.11%
cases:0.69%
controls:0.20%
13
22
1824
17207
9
17
1852
17416
—
—
—
11
19
1755
16838
10
28
1440
13927
Home Visit
OMOP4822459 [581476]
4.4e-01
6.1e-01
8.2e-01
8.0e-01
1.1e+00
8.5e-01
4.2e-01
cases:13.39%
controls:9.03%
cases:8.17%
controls:4.59%
cases:3.71%
controls:1.67%
cases:1.45%
controls:0.66%
cases:4.90%
controls:1.75%
cases:11.04%
controls:5.05%
cases:13.45%
controls:9.29%
246
1555
1591
15674
152
801
1709
16632
69
292
1792
17141
27
115
1834
17318
91
304
1765
17088
195
852
1571
16005
195
1297
1255
12658
Weakness/tiredness general
A04 [2002000145]
4.4e-01
9.0e-01
1.3e+00
2.1e+00
1.1e+00
6.7e-01
1.8e-01
cases:3.59%
controls:2.34%
cases:2.04%
controls:0.84%
cases:0.59%
controls:0.15%
cases:0.32%
controls:0.04%
cases:0.54%
controls:0.18%
cases:1.87%
controls:0.97%
cases:3.17%
controls:2.66%
66
403
1771
16826
38
147
1823
17286
11
27
1850
17406
6
7
1855
17426
10
32
1846
17360
33
163
1733
16694
46
371
1404
13584
Respiratory and circulatory monitoring
WX700 [2001310817]
3.9e-01
8.6e-01
1.3e+00
—
1.9e+00
1.2e+00
6.7e-01
cases:5.01%
controls:3.45%
cases:1.93%
controls:0.83%
cases:0.32%
controls:0.09%
—
—
cases:0.54%
controls:0.08%
cases:1.76%
controls:0.56%
cases:2.97%
controls:1.54%
92
595
1745
16634
36
144
1825
17289
6
16
1855
17417
—
10
14
1846
17378
31
94
1735
16763
43
215
1407
13740
Delirium, unspecified
F05.9 [45591078]
8.5e-01
3.0e+00
—
—
—
1.9e+00
1.4e-01
cases:0.27%
controls:0.12%
cases:0.59%
controls:0.03%
—
—
—
—
—
—
cases:0.45%
controls:0.07%
cases:0.34%
controls:0.30%
5
20
1832
17209
11
5
1850
17428
—
—
—
8
11
1758
16846
5
42
1445
13913
Epilepsy and comparable convulsive disorders
111 [2001600111]
7.3e-01
1.0e+00
—
—
—
2.2e+00
2.0e+00
cases:1.42%
controls:0.68%
cases:0.43%
controls:0.15%
—
—
—
—
—
—
cases:1.19%
controls:0.13%
cases:2.41%
controls:0.34%
26
118
1811
17111
8
27
1853
17406
—
—
—
21
22
1745
16835
35
47
1415
13908
Psychiatric family contact
IGP01 [2001304317]
1.4e+00
1.5e+00
—
—
—
2.0e+00
1.4e+00
cases:0.49%
controls:0.12%
cases:0.48%
controls:0.11%
—
—
—
—
—
—
cases:0.85%
controls:0.11%
cases:1.38%
controls:0.34%
9
20
1828
17209
9
19
1852
17414
—
—
—
15
19
1751
16838
20
47
1430
13908
Undifferentiated schizophrenia continuous
F20.30 [2000501944]
2.0e+00
2.2e+00
—
—
—
—
2.9e+00
cases:0.49%
controls:0.06%
cases:0.27%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.62%
controls:0.04%
9
11
1828
17218
5
5
1856
17428
—
—
—
—
9
5
1441
13950
venlafaxine; oral
N06AX16 [21604745]
8.2e-01
8.4e-01
8.1e-01
—
1.4e+00
8.4e-01
1.0e+00
cases:3.05%
controls:1.36%
cases:1.67%
controls:0.73%
cases:0.54%
controls:0.24%
—
—
cases:0.86%
controls:0.22%
cases:1.87%
controls:0.81%
cases:3.17%
controls:1.15%
56
235
1781
16994
31
127
1830
17306
10
42
1851
17391
—
16
39
1840
17353
33
137
1733
16720
46
160
1404
13795
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
7.5e-01
1.4e+00
1.8e+00
—
—
1.3e+00
1.4e+00
cases:1.47%
controls:0.70%
cases:0.81%
controls:0.20%
cases:0.27%
controls:0.05%
—
—
—
—
cases:0.62%
controls:0.17%
cases:1.31%
controls:0.32%
27
121
1810
17108
15
34
1846
17399
5
8
1856
17425
—
—
11
29
1755
16828
19
45
1431
13910
pH of Arterial blood
2744-1 [3019977]
6.5e-01
8.0e-01
1.2e+00
1.0e+50
2.8e+00
5.4e-01
5.8e-01
cases:3.92%
controls:2.08%
cases:1.88%
controls:0.85%
cases:0.38%
controls:0.11%
cases:0.86%
controls:0.00%
cases:1.24%
controls:0.07%
cases:1.64%
controls:0.97%
cases:4.28%
controls:2.45%
72
359
1765
16870
35
149
1826
17284
7
20
1854
17413
16
0
1845
17433
23
13
1833
17379
29
163
1737
16694
62
342
1388
13613
Nursing episode
950 [44777714]
4.0e-01
6.3e-01
7.7e-01
1.4e+00
1.0e+00
9.0e-01
9.7e-02
cases:3.48%
controls:2.36%
cases:2.58%
controls:1.39%
cases:1.29%
controls:0.60%
cases:0.64%
controls:0.15%
cases:1.67%
controls:0.59%
cases:3.57%
controls:1.48%
cases:3.10%
controls:2.82%
64
407
1773
16822
48
243
1813
17190
24
105
1837
17328
12
27
1849
17406
31
103
1825
17289
63
249
1703
16608
45
394
1405
13561
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
5.6e-01
1.4e+00
2.6e+00
—
—
8.5e-01
6.9e-01
cases:1.20%
controls:0.69%
cases:1.18%
controls:0.29%
cases:0.64%
controls:0.05%
—
—
—
—
cases:1.02%
controls:0.44%
cases:2.34%
controls:1.19%
22
119
1815
17110
22
50
1839
17383
12
8
1849
17425
—
—
18
74
1748
16783
34
166
1416
13789
Pure hypercholesterolaemia
E78.01 [2000501514]
1.8e-01
6.6e-01
1.0e+00
—
1.9e+00
8.1e-01
4.0e-01
cases:3.81%
controls:3.20%
cases:2.96%
controls:1.55%
cases:0.86%
controls:0.31%
—
—
cases:1.72%
controls:0.27%
cases:3.74%
controls:1.70%
cases:6.07%
controls:4.15%
70
551
1767
16678
55
271
1806
17162
16
54
1845
17379
—
32
47
1824
17345
66
287
1700
16570
88
579
1362
13376
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
1.1e-01
4.2e-01
6.8e-01
2.4e+00
1.6e+00
7.5e-01
2.8e-01
cases:7.08%
controls:6.38%
cases:3.98%
controls:2.65%
cases:0.70%
controls:0.36%
cases:0.38%
controls:0.03%
cases:1.56%
controls:0.32%
cases:4.19%
controls:2.02%
cases:6.34%
controls:4.86%
130
1100
1707
16129
74
462
1787
16971
13
62
1848
17371
7
6
1854
17427
29
55
1827
17337
74
340
1692
16517
92
678
1358
13277
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
5.5e-01
9.1e-01
1.1e+00
—
1.5e+00
1.3e+00
1.9e+00
cases:2.56%
controls:1.50%
cases:1.61%
controls:0.65%
cases:0.43%
controls:0.14%
—
—
cases:0.38%
controls:0.09%
cases:1.25%
controls:0.33%
cases:1.93%
controls:0.28%
47
258
1790
16971
30
114
1831
17319
8
24
1853
17409
—
7
15
1849
17377
22
55
1744
16802
28
39
1422
13916
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
3.9e-01
8.0e-01
1.3e+00
—
1.3e+00
9.0e-01
5.0e-01
cases:4.74%
controls:3.26%
cases:3.49%
controls:1.60%
cases:0.75%
controls:0.21%
—
—
cases:0.86%
controls:0.24%
cases:3.74%
controls:1.55%
cases:7.93%
controls:4.97%
87
562
1750
16667
65
279
1796
17154
14
37
1847
17396
—
16
42
1840
17350
66
262
1700
16595
115
694
1335
13261
Bacteria identified in Blood by Culture
600-7 [3023368]
3.3e-01
7.3e-01
1.2e+00
—
1.8e+00
7.0e-01
2.7e-01
cases:8.87%
controls:6.51%
cases:5.37%
controls:2.66%
cases:1.18%
controls:0.36%
—
—
cases:2.21%
controls:0.39%
cases:5.21%
controls:2.65%
cases:8.76%
controls:6.81%
163
1122
1674
16107
100
464
1761
16969
22
62
1839
17371
—
41
67
1815
17325
92
447
1674
16410
127
951
1323
13004
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
4.0e-01
5.3e-01
9.3e-01
—
2.2e+00
6.7e-01
1.5e-01
cases:13.66%
controls:9.59%
cases:8.01%
controls:4.87%
cases:1.56%
controls:0.62%
—
—
cases:3.29%
controls:0.37%
cases:9.29%
controls:4.97%
cases:13.52%
controls:11.89%
251
1652
1586
15577
149
849
1712
16584
29
108
1832
17325
—
61
65
1795
17327
164
838
1602
16019
196
1659
1254
12296
lithium; oral
N05AN01 [21604556]
1.5e+00
1.4e+00
—
—
—
1.6e+00
1.6e+00
cases:0.65%
controls:0.15%
cases:0.38%
controls:0.09%
—
—
—
—
—
—
cases:0.51%
controls:0.10%
cases:0.62%
controls:0.13%
12
25
1825
17204
7
16
1854
17417
—
—
—
9
17
1757
16840
9
18
1441
13937
Implementation of occupational therapy rehabilitation plan
SPAT1226 [2001700327]
8.1e-01
2.0e+00
—
—
—
2.7e+00
1.2e+00
cases:0.65%
controls:0.29%
cases:0.54%
controls:0.07%
—
—
—
—
—
—
cases:0.62%
controls:0.04%
cases:0.48%
controls:0.15%
12
50
1825
17179
10
13
1851
17420
—
—
—
11
7
1755
16850
7
21
1443
13934
Thorax X-ray examination
GD1AA [2001303617]
3.4e-01
6.6e-01
1.1e+00
—
1.4e+00
8.2e-01
3.8e-01
cases:13.83%
controls:10.22%
cases:7.15%
controls:3.81%
cases:1.29%
controls:0.43%
—
—
cases:1.62%
controls:0.41%
cases:6.17%
controls:2.81%
cases:10.69%
controls:7.55%
254
1760
1583
15469
133
665
1728
16768
24
75
1837
17358
—
30
72
1826
17320
109
474
1657
16383
155
1053
1295
12902
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
4.4e-01
5.0e-01
2.1e+00
1.0e+50
3.1e+00
1.6e+00
9.8e-02
cases:1.91%
controls:1.23%
cases:0.54%
controls:0.33%
cases:0.27%
controls:0.03%
cases:0.38%
controls:0.00%
cases:0.92%
controls:0.04%
cases:1.25%
controls:0.27%
cases:1.03%
controls:0.94%
35
212
1802
17017
10
57
1851
17376
5
6
1856
17427
7
0
1854
17433
17
7
1839
17385
22
45
1744
16812
15
131
1435
13824
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
2.1e+00
2.4e+00
—
—
—
2.3e+00
1.5e+00
cases:0.27%
controls:0.03%
cases:0.32%
controls:0.03%
—
—
—
—
—
—
cases:0.34%
controls:0.04%
cases:0.41%
controls:0.09%
5
6
1832
17223
6
5
1855
17428
—
—
—
6
6
1760
16851
6
13
1444
13942
Examination of ears and hearing
Z01.1 [45547279]
4.4e-01
7.7e-01
1.2e+00
—
1.7e+00
1.3e+00
4.7e-01
cases:5.39%
controls:3.53%
cases:2.10%
controls:0.98%
cases:0.38%
controls:0.11%
—
—
cases:0.65%
controls:0.12%
cases:3.23%
controls:0.90%
cases:4.76%
controls:3.04%
99
608
1738
16621
39
171
1822
17262
7
20
1854
17413
—
12
21
1844
17371
57
151
1709
16706
69
424
1381
13531
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
6.3e-01
8.0e-01
1.1e+00
1.0e+50
2.7e+00
5.6e-01
5.6e-01
cases:3.86%
controls:2.10%
cases:1.88%
controls:0.85%
cases:0.38%
controls:0.12%
cases:0.86%
controls:0.00%
cases:1.24%
controls:0.09%
cases:1.64%
controls:0.95%
cases:4.21%
controls:2.44%
71
362
1766
16867
35
149
1826
17284
7
21
1854
17412
16
0
1845
17433
23
15
1833
17377
29
160
1737
16697
61
340
1389
13615
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
6.3e-01
8.0e-01
1.1e+00
1.0e+50
2.7e+00
5.6e-01
5.6e-01
cases:3.86%
controls:2.10%
cases:1.88%
controls:0.85%
cases:0.38%
controls:0.12%
cases:0.86%
controls:0.00%
cases:1.24%
controls:0.09%
cases:1.64%
controls:0.95%
cases:4.21%
controls:2.44%
71
362
1766
16867
35
149
1826
17284
7
21
1854
17412
16
0
1845
17433
23
15
1833
17377
29
160
1737
16697
61
340
1389
13615
Specific gravity of Urine by Test strip
5811-5 [3000330]
5.6e-01
8.6e-01
1.8e+00
—
2.0e+00
7.0e-01
2.9e-01
cases:1.69%
controls:0.98%
cases:1.34%
controls:0.57%
cases:0.43%
controls:0.07%
—
—
cases:0.48%
controls:0.06%
cases:1.42%
controls:0.71%
cases:2.83%
controls:2.12%
31
168
1806
17061
25
100
1836
17333
8
13
1853
17420
—
9
11
1847
17381
25
119
1741
16738
41
296
1409
13659
Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]
1.3e+00
2.2e+00
—
—
—
1.2e+00
1.2e+00
cases:1.42%
controls:0.39%
cases:1.34%
controls:0.15%
—
—
—
—
—
—
cases:0.57%
controls:0.18%
cases:1.59%
controls:0.49%
26
68
1811
17161
25
27
1836
17406
—
—
—
10
30
1756
16827
23
68
1427
13887
Base excess in Arterial blood by calculation
1925-7 [3003396]
6.4e-01
7.4e-01
1.1e+00
1.0e+50
2.7e+00
5.6e-01
5.7e-01
cases:3.92%
controls:2.10%
cases:1.72%
controls:0.83%
cases:0.38%
controls:0.12%
cases:0.75%
controls:0.00%
cases:1.19%
controls:0.08%
cases:1.64%
controls:0.95%
cases:4.28%
controls:2.47%
72
362
1765
16867
32
145
1829
17288
7
21
1854
17412
14
0
1847
17433
22
14
1834
17378
29
160
1737
16697
62
344
1388
13611
Functional dysphonia
R49.01 [2000503597]
5.5e-01
1.8e+00
—
—
—
2.6e+00
2.0e+00
cases:0.27%
controls:0.16%
cases:0.32%
controls:0.05%
—
—
—
—
—
—
cases:0.40%
controls:0.03%
cases:0.55%
controls:0.07%
5
27
1832
17202
6
9
1855
17424
—
—
—
7
5
1759
16852
8
10
1442
13945
Other rehabilitation service
R5599 [2001310270]
9.7e-01
1.8e+00
—
—
—
2.5e+00
2.1e+00
cases:0.65%
controls:0.25%
cases:0.27%
controls:0.05%
—
—
—
—
—
—
cases:0.51%
controls:0.04%
cases:1.10%
controls:0.14%
12
43
1825
17186
5
8
1856
17425
—
—
—
9
7
1757
16850
16
19
1434
13936
Headache
R51.80 [2000503603]
6.7e-01
6.2e-01
1.4e+00
1.0e+50
2.2e+00
1.2e+00
4.8e-01
cases:3.48%
controls:1.82%
cases:1.29%
controls:0.70%
cases:0.32%
controls:0.08%
cases:1.07%
controls:0.00%
cases:0.54%
controls:0.06%
cases:2.04%
controls:0.62%
cases:4.83%
controls:3.04%
64
313
1773
16916
24
122
1837
17311
6
14
1855
17419
20
0
1841
17433
10
10
1846
17382
36
104
1730
16753
70
424
1380
13531
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
4.7e-01
3.4e-01
2.1e+00
1.0e+50
3.1e+00
1.5e+00
1.7e-02
cases:2.18%
controls:1.38%
cases:0.54%
controls:0.38%
cases:0.27%
controls:0.03%
cases:0.38%
controls:0.00%
cases:0.97%
controls:0.05%
cases:1.25%
controls:0.28%
cases:1.03%
controls:1.02%
40
237
1797
16992
10
67
1851
17366
5
6
1856
17427
7
0
1854
17433
18
8
1838
17384
22
47
1744
16810
15
142
1435
13813
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
1.4e+00
1.8e+00
—
—
—
1.4e+00
7.5e-01
cases:0.60%
controls:0.15%
cases:1.02%
controls:0.18%
—
—
—
—
—
—
cases:0.91%
controls:0.22%
cases:1.59%
controls:0.75%
11
26
1826
17203
19
31
1842
17402
—
—
—
16
37
1750
16820
23
105
1427
13850
Glucose [Moles/volume] in Venous blood
39480-9 [3038515]
7.2e-01
1.4e+00
—
—
3.1e+00
9.5e-01
3.6e-01
cases:1.03%
controls:0.50%
cases:1.02%
controls:0.25%
—
—
—
—
cases:0.65%
controls:0.03%
cases:0.74%
controls:0.28%
cases:1.17%
controls:0.82%
19
87
1818
17142
19
43
1842
17390
—
—
12
5
1844
17387
13
48
1753
16809
17
114
1433
13841
Atherosclerotic heart disease
I25.1 [45596196]
1.7e-01
-4.1e-03
3.5e-01
3.4e+00
1.1e+00
3.6e-01
2.7e-01
cases:4.90%
controls:4.15%
cases:2.26%
controls:2.27%
cases:0.70%
controls:0.49%
cases:1.18%
controls:0.04%
cases:1.29%
controls:0.41%
cases:3.11%
controls:2.19%
cases:5.17%
controls:4.01%
90
715
1747
16514
42
395
1819
17038
13
86
1848
17347
22
7
1839
17426
24
72
1832
17320
55
370
1711
16487
75
560
1375
13395
Bipolar affective disorder, current episode mixed
F31.6 [45571757]
2.0e+00
—
—
—
—
—
2.5e+00
cases:0.44%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.62%
controls:0.05%
8
10
1829
17219
—
—
—
—
—
9
7
1441
13948
Recurrent depressive disorder, unspecified
F33.9 [45581458]
1.4e+00
1.9e+00
—
—
—
1.3e+00
1.3e+00
cases:0.76%
controls:0.20%
cases:0.48%
controls:0.07%
—
—
—
—
—
—
cases:0.28%
controls:0.08%
cases:0.90%
controls:0.24%
14
34
1823
17195
9
13
1852
17420
—
—
—
5
13
1761
16844
13
34
1437
13921
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
2.0e-03
2.0e-01
5.1e-01
3.5e+00
7.6e-01
3.0e-01
6.4e-02
cases:10.83%
controls:10.81%
cases:8.22%
controls:6.85%
cases:1.88%
controls:1.14%
cases:1.07%
controls:0.03%
cases:2.16%
controls:1.02%
cases:9.57%
controls:7.26%
cases:19.79%
controls:18.80%
199
1863
1638
15366
153
1194
1708
16239
35
199
1826
17234
20
6
1841
17427
40
178
1816
17214
169
1223
1597
15634
287
2624
1163
11331
platelet aggregation inhibitors excl. heparin - combinations
B01AC30 [21601005]
7.1e-01
5.8e-01
7.5e-01
—
1.4e+00
1.2e+00
1.2e+00
cases:1.96%
controls:0.97%
cases:1.29%
controls:0.72%
cases:0.48%
controls:0.23%
—
—
cases:0.86%
controls:0.21%
cases:1.87%
controls:0.60%
cases:1.86%
controls:0.57%
36
167
1801
17062
24
126
1837
17307
9
40
1852
17393
—
16
36
1840
17356
33
101
1733
16756
27
79
1423
13876
acetylsalicylic acid, combinations excl. psycholeptics
N02BA51 [21604320]
7.1e-01
5.8e-01
7.5e-01
—
1.4e+00
1.2e+00
1.2e+00
cases:1.96%
controls:0.97%
cases:1.29%
controls:0.72%
cases:0.48%
controls:0.23%
—
—
cases:0.86%
controls:0.21%
cases:1.87%
controls:0.60%
cases:1.86%
controls:0.57%
36
167
1801
17062
24
126
1837
17307
9
40
1852
17393
—
16
36
1840
17356
33
101
1733
16756
27
79
1423
13876
Occupational Medicine Clinic/Center
261QX0100X [38004267]
1.0e+00
2.2e+00
—
—
1.0e+50
2.3e+00
-1.0e+50
cases:0.49%
controls:0.17%
cases:0.38%
controls:0.04%
—
—
—
—
cases:0.27%
controls:0.00%
cases:0.40%
controls:0.04%
cases:0.00%
controls:0.06%
9
30
1828
17199
7
7
1854
17426
—
—
5
0
1851
17392
7
7
1759
16850
0
8
1450
13947
ECG with 12 standard connections
XF400 [2001303368]
5.5e-01
8.1e-01
1.3e+00
1.0e+50
1.4e+00
8.3e-01
8.9e-01
cases:5.77%
controls:3.42%
cases:2.85%
controls:1.29%
cases:0.48%
controls:0.14%
cases:1.93%
controls:0.00%
cases:0.59%
controls:0.14%
cases:1.93%
controls:0.85%
cases:4.07%
controls:1.71%
106
590
1731
16639
53
225
1808
17208
9
24
1852
17409
36
0
1825
17433
11
25
1845
17367
34
143
1732
16714
59
239
1391
13716
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
4.4e-01
9.3e-01
1.8e+00
—
1.7e+00
5.1e-01
4.6e-01
cases:2.12%
controls:1.38%
cases:1.77%
controls:0.71%
cases:0.75%
controls:0.12%
—
—
cases:0.81%
controls:0.15%
cases:1.30%
controls:0.78%
cases:3.38%
controls:2.15%
39
237
1798
16992
33
123
1828
17310
14
21
1847
17412
—
15
26
1841
17366
23
132
1743
16725
49
300
1401
13655
Hyperkinetic disorder, unspecified
F90.9 [45533124]
—
2.4e+00
—
—
—
2.1e+00
8.6e-01
—
—
cases:0.38%
controls:0.03%
—
—
—
—
—
—
cases:0.51%
controls:0.07%
cases:0.83%
controls:0.35%
—
7
6
1854
17427
—
—
—
9
11
1757
16846
12
49
1438
13906
Monitored bed care
WX892 [2001310850]
6.8e-01
8.2e-01
1.8e+00
1.0e+50
2.0e+00
9.6e-01
7.7e-01
cases:3.05%
controls:1.57%
cases:1.02%
controls:0.45%
cases:0.38%
controls:0.06%
cases:0.32%
controls:0.00%
cases:0.38%
controls:0.05%
cases:0.68%
controls:0.26%
cases:1.24%
controls:0.58%
56
271
1781
16958
19
79
1842
17354
7
11
1854
17422
6
0
1855
17433
7
9
1849
17383
12
44
1754
16813
18
81
1432
13874
clonazepam; oral, parenteral
N03AE01 [21604415]
9.3e-01
1.1e+00
1.0e+00
—
1.3e+00
1.1e+00
1.3e+00
cases:1.58%
controls:0.63%
cases:1.13%
controls:0.39%
cases:0.38%
controls:0.14%
—
—
cases:0.48%
controls:0.14%
cases:1.19%
controls:0.38%
cases:1.24%
controls:0.34%
29
108
1808
17121
21
68
1840
17365
7
24
1854
17409
—
9
24
1847
17368
21
64
1745
16793
18
48
1432
13907
Cocaine [Presence] in Urine
3397-7 [3016879]
1.1e+00
2.1e+00
—
—
—
1.1e+00
1.2e+00
cases:1.42%
controls:0.48%
cases:1.45%
controls:0.17%
—
—
—
—
—
—
cases:0.62%
controls:0.21%
cases:1.79%
controls:0.55%
26
82
1811
17147
27
30
1834
17403
—
—
—
11
36
1755
16821
26
77
1424
13878
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
1.5e-01
2.8e-01
7.3e-01
1.8e+00
1.1e+00
5.1e-01
2.1e-01
cases:19.22%
controls:17.06%
cases:13.33%
controls:10.42%
cases:4.84%
controls:2.40%
cases:1.02%
controls:0.17%
cases:6.47%
controls:2.21%
cases:14.50%
controls:9.21%
cases:19.66%
controls:16.57%
353
2939
1484
14290
248
1817
1613
15616
90
418
1771
17015
19
30
1842
17403
120
385
1736
17007
256
1553
1510
15304
285
2313
1165
11642
Other psychiatric family intervention
IEP99 [2001304203]
1.8e+00
—
—
—
—
2.3e+00
2.2e+00
cases:0.27%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.04%
cases:0.62%
controls:0.07%
5
8
1832
17221
—
—
—
—
7
7
1759
16850
9
10
1441
13945
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
G40.19 [2000502138]
1.5e+00
2.2e+00
—
1.0e+50
—
2.4e+00
2.0e+00
cases:0.38%
controls:0.09%
cases:0.27%
controls:0.03%
—
—
cases:0.32%
controls:0.00%
—
—
cases:0.45%
controls:0.04%
cases:0.76%
controls:0.10%
7
15
1830
17214
5
5
1856
17428
—
6
0
1855
17433
—
8
7
1758
16850
11
14
1439
13941
Simple partial seizures with secondary generalization
G40.12 [2000502137]
1.5e+00
—
—
—
—
2.4e+00
2.0e+00
cases:0.27%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.04%
cases:0.69%
controls:0.09%
5
11
1832
17218
—
—
—
—
8
7
1758
16850
10
13
1440
13942
Observation for suspected nervous system disorder
Z03.3 [45609903]
5.6e-01
9.3e-01
—
—
2.0e+00
1.6e+00
7.8e-01
cases:1.36%
controls:0.78%
cases:0.75%
controls:0.30%
—
—
—
—
cases:0.38%
controls:0.05%
cases:1.02%
controls:0.20%
cases:1.59%
controls:0.73%
25
135
1812
17094
14
52
1847
17381
—
—
7
9
1849
17383
18
34
1748
16823
23
102
1427
13853
Monocytes/Leukocytes in Blood
26485-3 [3019069]
1.8e-01
3.1e-01
6.5e-01
1.6e+00
1.3e+00
5.2e-01
2.0e-01
cases:16.88%
controls:14.45%
cases:11.23%
controls:8.53%
cases:3.22%
controls:1.71%
cases:0.48%
controls:0.10%
cases:5.28%
controls:1.53%
cases:12.40%
controls:7.77%
cases:16.97%
controls:14.29%
310
2489
1527
14740
209
1487
1652
15946
60
298
1801
17135
9
17
1852
17416
98
266
1758
17126
219
1310
1547
15547
246
1994
1204
11961
Physical Medicine And Rehabilitation
25 [38004468]
4.1e-01
8.2e-01
-1.4e-01
—
1.7e+00
9.1e-01
5.3e-01
cases:7.51%
controls:5.13%
cases:4.19%
controls:1.88%
cases:0.27%
controls:0.31%
—
—
cases:1.35%
controls:0.25%
cases:4.13%
controls:1.71%
cases:7.93%
controls:4.82%
138
883
1699
16346
78
328
1783
17105
5
54
1856
17379
—
25
44
1831
17348
73
288
1693
16569
115
672
1335
13283
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
2.0e-01
3.0e-01
6.5e-01
1.6e+00
1.3e+00
5.2e-01
2.1e-01
cases:16.98%
controls:14.37%
cases:11.12%
controls:8.51%
cases:3.22%
controls:1.70%
cases:0.48%
controls:0.10%
cases:5.28%
controls:1.54%
cases:12.40%
controls:7.76%
cases:17.10%
controls:14.28%
312
2476
1525
14753
207
1484
1654
15949
60
297
1801
17136
9
17
1852
17416
98
267
1758
17125
219
1308
1547
15549
248
1993
1202
11962
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
1.9e-01
3.1e-01
6.4e-01
1.6e+00
1.3e+00
4.9e-01
2.0e-01
cases:16.93%
controls:14.41%
cases:11.34%
controls:8.60%
cases:3.22%
controls:1.73%
cases:0.48%
controls:0.10%
cases:5.33%
controls:1.51%
cases:12.06%
controls:7.75%
cases:17.24%
controls:14.53%
311
2482
1526
14747
211
1500
1650
15933
60
302
1801
17131
9
17
1852
17416
99
262
1757
17130
213
1307
1553
15550
250
2028
1200
11927
Basophils/Leukocytes in Blood
30180-4 [3022096]
2.0e-01
2.9e-01
6.4e-01
1.6e+00
1.3e+00
5.2e-01
2.2e-01
cases:16.98%
controls:14.32%
cases:11.07%
controls:8.50%
cases:3.22%
controls:1.73%
cases:0.48%
controls:0.10%
cases:5.28%
controls:1.54%
cases:12.40%
controls:7.78%
cases:17.24%
controls:14.36%
312
2467
1525
14762
206
1481
1655
15952
60
302
1801
17131
9
17
1852
17416
98
267
1758
17125
219
1311
1547
15546
250
2004
1200
11951
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
1.7e-01
7.0e-01
1.1e+00
1.0e+50
1.4e+00
7.1e-01
4.3e-01
cases:5.44%
controls:4.63%
cases:3.49%
controls:1.76%
cases:0.81%
controls:0.27%
cases:0.54%
controls:0.00%
cases:1.13%
controls:0.29%
cases:3.57%
controls:1.79%
cases:8.07%
controls:5.38%
100
797
1737
16432
65
307
1796
17126
15
47
1846
17386
10
0
1851
17433
21
50
1835
17342
63
301
1703
16556
117
751
1333
13204
Psychiatric treatment plan, standard
ICB01 [2001304098]
1.4e+00
1.2e+00
—
1.0e+50
1.9e+00
1.4e+00
1.6e+00
cases:0.76%
controls:0.20%
cases:0.54%
controls:0.15%
—
—
cases:0.27%
controls:0.00%
cases:0.27%
controls:0.04%
cases:0.91%
controls:0.23%
cases:2.76%
controls:0.59%
14
34
1823
17195
10
27
1851
17406
—
5
0
1856
17433
5
7
1851
17385
16
38
1750
16819
40
82
1410
13873
Limited function/disability NOS
A28 [2002000162]
5.0e-01
6.7e-01
8.4e-01
7.2e-01
1.3e+00
1.0e+00
2.3e-01
cases:5.39%
controls:3.33%
cases:3.82%
controls:1.98%
cases:1.88%
controls:0.82%
cases:0.64%
controls:0.32%
cases:2.75%
controls:0.78%
cases:5.72%
controls:2.16%
cases:5.72%
controls:4.59%
99
573
1738
16656
71
346
1790
17087
35
143
1826
17290
12
55
1849
17378
51
135
1805
17257
101
364
1665
16493
83
640
1367
13315
dexamethasone; oral, parenteral
H02AB02 [21602730]
2.1e-02
4.6e-01
1.3e+00
—
2.2e+00
8.1e-01
-2.2e-01
cases:3.10%
controls:3.04%
cases:2.15%
controls:1.37%
cases:0.64%
controls:0.18%
—
—
cases:1.62%
controls:0.18%
cases:2.38%
controls:1.07%
cases:2.00%
controls:2.47%
57
524
1780
16705
40
239
1821
17194
12
31
1849
17402
—
30
32
1826
17360
42
180
1724
16677
29
345
1421
13610
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
182 [2001600181]
1.2e+00
—
—
—
—
2.4e+00
1.9e+00
cases:0.54%
controls:0.17%
—
—
—
—
—
—
—
—
cases:0.91%
controls:0.08%
cases:1.03%
controls:0.16%
10
29
1827
17200
—
—
—
—
16
14
1750
16843
15
22
1435
13933
Case Management Agency
251B00000X [38004193]
-2.6e-01
-2.2e-02
4.4e-01
3.5e+00
6.0e-01
9.4e-03
-7.2e-02
cases:59.83%
controls:65.90%
cases:56.90%
controls:57.44%
cases:34.61%
controls:25.34%
cases:36.32%
controls:1.72%
cases:37.98%
controls:25.20%
cases:57.70%
controls:57.47%
cases:62.34%
controls:64.01%
1099
11354
738
5875
1059
10014
802
7419
644
4417
1217
13016
676
300
1185
17133
705
4382
1151
13010
1019
9688
747
7169
904
8933
546
5022
Other psychiatric network intervention
IEV99 [2001304218]
—
—
—
—
—
2.5e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.04%
cases:0.62%
controls:0.11%
—
—
—
—
—
8
6
1758
16851
9
16
1441
13939
Amphetamines [Presence] in Urine
3349-8 [3027944]
1.1e+00
2.1e+00
—
—
—
9.2e-01
1.1e+00
cases:1.42%
controls:0.49%
cases:1.45%
controls:0.18%
—
—
—
—
—
—
cases:0.57%
controls:0.23%
cases:1.79%
controls:0.61%
26
85
1811
17144
27
32
1834
17401
—
—
—
10
38
1756
16819
26
85
1424
13870
Counselling and guidance related to nutrition and weight management
SPAT1306 [2001700407]
3.1e-01
1.0e+00
1.2e+00
1.2e+00
1.2e+00
7.6e-01
1.6e-01
cases:2.67%
controls:1.96%
cases:1.77%
controls:0.64%
cases:0.70%
controls:0.21%
cases:0.27%
controls:0.08%
cases:0.92%
controls:0.28%
cases:1.42%
controls:0.66%
cases:1.86%
controls:1.58%
49
338
1788
16891
33
112
1828
17321
13
36
1848
17397
5
14
1856
17419
17
48
1839
17344
25
112
1741
16745
27
221
1423
13734
Sleep apnoea
G47.3 [45562094]
3.6e-01
4.2e-01
1.0e+00
3.2e+00
8.9e-01
4.4e-01
1.9e-01
cases:4.46%
controls:3.15%
cases:3.06%
controls:2.02%
cases:1.07%
controls:0.40%
cases:1.13%
controls:0.05%
cases:0.92%
controls:0.38%
cases:3.06%
controls:1.99%
cases:3.93%
controls:3.27%
82
543
1755
16686
57
353
1804
17080
20
69
1841
17364
21
8
1840
17425
17
66
1839
17326
54
336
1712
16521
57
457
1393
13498
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1.1e-01
2.6e-01
1.7e-01
2.4e+00
1.2e+00
6.6e-01
3.7e-01
cases:4.74%
controls:4.27%
cases:2.96%
controls:2.30%
cases:0.48%
controls:0.41%
cases:0.43%
controls:0.04%
cases:1.19%
controls:0.37%
cases:3.34%
controls:1.75%
cases:4.97%
controls:3.47%
87
736
1750
16493
55
401
1806
17032
9
71
1852
17362
8
7
1853
17426
22
64
1834
17328
59
295
1707
16562
72
484
1378
13471
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
1.7e-01
2.7e-01
6.1e-01
1.6e+00
1.3e+00
4.7e-01
1.9e-01
cases:17.20%
controls:14.89%
cases:11.34%
controls:8.93%
cases:3.22%
controls:1.77%
cases:0.48%
controls:0.10%
cases:5.28%
controls:1.56%
cases:12.40%
controls:8.09%
cases:17.66%
controls:15.07%
316
2566
1521
14663
211
1556
1650
15877
60
309
1801
17124
9
17
1852
17416
98
272
1758
17120
219
1364
1547
15493
256
2103
1194
11852
Benzodiazepines [Presence] in Urine
3390-2 [3000764]
1.1e+00
2.0e+00
—
—
—
9.7e-01
1.1e+00
cases:1.47%
controls:0.49%
cases:1.45%
controls:0.20%
—
—
—
—
—
—
cases:0.62%
controls:0.24%
cases:1.79%
controls:0.62%
27
85
1810
17144
27
34
1834
17399
—
—
—
11
40
1755
16817
26
86
1424
13869
Psychiatric monitoring contact
IGY02 [2001304322]
8.7e-01
1.3e+00
1.4e+00
—
1.8e+00
1.5e+00
1.3e+00
cases:0.93%
controls:0.39%
cases:0.91%
controls:0.24%
cases:0.32%
controls:0.08%
—
—
cases:0.27%
controls:0.05%
cases:1.08%
controls:0.24%
cases:2.41%
controls:0.64%
17
67
1820
17162
17
42
1844
17391
6
14
1855
17419
—
5
8
1851
17384
19
40
1747
16817
35
90
1415
13865
Opiates [Presence] in Urine
3879-4 [3027008]
1.1e+00
2.0e+00
—
—
—
9.7e-01
1.1e+00
cases:1.47%
controls:0.51%
cases:1.45%
controls:0.19%
—
—
—
—
—
—
cases:0.62%
controls:0.24%
cases:1.79%
controls:0.62%
27
88
1810
17141
27
33
1834
17400
—
—
—
11
40
1755
16817
26
86
1424
13869
Schizophrenia, unspecified
F20.9 [45576533]
1.4e+00
1.6e+00
—
—
—
2.6e+00
1.6e+00
cases:0.54%
controls:0.14%
cases:0.32%
controls:0.06%
—
—
—
—
—
—
cases:0.57%
controls:0.04%
cases:0.62%
controls:0.13%
10
24
1827
17205
6
11
1855
17422
—
—
—
10
7
1756
16850
9
18
1441
13937
Basophils [#/volume] in Blood
26444-0 [3006315]
1.6e-01
2.6e-01
6.1e-01
1.5e+00
1.3e+00
5.1e-01
2.3e-01
cases:17.20%
controls:14.99%
cases:11.34%
controls:8.94%
cases:3.28%
controls:1.80%
cases:0.48%
controls:0.11%
cases:5.55%
controls:1.57%
cases:12.80%
controls:8.12%
cases:18.48%
controls:15.28%
316
2582
1521
14647
211
1559
1650
15874
61
314
1800
17119
9
19
1852
17414
103
273
1753
17119
226
1368
1540
15489
268
2133
1182
11822
Conditioning play audiometry
6339003 [4272008]
1.3e+00
1.1e+00
—
—
—
2.9e+00
—
cases:0.82%
controls:0.23%
cases:0.27%
controls:0.09%
—
—
—
—
—
—
cases:0.74%
controls:0.04%
—
—
15
39
1822
17190
5
15
1856
17418
—
—
—
13
7
1753
16850
—
Cannabinoids [Presence] in Urine
3427-2 [3028300]
1.1e+00
2.0e+00
—
—
—
9.7e-01
1.1e+00
cases:1.47%
controls:0.51%
cases:1.45%
controls:0.20%
—
—
—
—
—
—
cases:0.62%
controls:0.24%
cases:1.79%
controls:0.62%
27
88
1810
17141
27
34
1834
17399
—
—
—
11
40
1755
16817
26
86
1424
13869
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
1.1e+00
1.9e+00
—
—
—
1.2e+00
1.2e+00
cases:1.09%
controls:0.37%
cases:1.13%
controls:0.17%
—
—
—
—
—
—
cases:0.51%
controls:0.15%
cases:1.38%
controls:0.43%
20
63
1817
17166
21
30
1840
17403
—
—
—
9
26
1757
16831
20
60
1430
13895
Medical doctor
Z2221 [2001311556]
7.3e-01
7.5e-01
9.9e-01
—
1.0e+00
1.4e+00
1.3e+00
cases:8.33%
controls:4.19%
cases:2.31%
controls:1.11%
cases:0.54%
controls:0.20%
—
—
cases:0.43%
controls:0.16%
cases:3.11%
controls:0.80%
cases:5.45%
controls:1.58%
153
722
1684
16507
43
193
1818
17240
10
35
1851
17398
—
8
27
1848
17365
55
135
1711
16722
79
220
1371
13735
Monocytes [#/volume] in Blood
26484-6 [3001604]
1.6e-01
2.6e-01
5.8e-01
1.5e+00
1.3e+00
5.0e-01
2.2e-01
cases:17.04%
controls:14.94%
cases:11.28%
controls:8.93%
cases:3.17%
controls:1.80%
cases:0.48%
controls:0.11%
cases:5.55%
controls:1.57%
cases:12.63%
controls:8.09%
cases:18.34%
controls:15.22%
313
2574
1524
14655
210
1557
1651
15876
59
314
1802
17119
9
19
1852
17414
103
273
1753
17119
223
1364
1543
15493
266
2124
1184
11831
Dysthymia
F34.1 [45586238]
—
2.1e+00
—
1.0e+50
—
1.9e+00
8.0e-01
—
—
cases:0.48%
controls:0.06%
—
—
cases:0.27%
controls:0.00%
—
—
cases:0.74%
controls:0.11%
cases:0.62%
controls:0.28%
—
9
10
1852
17423
—
5
0
1856
17433
—
13
18
1753
16839
9
39
1441
13916
Triglyceride [Moles/volume] in Serum or Plasma
14927-8 [3025839]
2.5e-01
5.7e-01
1.2e+00
—
1.9e+00
4.0e-01
2.7e-03
cases:3.97%
controls:3.12%
cases:4.62%
controls:2.67%
cases:1.13%
controls:0.33%
—
—
cases:2.16%
controls:0.34%
cases:5.15%
controls:3.51%
cases:10.55%
controls:10.53%
73
538
1764
16691
86
465
1775
16968
21
58
1840
17375
—
40
59
1816
17333
91
591
1675
16266
153
1469
1297
12486
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
5.1e-01
8.2e-01
1.5e+00
1.0e+50
2.7e+00
5.8e-01
5.3e-01
cases:2.50%
controls:1.51%
cases:1.40%
controls:0.62%
cases:0.38%
controls:0.09%
cases:0.81%
controls:0.00%
cases:0.86%
controls:0.06%
cases:1.30%
controls:0.74%
cases:3.66%
controls:2.19%
46
261
1791
16968
26
108
1835
17325
7
15
1854
17418
15
0
1846
17433
16
10
1840
17382
23
124
1743
16733
53
306
1397
13649
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
1.3e+00
1.2e+00
—
1.0e+50
2.1e+00
1.5e+00
1.2e+00
cases:1.20%
controls:0.33%
cases:0.59%
controls:0.17%
—
—
cases:0.38%
controls:0.00%
cases:0.27%
controls:0.03%
cases:0.79%
controls:0.18%
cases:1.17%
controls:0.35%
22
57
1815
17172
11
30
1850
17403
—
7
0
1854
17433
5
6
1851
17386
14
30
1752
16827
17
49
1433
13906
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
3.6e-01
8.1e-01
4.1e-01
—
2.4e+00
7.8e-01
2.6e-01
cases:5.17%
controls:3.66%
cases:5.27%
controls:2.42%
cases:0.54%
controls:0.36%
—
—
cases:2.37%
controls:0.22%
cases:6.06%
controls:2.87%
cases:10.62%
controls:8.40%
95
631
1742
16598
98
422
1763
17011
10
62
1851
17371
—
44
38
1812
17354
107
483
1659
16374
154
1172
1296
12783
Unspecified mood [affective] disorder
F39 [45591137]
1.9e+00
2.1e+00
—
—
—
—
—
cases:0.54%
controls:0.08%
cases:0.32%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
10
14
1827
17215
6
7
1855
17426
—
—
—
—
—
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
4.0e-01
7.6e-01
1.2e+00
—
1.7e+00
1.0e+00
4.7e-01
cases:3.59%
controls:2.44%
cases:2.47%
controls:1.17%
cases:0.59%
controls:0.17%
—
—
cases:0.81%
controls:0.14%
cases:3.34%
controls:1.25%
cases:6.48%
controls:4.13%
66
420
1771
16809
46
204
1815
17229
11
30
1850
17403
—
15
25
1841
17367
59
210
1707
16647
94
577
1356
13378
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
3.6e-01
8.1e-01
1.5e+00
—
2.2e+00
1.1e+00
7.0e-01
cases:2.07%
controls:1.46%
cases:1.07%
controls:0.48%
cases:0.27%
controls:0.06%
—
—
cases:0.70%
controls:0.08%
cases:1.47%
controls:0.49%
cases:2.69%
controls:1.35%
38
251
1799
16978
20
84
1841
17349
5
11
1856
17422
—
13
14
1843
17378
26
83
1740
16774
39
189
1411
13766
Short blood count panel - Blood
55429-5 [40758558]
4.9e-03
1.8e-01
5.6e-01
2.1e+00
9.9e-01
4.8e-01
3.6e-01
cases:9.36%
controls:9.32%
cases:5.43%
controls:4.58%
cases:1.61%
controls:0.93%
cases:0.48%
controls:0.06%
cases:1.99%
controls:0.75%
cases:5.21%
controls:3.30%
cases:8.90%
controls:6.36%
172
1606
1665
15623
101
798
1760
16635
30
162
1831
17271
9
10
1852
17423
37
130
1819
17262
92
556
1674
16301
129
888
1321
13067
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
4.9e-01
7.2e-01
—
—
1.8e+00
9.5e-01
4.6e-01
cases:4.03%
controls:2.52%
cases:2.15%
controls:1.06%
—
—
—
—
cases:0.70%
controls:0.11%
cases:2.38%
controls:0.94%
cases:3.45%
controls:2.21%
74
434
1763
16795
40
184
1821
17249
—
—
13
20
1843
17372
42
158
1724
16699
50
308
1400
13647
Bipolar affective disorder, currently in remission
F31.7 [45581457]
2.0e+00
1.5e+00
—
—
—
1.7e+00
1.9e+00
cases:0.71%
controls:0.09%
cases:0.32%
controls:0.07%
—
—
—
—
—
—
cases:0.34%
controls:0.07%
cases:0.83%
controls:0.12%
13
16
1824
17213
6
12
1855
17421
—
—
—
6
11
1760
16846
12
17
1438
13938
Specific learning problem
P24 [2002000819]
2.0e+00
2.0e+00
—
—
—
8.4e-01
7.6e-01
cases:1.36%
controls:0.19%
cases:1.40%
controls:0.20%
—
—
—
—
—
—
cases:0.40%
controls:0.17%
cases:1.52%
controls:0.72%
25
32
1812
17197
26
35
1835
17398
—
—
—
7
29
1759
16828
22
100
1428
13855
Lactate [Moles/volume] in Cerebral spinal fluid
2520-5 [3035999]
1.5e+00
2.1e+00
—
1.0e+50
1.0e+50
2.4e+00
—
cases:0.71%
controls:0.16%
cases:0.27%
controls:0.03%
—
—
cases:0.48%
controls:0.00%
cases:0.70%
controls:0.00%
cases:0.34%
controls:0.03%
—
—
13
27
1824
17202
5
6
1856
17427
—
9
0
1852
17433
13
0
1843
17392
6
5
1760
16852
—
Undescended testicle, unilateral
Q53.1 [45597134]
1.5e+00
2.5e+00
—
—
—
1.3e+00
4.1e-01
cases:0.82%
controls:0.19%
cases:0.48%
controls:0.04%
—
—
—
—
—
—
cases:0.28%
controls:0.08%
cases:0.34%
controls:0.23%
15
33
1822
17196
9
7
1852
17426
—
—
—
5
13
1761
16844
5
32
1445
13923
Eosinophils [#/volume] in Blood
26449-9 [3013115]
1.4e-01
2.5e-01
5.9e-01
1.5e+00
1.3e+00
4.9e-01
2.2e-01
cases:17.64%
controls:15.69%
cases:11.55%
controls:9.24%
cases:3.33%
controls:1.87%
cases:0.54%
controls:0.11%
cases:5.66%
controls:1.62%
cases:12.97%
controls:8.40%
cases:18.90%
controls:15.70%
324
2703
1513
14526
215
1611
1646
15822
62
326
1799
17107
10
20
1851
17413
105
281
1751
17111
229
1416
1537
15441
274
2191
1176
11764
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
2.0e-01
4.5e-01
6.7e-01
1.7e+00
1.2e+00
5.3e-01
3.5e-01
cases:6.31%
controls:5.25%
cases:4.25%
controls:2.76%
cases:1.24%
controls:0.64%
cases:0.43%
controls:0.08%
cases:1.99%
controls:0.60%
cases:4.08%
controls:2.44%
cases:5.59%
controls:4.02%
116
904
1721
16325
79
481
1782
16952
23
111
1838
17322
8
14
1853
17419
37
104
1819
17288
72
411
1694
16446
81
561
1369
13394
Traumatic subdural haemorrhage
S06.5 [45563422]
1.0e+00
2.0e+00
—
1.0e+50
—
1.8e+00
8.8e-01
cases:0.65%
controls:0.24%
cases:0.48%
controls:0.06%
—
—
cases:0.27%
controls:0.00%
—
—
cases:0.74%
controls:0.12%
cases:0.55%
controls:0.23%
12
41
1825
17188
9
11
1852
17422
—
5
0
1856
17433
—
13
20
1753
16837
8
32
1442
13923
Dysphagia
R13 [45573013]
4.1e-01
7.3e-01
1.8e+00
—
2.0e+00
1.8e+00
7.4e-01
cases:1.20%
controls:0.80%
cases:0.59%
controls:0.29%
cases:0.32%
controls:0.05%
—
—
cases:0.48%
controls:0.06%
cases:1.42%
controls:0.24%
cases:1.31%
controls:0.63%
22
138
1815
17091
11
50
1850
17383
6
9
1855
17424
—
9
11
1847
17381
25
40
1741
16817
19
88
1431
13867
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
1.6e-01
2.4e-01
5.8e-01
1.5e+00
1.3e+00
4.7e-01
2.2e-01
cases:17.64%
controls:15.47%
cases:11.39%
controls:9.17%
cases:3.22%
controls:1.83%
cases:0.48%
controls:0.11%
cases:5.55%
controls:1.59%
cases:12.68%
controls:8.33%
cases:18.69%
controls:15.63%
324
2665
1513
14564
212
1598
1649
15835
60
319
1801
17114
9
19
1852
17414
103
276
1753
17116
224
1404
1542
15453
271
2181
1179
11774
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
2.5e-01
5.2e-01
1.2e+00
—
1.4e+00
6.4e-01
2.3e-01
cases:5.06%
controls:4.00%
cases:3.17%
controls:1.91%
cases:0.75%
controls:0.22%
—
—
cases:1.02%
controls:0.26%
cases:3.34%
controls:1.80%
cases:5.72%
controls:4.59%
93
690
1744
16539
59
333
1802
17100
14
39
1847
17394
—
19
45
1837
17347
59
303
1707
16554
83
641
1367
13314
Medical Oncology
90 [38004507]
1.1e-01
4.1e-02
7.4e-01
2.0e+00
1.0e+00
4.0e-01
-2.2e-01
cases:4.08%
controls:3.69%
cases:2.63%
controls:2.53%
cases:1.72%
controls:0.83%
cases:0.54%
controls:0.07%
cases:2.05%
controls:0.75%
cases:3.23%
controls:2.18%
cases:2.28%
controls:2.82%
75
635
1762
16594
49
441
1812
16992
32
145
1829
17288
10
13
1851
17420
38
131
1818
17261
57
367
1709
16490
33
393
1417
13562
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
F98.8 [45605524]
1.5e+00
—
—
—
—
2.1e+00
1.6e+00
cases:0.27%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.05%
cases:0.90%
controls:0.19%
5
10
1832
17219
—
—
—
—
8
9
1758
16848
13
26
1437
13929
No procedures
SPAT1301 [2001700402]
2.6e-01
6.1e-01
8.6e-01
1.3e+00
7.0e-01
6.0e-01
3.7e-01
cases:9.25%
controls:7.27%
cases:4.62%
controls:2.56%
cases:1.72%
controls:0.73%
cases:0.70%
controls:0.20%
cases:1.45%
controls:0.72%
cases:4.59%
controls:2.58%
cases:7.59%
controls:5.37%
170
1253
1667
15976
86
447
1775
16986
32
128
1829
17305
13
35
1848
17398
27
126
1829
17266
81
435
1685
16422
110
750
1340
13205
Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5013-8 [3008733]
1.2e+00
1.5e+00
—
1.0e+50
1.0e+50
2.4e+00
—
cases:0.82%
controls:0.24%
cases:0.32%
controls:0.07%
—
—
cases:0.32%
controls:0.00%
cases:0.59%
controls:0.00%
cases:0.34%
controls:0.03%
—
—
15
41
1822
17188
6
12
1855
17421
—
6
0
1855
17433
11
0
1845
17392
6
5
1760
16852
—
Thrombin time
3243-3 [3036489]
4.5e-01
9.9e-01
7.1e-01
1.0e+50
2.7e+00
6.5e-01
6.7e-01
cases:2.29%
controls:1.47%
cases:1.72%
controls:0.65%
cases:0.27%
controls:0.13%
cases:1.18%
controls:0.00%
cases:0.92%
controls:0.06%
cases:0.91%
controls:0.47%
cases:1.93%
controls:1.00%
42
253
1795
16976
32
113
1829
17320
5
23
1856
17410
22
0
1839
17433
17
11
1839
17381
16
80
1750
16777
28
139
1422
13816
Psychiatric network contact
IGV01 [2001304319]
1.8e+00
2.0e+00
—
—
—
2.0e+00
1.6e+00
cases:0.33%
controls:0.05%
cases:0.32%
controls:0.05%
—
—
—
—
—
—
cases:0.62%
controls:0.08%
cases:1.03%
controls:0.21%
6
9
1831
17220
6
8
1855
17425
—
—
—
11
14
1755
16843
15
29
1435
13926
risperidone; oral, parenteral
N05AX08 [21604559]
7.8e-01
8.4e-01
7.2e-01
—
3.9e-01
1.1e+00
9.1e-01
cases:1.85%
controls:0.85%
cases:1.34%
controls:0.59%
cases:0.64%
controls:0.32%
—
—
cases:0.43%
controls:0.29%
cases:1.98%
controls:0.67%
cases:3.10%
controls:1.28%
34
147
1803
17082
25
102
1836
17331
12
55
1849
17378
—
8
51
1848
17341
35
113
1731
16744
45
178
1405
13777
Oral Surgery
19 [38004464]
5.2e-01
1.4e+00
—
—
1.8e+00
1.4e+00
8.8e-01
cases:1.25%
controls:0.75%
cases:0.91%
controls:0.24%
—
—
—
—
cases:0.27%
controls:0.05%
cases:0.79%
controls:0.20%
cases:1.59%
controls:0.67%
23
129
1814
17100
17
41
1844
17392
—
—
5
8
1851
17384
14
34
1752
16823
23
93
1427
13862
Limited function/disability (N)
N28 [2002000733]
1.5e+00
2.1e+00
—
—
—
2.1e+00
8.1e-01
cases:0.49%
controls:0.11%
cases:0.27%
controls:0.03%
—
—
—
—
—
—
cases:0.34%
controls:0.04%
cases:0.48%
controls:0.21%
9
19
1828
17210
5
6
1856
17427
—
—
—
6
7
1760
16850
7
30
1443
13925

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
724
2999
2.81
111.01
3.6
3.4
29.50
29.71
s
0.46
712
2929
980
4930
2.43
98.76
3.2
2.3
194.98
265.25
u/l
1.57
961
4698
1337
8537
2.00
66.59
11.1
8.2
1.22
1.22
mmol/l
0.63
1282
7963
1431
9435
1.97
64.11
11.3
8.3
1.21
1.22
mmol/l
0.49
1322
8309
152
371
4.12
53.25
6.4
5.9
393.38
386.56
umol/l
0.21
141
348
523
2608
2.15
48.76
7.5
7.0
5.74
5.84
kpa
1.45
508
2534
519
2596
2.14
47.93
7.6
7.2
7.37
7.37
ph
0.27
337
1615
510
2550
2.14
47.07
7.6
7.1
1.17
1.48
mmol/l
1.05
426
2147
477
2324
2.19
47.02
7.6
6.9
4.89
4.85
kpa
0.13
463
2263
1585
11506
1.78
45.71
7.7
5.7
6.34
6.39
mmol/l
0.42
1521
10681
593
3244
1.97
42.35
5.2
3.7
320.69
483.43
ng/l
1.31
435
2177
1166
7869
1.75
42.18
7.1
5.9
36.63
36.97
g/l
1.17
1106
7394
844
5201
1.82
41.56
4.6
4.1
7.39
7.39
ph
0.13
606
3583
834
5135
1.81
41.10
6.7
5.2
87.61
88.76
%
0.69
824
5046
537
2885
1.99
40.17
10.2
8.4
1.16
1.16
mmol/l
0.19
510
2703
1094
7382
1.72
38.61
2.3
1.9
94.33
96.55
pmol/l
0.92
581
3961
446
2303
2.04
37.04
11.1
10.1
—
—
—
0
0
1026
6872
1.70
36.72
4.6
3.6
31.90
31.69
u/l
0.05
993
6534
1075
7292
1.70
36.69
15.2
11.8
1.23
1.21
inr
0.65
921
6129
770
4775
1.77
36.20
1.8
1.6
18.99
19.58
nmol/l
0.56
692
4168
1815
14267
1.68
33.81
8.9
7.4
92.10
84.18
u/l
5.41
1720
13553
143
454
3.15
33.70
3.1
3.2
32.17
33.85
umol/l
0.32
135
418
595
3487
1.82
33.45
4.3
3.2
3.81
2.62
e6/l
1.29
297
1667
362
1803
2.08
32.92
8.8
10.3
1.33
1.38
mmol/l
0.55
352
1766
162
560
2.90
32.91
1.9
2.5
—
—
—
0
0
615
3659
1.80
32.81
4.3
3.0
0.82
1.00
e6/l
0.90
324
1836
235
981
2.43
32.77
4.3
4.5
21.31
21.42
s
0.10
216
906
166
600
2.77
31.03
1.7
2.3
3.57
3.56
mmol/l
0.04
156
568
895
6005
1.65
30.44
3.7
3.1
2.36
2.37
mmol/l
0.69
827
5505
946
6466
1.63
29.72
8.4
6.7
—
—
—
0
0
2252
19099
1.79
28.28
5.9
4.8
1.89
1.85
mu/l
0.92
2147
17990
515
3035
1.78
27.86
8.5
5.7
0.81
0.82
mmol/l
0.77
491
2880
2352
20242
1.89
27.73
23.8
14.5
3.94
3.94
mmol/l
0.19
2305
19678
346
1802
1.97
27.54
9.2
9.3
0.82
0.61
mmol/l
0.41
271
1467
859
5821
1.62
27.47
5.1
3.4
0.36
0.34
e6/l
0.05
618
4158
2000
16475
1.64
27.42
4.7
4.0
14.62
14.70
pmol/l
0.80
1870
15025
2348
20213
1.87
27.42
23.8
14.5
139.50
139.55
mmol/l
0.51
2306
19711
1271
9447
1.56
27.20
7.9
6.3
14.12
13.36
umol/l
0.46
1206
8896
159
606
2.62
26.78
1.9
2.4
1323.25
7226.95
e6/l
0.42
121
447
346
1828
1.94
26.36
9.4
9.3
7.42
7.41
ph
1.45
188
954
356
1900
1.93
26.32
12.6
10.4
7.04
7.58
mmol/l
1.03
343
1834
1408
10754
1.54
26.31
9.7
7.7
8.66
8.61
%
0.31
1344
10221
942
6582
1.58
26.20
5.2
3.5
122.56
69.78
e6/l
0.25
699
4893
1232
9144
1.55
26.20
3.6
2.7
69.89
71.89
nmol/l
1.70
1144
8516
1401
10700
1.54
26.11
9.7
7.7
0.65
0.66
%
0.13
1334
10169
1490
11544
1.54
25.92
9.6
7.4
0.58
0.57
e9/l
1.22
1267
9931
742
4916
1.62
25.70
4.8
4.2
—
—
—
0
0
344
1830
1.93
25.64
9.3
9.2
5.05
5.11
kpa
0.54
324
1758
344
1831
1.93
25.60
9.3
9.2
12.84
13.14
kpa
0.44
323
1759
1489
11554
1.53
25.56
9.6
7.5
0.04
0.04
e9/l
0.24
1265
9946
1400
10725
1.53
25.47
9.7
7.6
2.89
2.92
%
0.18
1337
10180
1527
11924
1.53
25.38
10.4
7.8
0.19
0.19
e9/l
0.27
1317
10424
155
601
2.57
25.21
1.9
2.4
23.20
13.94
e6/l
0.49
112
422
432
2503
1.79
24.49
1.8
1.7
964.09
1182.03
nmol/l
6.98
351
1895
821
5627
1.58
24.45
4.0
2.9
—
—
—
0
0
61
136
4.40
24.07
3.0
2.7
62.72
51.46
umol/l
1.71
50
126
1606
12758
1.52
24.00
14.4
9.9
3.97
3.92
e9/l
0.48
1375
10991
207
941
2.21
23.56
11.5
12.0
16.24
16.05
%
0.39
200
903
1514
11952
1.50
22.75
9.6
7.4
2.05
2.07
e9/l
0.27
1319
10566
159
655
2.42
22.74
6.8
5.5
1.61
1.60
%
0.05
149
611
156
641
2.43
22.44
2.6
2.7
201.50
382.67
ug/l
1.34
142
603
492
3025
1.69
22.42
3.2
2.7
2.44
2.41
g/l
0.56
451
2827
520
3249
1.67
22.29
3.2
2.7
12.10
13.83
umol/l
6.70
488
3048
148
598
2.46
22.08
7.0
5.6
0.89
0.89
%
0.05
139
555
1413
11050
1.48
21.89
9.5
7.3
54.68
54.42
%
0.33
1368
10672
602
3919
1.62
21.88
4.0
2.9
542.95
554.06
mosm/kgh2o
0.55
537
3453
1433
11248
1.48
21.72
9.6
7.5
30.70
30.85
%
0.19
1380
10801
234
1154
2.04
21.54
5.9
6.9
130.52
130.33
g/l
0.04
226
1122
453
2765
1.69
21.11
3.4
2.7
19.87
23.21
%
7.34
427
2600
1068
7939
1.49
21.07
6.2
4.2
44.72
84.22
e6/l
2.09
729
5238
98
336
2.88
20.24
2.2
3.3
—
—
—
0
0
380
2241
1.74
20.00
4.8
4.1
1.59
1.64
%
0.46
346
2068
292
1593
1.86
19.95
11.4
7.3
—
—
—
0
0
783
5514
1.52
19.82
2.9
2.6
2.71
2.65
mg/l
0.26
702
4832
229
1156
1.99
19.73
3.2
3.2
—
—
—
0
0
348
2009
1.77
19.72
10.8
7.1
7.41
7.41
ph
0.02
298
1647
350
2031
1.76
19.47
10.7
7.1
5.08
5.07
kpa
0.12
337
1963
744
5201
1.52
19.43
4.5
3.6
0.67
0.15
—
6
33
379
2263
1.71
19.02
2.8
2.2
330.00
375.39
nmol/l
4.80
355
2109
294
1638
1.82
18.73
10.1
9.8
95.85
95.67
%
0.15
276
1583
226
1157
1.96
18.69
5.2
3.6
185.83
204.83
ng/l
0.35
216
1023
626
4264
1.54
18.27
3.1
2.4
1.47
1.26
mg/l
0.63
488
3060
2462
22024
1.82
18.24
13.8
9.9
27.67
27.19
u/l
0.50
2399
21462
272
1501
1.83
17.86
10.1
9.9
121.47
122.25
g/l
0.23
263
1466
273
1510
1.82
17.79
11.5
7.4
24.24
24.23
mmol/l
0.02
267
1470
2046
17587
1.49
17.11
4.8
3.8
5.75
5.65
mmol/l
2.41
1919
16328
2219
19445
1.54
16.46
26.0
16.0
13.41
13.26
%
6.40
2192
19196
84
297
2.78
16.44
8.7
7.6
12.12
11.48
mmol/l
0.69
75
264
1629
13469
1.41
16.42
6.5
4.3
1571.56
2237.33
e6/l
0.22
27
181
84
298
2.77
16.33
8.7
7.6
105.13
105.14
mmol/l
0.01
75
265
410
2605
1.61
16.00
2.0
1.7
—
—
—
0
0
125
548
2.26
15.55
2.9
3.2
5.63
3.25
index
0.79
73
307
578
3990
1.50
15.52
4.3
3.8
1410.74
1277.02
ng/l
0.26
496
3307
1748
14721
1.40
15.23
4.8
3.3
41.31
37.15
u/l
1.30
1688
14085
2459
22174
1.72
15.14
23.1
14.7
71.94
72.96
umol/l
0.71
2430
21869
280
1641
1.72
14.90
4.5
3.6
65.96
68.00
e9/l
0.42
201
1126
1288
10367
1.37
14.44
13.4
10.8
0.00
0.00
e9/l
0.30
1012
8306
617
4379
1.46
14.27
4.0
2.8
7.13
6.60
e6/l
0.34
563
3968
108
462
2.30
14.25
7.6
6.1
1.47
1.26
mmol/l
0.66
97
404
846
6377
1.40
14.00
3.1
2.6
—
—
—
0
0
248
1436
1.73
13.76
8.3
5.6
74.01
75.53
ng/l
0.11
231
1304
840
6339
1.40
13.76
4.3
3.9
8.20
8.48
mmol/l
0.71
757
5619
248
1440
1.73
13.62
12.6
7.8
9.60
9.44
kpa
0.67
239
1405
1965
17017
1.41
13.59
5.9
4.8
37.68
37.32
mmol/mol
0.83
1878
16166
175
917
1.90
13.49
5.7
5.3
3.34
3.18
g/l
0.62
167
895
57
183
3.04
13.31
13.0
12.3
0.56
0.58
mmol/l
0.38
52
172
71
258
2.70
13.25
7.3
7.4
10.81
10.16
mg/l
0.44
63
241
767
5737
1.40
13.11
3.2
2.7
55.25
73.05
u/l
0.69
719
5318
366
2373
1.56
12.95
5.5
4.1
9.18
7.42
umol/l
0.73
310
2035
170
901
1.87
12.66
7.0
6.7
24.38
24.24
mmol/l
0.15
155
854
308
1929
1.61
12.62
2.6
2.4
27.84
60.52
u/l
0.70
270
1601
1147
9202
1.35
12.49
4.5
3.3
6.34
6.29
ph
0.88
584
4964
208
1182
1.75
12.32
2.3
2.8
65.91
66.40
g/l
0.39
192
1100
1671
14236
1.34
11.82
6.4
4.3
—
2.86
—
0
20
1131
9118
1.33
11.66
3.3
2.9
—
—
estimate
—
0
0
300
1907
1.58
11.52
3.7
3.3
0.21
0.22
g/l
0.15
283
1798
2393
21681
1.53
11.43
20.5
12.9
23.39
23.14
mg/l
0.13
1963
16924
116
559
2.04
11.41
5.5
8.8
66.15
64.98
%
0.22
108
545
776
5948
1.36
11.07
5.1
3.3
38.75
102.61
ng/l
1.04
514
3465
215
1272
1.68
11.01
1.9
1.7
0.22
0.24
mg/l
0.28
96
578
443
3088
1.46
10.97
3.2
2.6
2.45
2.43
mmol/l
1.38
384
2749
393
2684
1.48
10.80
2.3
2.0
—
—
—
0
0
71
286
2.43
10.79
3.1
2.9
—
—
—
0
0
2233
20032
1.41
10.52
26.6
15.9
333.78
334.51
g/l
3.22
2220
19895
63
243
2.53
10.50
1.2
1.1
49.37
37.66
mg/l
0.72
57
194
920
7280
1.33
10.48
2.0
1.8
1.40
1.32
mmol/l
1.31
836
6462
2614
24297
1.95
10.35
30.5
19.1
257.58
256.64
e9/l
0.31
2545
23688
153
838
1.80
10.29
4.2
3.2
1.02
1.02
ratio
0.25
133
750
823
6422
1.34
10.28
4.0
2.9
0.06
0.03
0.15
18
93
2615
24314
1.95
10.27
31.3
19.6
40.49
41.48
%
2.14
2594
24065
2615
24315
1.95
10.26
30.4
19.0
29.66
29.84
pg
4.99
2595
24079
2615
24316
1.95
10.24
30.4
19.0
4.60
4.62
e12/l
1.26
2534
23660
2614
24310
1.94
10.13
30.4
19.0
88.65
88.99
fl
2.96
2594
24075
2615
24324
1.94
10.10
30.7
19.2
135.63
137.18
g/l
5.87
2595
24091
2615
24332
1.93
9.96
30.5
19.1
6.88
6.78
e9/l
1.36
2538
23670
23
48
4.65
9.93
2.1
3.4
—
—
—
0
0
40
125
3.11
9.85
1.9
2.7
158.14
146.52
nmol/l
0.28
35
108
177
1026
1.71
9.79
18.0
12.9
1.21
1.20
mg/l
0.11
170
976
152
852
1.76
9.48
4.9
5.2
223.30
386.56
mg/l
1.97
97
495
111
564
1.93
9.46
2.4
1.9
2.44
2.27
ug/l
0.05
89
494
1354
11398
1.29
9.42
3.8
3.2
93.33
92.24
ug/l
0.07
1296
10781
179
1062
1.67
9.09
12.1
12.2
0.62
0.66
%
0.73
174
1054
1963
17390
1.31
9.00
4.1
3.4
1.29
1.22
mmol/l
4.02
1865
16337
19
23
8.01
8.81
1.0
1.3
—
—
—
0
0
57
229
2.43
8.78
1.9
1.4
0.97
1.27
promille
0.81
46
180
2104
18872
1.33
8.48
5.2
4.2
2.61
2.71
mmol/l
6.29
2016
17824
785
6235
1.30
8.29
1.7
1.6
2.04
2.04
g/l
0.00
438
3836
366
2590
1.42
8.23
1.3
1.2
—
—
—
0
0
179
1096
1.61
8.05
12.1
11.8
1.24
1.27
%
0.14
173
1087
132
752
1.73
7.82
1.7
2.1
1.62
1.37
g/l
1.89
114
669
1319
11225
1.26
7.79
5.1
3.6
0.01
3.96
estimate
1.81
249
2299
37
128
2.81
7.70
2.1
3.4
121.32
144.00
umol/l
0.23
19
73
2085
18764
1.30
7.59
4.8
3.9
4.36
4.53
mmol/l
13.32
2007
17821
78
382
2.00
7.45
2.3
1.8
—
—
—
0
0
78
382
2.00
7.45
2.3
1.8
—
—
—
0
0
78
382
2.00
7.45
2.3
1.8
—
—
—
0
0
78
382
2.00
7.45
2.3
1.8
—
—
—
0
0
2070
18630
1.30
7.40
4.7
3.8
1.33
1.40
mmol/l
14.67
1982
17587
73
352
2.03
7.29
3.3
2.2
69.60
69.26
mmol/l
0.02
62
293
174
1089
1.58
7.16
12.4
12.0
94.10
94.49
%
0.32
174
1084
1301
11123
1.24
7.13
5.1
3.6
0.00
0.00
estimate
0.50
254
2311
1316
11267
1.24
7.11
5.1
3.7
0.02
0.14
estimate
0.44
239
2235
2412
22226
1.40
7.11
17.1
10.8
—
—
—
0
0
50
210
2.32
7.05
2.9
3.9
16.43
14.83
index
0.39
35
161
93
497
1.83
6.88
6.5
9.1
65.33
64.52
%
0.13
93
492
685
7874
0.78
6.86
2.8
2.4
—
—
—
0
0
135
803
1.65
6.85
2.1
1.8
—
—
—
0
0
28
90
3.02
6.66
1.7
2.1
17.05
14.88
umol/l
0.51
28
90
284
1998
1.41
6.58
3.7
3.0
9.92
10.18
g/l
0.51
273
1855
29
96
2.93
6.57
1.2
1.0
84.83
116.83
ng/l
—
6
18
668
5330
1.27
6.56
4.6
3.5
1.02
1.32
kg/l
0.50
443
3357
138
838
1.62
6.47
1.8
2.3
—
—
—
0
0
81
424
1.87
6.42
1.9
2.2
10.09
10.47
g/l
0.36
72
381
435
3289
1.33
6.40
1.7
1.7
23262463.78
20533295.41
pmol/l
0.05
374
2815
49
216
2.21
6.21
4.3
3.5
1.71
1.77
umol/l
0.17
49
209
32
119
2.61
5.88
1.2
1.1
4.48
1.45
nmol/l
0.30
11
16
72
376
1.87
5.78
1.9
3.5
33.43
65.06
mg/l
1.26
62
321
72
378
1.86
5.69
1.9
3.5
30.55
52.19
mg/l
1.23
62
325
555
4401
1.27
5.65
4.4
4.5
10.42
13.93
mg/mmol
0.37
384
2971
46
206
2.17
5.64
1.2
1.2
0.73
0.66
ratio
0.19
30
106
840
7000
1.23
5.45
1.5
1.6
2.91
2.20
u/ml
0.37
183
1727
191
1300
1.45
5.34
1.3
1.3
43.93
44.63
au/ml
—
10
69
239
1702
1.39
5.18
2.2
2.0
0.00
0.02
estimate
1.30
51
402
184
1252
1.45
5.16
3.3
3.4
4.77
4.75
pmol/l
0.07
170
1133
64
336
1.86
5.10
1.8
3.3
1.30
3.43
ratio
1.26
34
198
167
1120
1.47
5.05
2.6
2.4
5.51
7.17
ug/l
0.79
145
973
498
3948
1.26
5.04
3.6
3.0
337.55
338.53
umol/l
0.07
452
3573
35
148
2.29
4.95
54.3
44.0
6.55
6.86
ug/l
0.44
30
135
325
2444
1.32
4.94
1.7
1.5
—
—
—
0
0
28
107
2.54
4.92
1.6
1.3
54.33
86.38
%
—
6
13
207
1452
1.40
4.91
1.9
1.7
430.98
304.11
mu/l
3.76
189
1314
28
108
2.51
4.83
1.3
1.2
—
—
—
0
0
276
2038
1.34
4.77
3.4
2.9
—
—
—
0
0
10
13
7.44
4.72
1.0
1.6
44.70
19.85
nmol/l
—
10
13
201
1415
1.40
4.68
2.5
2.4
24.91
17.05
au/ml
0.39
18
154
55
284
1.88
4.64
8.9
13.5
11.67
11.23
%
0.32
55
284
12
21
5.52
4.60
1.2
1.4
—
—
—
0
0
12
21
5.52
4.60
1.2
1.0
—
—
—
0
0
534
4319
1.24
4.49
4.0
3.8
64.32
64.57
mg/l
0.01
388
2991
203
2607
0.73
4.44
1.3
1.2
—
—
—
0
0
25
96
2.52
4.38
1.3
1.3
173.24
141.72
nmol/l
1.32
25
96
54
284
1.85
4.33
2.8
2.8
611.75
561.84
e6/l
0.22
40
197
306
2327
1.30
4.30
2.7
2.3
—
—
—
0
0
186
1313
1.39
4.29
1.2
1.2
—
—
—
0
0
187
1322
1.39
4.27
2.1
1.8
7.28
6.92
u/l
0.17
128
965
293
2225
1.30
4.16
1.3
1.3
—
—
—
0
0
73
426
1.67
4.12
2.1
2.6
—
—
—
0
0
35
161
2.11
4.10
3.0
4.1
0.57
0.83
index
1.52
35
161
115
750
1.50
4.06
2.5
2.4
—
—
—
0
0
55
298
1.79
4.03
1.1
1.2
—
—
—
0
0
134
904
1.45
3.99
1.2
1.2
—
—
—
0
0
58
322
1.75
3.93
3.0
2.8
1537.85
1440.38
e6/l
0.24
47
239
64
366
1.70
3.91
1.5
1.3
5.21
4.77
u/ml
0.07
39
179
52
280
1.80
3.90
3.2
2.8
71.71
70.77
%
0.14
52
274
44
225
1.90
3.88
3.5
3.0
0.35
0.34
e9/l
0.03
27
117
348
2732
1.26
3.80
2.7
2.3
—
—
—
0
0
47
249
1.83
3.73
1.3
1.6
—
—
—
0
0
16
53
2.92
3.70
2.7
2.4
—
—
—
0
0
52
286
1.77
3.66
2.9
2.9
200.77
208.69
e6/l
0.10
39
203
15
374
0.38
3.64
1.5
1.5
0.44
0.52
e9/l
0.95
15
374
13
33
3.81
3.64
1.2
1.8
40.20
40.54
g/l
0.06
13
33
17
59
2.79
3.63
2.0
1.3
0.65
1.36
iu/ml
—
7
29
188
1375
1.34
3.51
3.0
2.7
0.20
0.46
e6/l
2.07
179
1305
52
290
1.74
3.50
1.8
1.8
284.59
285.08
mosm/kgh2o
0.05
34
212
313
2453
1.26
3.48
3.5
2.8
4.18
4.79
e9/l
1.22
275
2178
71
432
1.60
3.46
4.6
4.1
—
—
—
0
0
210
1567
1.32
3.43
2.0
1.8
1.05
1.18
g/l
1.09
196
1463
478
5362
0.83
3.41
2.0
2.0
—
—
—
0
0
67
1003
0.63
3.39
1.6
1.6
56.02
59.56
ug/l
0.35
67
1003
109
732
1.45
3.38
1.3
1.2
0.41
1.04
u/ml
—
8
41
72
1058
0.65
3.35
1.3
1.5
—
—
—
0
0
134
939
1.39
3.29
1.7
1.4
—
—
—
0
0
58
340
1.66
3.29
6.6
4.2
—
—
—
0
0
181
2254
0.76
3.24
1.5
1.5
3.45
3.36
mmol/l
0.42
117
1452
31
151
1.99
3.19
1.4
1.4
16866.41
1770.94
e6/l
0.62
22
96
12
33
3.51
3.15
1.4
1.2
—
—
—
0
0
46
257
1.74
3.12
1.4
1.4
340.00
386.93
pmol/l
0.24
34
226
66
406
1.58
3.10
1.8
1.6
481.83
344.95
mu/l
1.56
58
324
14
48
2.82
3.08
2.1
1.3
0.26
0.38
iu/ml
—
5
27
178
1325
1.31
2.99
2.1
1.7
11.42
12.02
iu/l
0.11
130
993
24
109
2.13
2.97
3.8
4.1
—
—
—
0
0
47
269
1.70
2.94
1.7
1.6
32.72
98.06
mu/l
1.16
42
246
47
269
1.70
2.94
2.6
2.4
—
—
—
0
0
15
55
2.64
2.93
2.9
2.5
0.60
0.62
mmol/l
0.55
15
55
173
1291
1.31
2.86
2.7
2.0
—
—
—
0
0
83
551
1.47
2.78
1.4
1.4
291.53
307.28
ug/g
0.30
49
289
360
2936
1.21
2.77
2.7
2.2
—
—
—
0
0
359
2929
1.21
2.76
2.7
2.2
—
—
—
0
0
74
1035
0.68
2.75
1.0
1.1
0.58
0.63
ratio
—
5
80
245
2874
0.80
2.72
1.6
1.6
3.66
3.54
ratio
0.66
186
2042
122
873
1.36
2.69
1.6
1.9
4.98
6.55
iu/ml
0.35
26
192
47
277
1.65
2.67
1.4
1.3
2.43
2.62
g/l
0.47
39
212
47
277
1.65
2.67
1.4
1.3
0.41
0.38
g/l
0.34
38
210
47
277
1.65
2.67
1.4
1.3
6.47
6.40
g/l
0.05
40
211
243
1916
1.24
2.61
1.4
1.4
308.32
340.43
u/ml
0.12
223
1778
26
129
1.95
2.59
1.3
1.4
—
—
—
0
0
355
2913
1.20
2.57
2.7
2.2
—
—
—
0
0
34
185
1.78
2.57
4.0
4.1
—
—
—
0
0
26
130
1.94
2.54
1.3
1.4
53999.29
89521.16
e6/l
0.28
14
68
14
54
2.51
2.51
1.0
1.2
—
—
—
0
0
206
2439
0.80
2.50
1.6
1.6
971.44
963.64
mu/l
0.04
176
2169
183
1403
1.28
2.50
5.9
3.8
7.35
7.34
ph
0.21
145
1008
46
275
1.62
2.49
1.4
1.4
—
—
—
0
0
26
132
1.91
2.44
1.3
1.5
—
—
—
0
0
352
2904
1.19
2.41
2.7
2.2
—
—
—
0
0
61
393
1.51
2.41
5.7
4.3
1.72
2.27
mmol/l
1.13
41
243
282
2279
1.21
2.41
2.4
2.3
11.83
13.09
nmol/l
1.40
261
2092
203
1584
1.25
2.40
2.8
2.4
6.22
6.23
ph
0.05
153
1036
42
249
1.63
2.36
7.6
6.6
7.57
6.68
mmol/l
0.61
35
204
214
1685
1.24
2.35
1.2
1.2
255.71
319.02
titre
—
7
59
15
62
2.34
2.34
3.4
2.5
—
—
—
0
0
41
243
1.64
2.32
1.2
1.2
0.51
7.90
nmol/l
0.50
41
230
359
2979
1.19
2.31
1.5
1.5
418.75
484.97
titre
0.49
64
531
13
51
2.46
2.26
1.5
1.4
4.09
6.99
pmol/l
—
5
23
36
208
1.68
2.25
1.2
1.2
—
—
—
0
0
16
70
2.21
2.22
1.4
1.3
191.06
87.01
nmol/24h
0.45
16
70
71
481
1.43
2.21
2.4
2.5
131.95
133.27
g/l
0.19
59
404
229
1834
1.22
2.16
1.4
1.2
108.15
142.98
u/ml
0.81
66
656
172
1335
1.26
2.16
1.6
1.4
—
—
—
0
0
80
558
1.39
2.13
1.2
1.2
—
—
—
0
0
460
3930
1.15
2.06
3.1
3.1
124.57
126.22
ug/g
0.04
376
3193
34
200
1.65
2.01
1.2
1.2
—
—
—
0
0
27
149
1.75
2.00
3.5
2.9
1090.48
802.40
u/ml
0.69
27
149
19
95
1.93
1.91
1.7
1.3
154.95
166.76
mmol/24h
0.23
19
95
23
123
1.81
1.90
1.2
1.1
301.25
391.52
nmol/l
1.22
16
112
262
2155
1.19
1.89
1.2
1.2
—
—
—
0
0
5
11
4.39
1.88
3.4
1.5
649.40
252.91
umol/l
—
5
11
18
89
1.95
1.87
1.7
1.9
—
—
—
0
0
99
732
1.31
1.85
2.6
1.8
126.23
121.46
au/ml
0.13
35
237
8
27
2.86
1.85
3.7
2.5
49.38
44.18
umol/l
—
8
22
129
989
1.27
1.84
1.4
1.3
—
—
—
0
0
103
769
1.30
1.80
2.5
1.8
—
—
—
0
0
7
22
3.07
1.80
1.4
1.5
—
—
—
0
0
7
22
3.07
1.80
2.1
1.5
21.77
27.28
g/l
—
7
16
16
77
2.01
1.79
7.3
6.8
1.21
1.21
mmol/l
0.15
16
71
78
560
1.35
1.79
1.3
1.2
1.55
4.19
u/ml
—
6
50
27
156
1.67
1.74
1.9
2.9
1.69
1.66
g/24h
0.02
16
96
7
23
2.94
1.72
1.6
1.2
38.29
28.71
%
—
7
14
103
775
1.29
1.72
1.1
1.1
1.83
8.55
eliau/ml
—
6
111
34
210
1.57
1.70
1.2
1.2
0.20
0.17
nmol/l
1.26
27
161
23
128
1.74
1.69
1.2
1.1
—
—
—
0
0
32
195
1.59
1.69
3.1
4.2
25.14
119.88
u/ml
—
5
61
65
458
1.38
1.69
1.3
1.8
0.58
0.77
g/l
1.51
53
373
21
114
1.78
1.68
4.2
3.7
72.50
131.36
umol/l
—
6
41
9
181
0.48
1.62
2.9
1.8
—
—
—
0
0
18
95
1.83
1.58
1.2
1.3
—
—
—
0
0
8
31
2.49
1.58
1.4
1.4
1.95
3.96
mmol/l
—
8
24
7
25
2.70
1.57
1.3
1.4
61.29
58.88
ug/l
—
7
25
213
1757
1.18
1.53
5.2
4.9
1.06
0.78
%
0.53
70
530
96
729
1.28
1.52
1.5
1.4
—
—
—
0
0
6
20
2.89
1.51
1.2
1.1
—
—
—
0
0
203
1674
1.18
1.47
5.0
4.6
0.90
0.53
%
0.79
67
497
5
15
3.22
1.47
1.8
1.1
544.60
20.63
u/l
—
5
8
204
1686
1.18
1.45
5.3
5.0
0.05
0.08
%
0.44
58
460
155
1255
1.20
1.39
5.1
4.1
1.23
1.23
mmol/l
0.25
143
1083
40
269
1.44
1.39
1.8
2.0
4.27
4.71
mmol/24h
0.39
35
241
14
241
0.56
1.39
6.1
6.2
8.29
9.01
%
0.21
14
241
14
241
0.56
1.39
3.1
3.1
42.21
43.80
%
0.09
14
241
46
319
1.40
1.36
1.0
1.0
9.16
8.93
mu/l
0.09
38
276
29
184
1.52
1.34
2.4
2.2
24.46
28.62
mg/l
0.26
24
118
90
1079
0.80
1.33
1.1
1.1
—
—
—
0
0
20
116
1.67
1.32
1.1
1.1
19.76
36.19
iu/ml
1.59
20
116
206
1720
1.17
1.31
5.8
5.2
0.04
0.11
%
1.21
54
436
31
201
1.49
1.30
1.4
1.2
—
—
—
0
0
120
1391
0.82
1.30
1.5
1.3
236.19
237.73
miu/ml
0.01
43
672
22
132
1.61
1.28
2.9
2.2
1.85
2.13
mmol/l
0.17
12
105
22
133
1.60
1.25
2.6
2.1
—
—
—
0
0
23
141
1.58
1.24
2.4
1.6
—
—
—
0
0
28
181
1.50
1.21
1.1
1.1
110.89
114.94
pmol/l
0.10
28
181
46
327
1.36
1.20
1.9
1.9
—
—
—
0
0
66
497
1.29
1.17
4.4
3.8
1.63
1.43
mmol/l
0.64
61
489
83
648
1.24
1.11
1.3
1.1
—
—
—
0
0
16
92
1.68
1.11
3.8
4.2
4.00
2.76
%
—
6
36
12
63
1.84
1.11
1.4
1.3
—
—
—
0
0
9
160
0.54
1.08
1.2
1.2
—
—
—
0
0
33
227
1.41
1.07
1.4
1.1
—
—
—
0
0
44
319
1.33
1.04
1.2
1.2
—
—
—
0
0
45
328
1.33
1.03
1.2
1.1
6.54
7.10
iu/ml
—
10
69
7
131
0.51
0.98
1.0
1.2
9.43
7.43
mm/h
—
7
131
64
494
1.25
0.97
2.4
2.4
1.03
0.68
nmol/l
1.10
54
427
7
35
1.93
0.96
1.7
1.8
—
—
—
0
0
51
385
1.28
0.93
1.2
1.1
—
—
—
0
0
12
68
1.70
0.90
1.2
1.6
—
—
—
0
0
393
3506
1.09
0.89
4.5
4.6
2.83
2.34
ug/l
0.30
350
3132
158
1339
1.15
0.89
1.4
1.2
—
—
—
0
0
113
937
1.17
0.86
1.1
1.1
—
—
—
0
0
229
1993
1.12
0.86
1.4
1.5
—
—
—
0
0
24
164
1.41
0.84
1.2
1.1
—
—
—
0
0
31
222
1.35
0.83
1.5
1.3
5.33
8.41
u/ml
0.49
18
144
18
117
1.49
0.81
2.6
2.7
—
—
—
0
0
73
588
1.20
0.79
2.4
2.0
3.19
12.56
iu/l
0.52
37
258
52
404
1.24
0.79
3.2
3.6
4.06
3.83
e9/l
0.35
52
404
6
32
1.81
0.78
1.2
1.2
—
—
—
0
0
51
396
1.25
0.78
3.5
4.0
3.83
3.88
mmol/l
0.43
46
390
809
8136
0.94
0.78
2.5
2.3
—
—
—
0
0
13
79
1.59
0.77
4.7
7.7
3.19
202.07
ug/l
—
7
59
120
1318
0.87
0.76
1.6
1.6
62.02
60.06
ug/l
0.21
98
1153
21
143
1.42
0.76
1.7
2.4
36.85
41.77
%
0.42
13
66
18
119
1.46
0.76
1.1
1.1
289.00
205.36
iu/ml
0.47
18
119
26
185
1.36
0.74
2.9
2.3
0.83
0.90
%
0.34
20
112
33
244
1.31
0.74
3.7
3.5
0.79
0.83
nmol/l
0.27
26
200
9
53
1.64
0.73
1.6
3.0
—
—
—
0
0
5
24
2.01
0.73
1.0
1.0
173.40
158.25
g/l
—
5
24
167
1788
0.89
0.72
5.7
3.6
—
—
—
0
0
28
203
1.33
0.72
1.2
1.2
—
—
nmol/l
—
0
0
12
73
1.59
0.72
2.3
2.5
83.33
106.70
ng/l
0.66
12
73
24
170
1.36
0.71
1.3
1.2
—
—
—
0
0
15
97
1.49
0.70
1.2
1.2
410.33
407.35
u/l
0.01
15
86
5
26
1.85
0.68
1.0
1.3
—
—
—
0
0
18
122
1.42
0.68
1.4
1.6
—
—
—
0
0
21
147
1.38
0.67
1.3
1.2
783.33
962.50
titre
—
6
24
625
6303
0.94
0.66
4.5
3.0
0.27
0.02
estimate
0.48
199
1896
34
258
1.27
0.65
1.1
1.4
—
142.14
—
0
14
115
980
1.14
0.65
2.2
1.6
196.05
196.10
u/ml
0.00
59
551
49
389
1.22
0.64
1.4
1.7
14398.71
18005.93
e6/l
0.26
35
275
28
208
1.30
0.63
1.6
1.5
—
—
—
0
0
462
4218
1.07
0.62
2.0
1.7
—
—
—
0
0
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
12
77
1.50
0.59
1.4
1.7
—
1982.22
—
0
9
21
151
1.34
0.59
1.5
1.2
—
—
—
0
0
23
168
1.32
0.59
4.1
3.1
—
—
—
0
0
83
698
1.15
0.58
1.3
1.1
11.83
17.80
au/ml
—
6
154
24
177
1.31
0.58
1.3
1.7
52.05
55.49
%
0.16
19
132
46
368
1.21
0.58
1.5
1.3
—
—
—
0
0
134
1164
1.11
0.58
1.3
1.2
2.92
2.79
u/ml
0.04
97
746
104
892
1.13
0.56
2.2
2.0
0.00
0.01
estimate
0.74
39
314
32
249
1.24
0.53
1.0
1.0
—
—
—
0
0
6
38
1.52
0.52
1.7
4.0
2.83
68.63
ug/l
—
6
38
6
38
1.52
0.52
2.0
3.9
—
—
—
0
0
56
462
1.17
0.52
1.1
1.1
3.72
3.78
eliau/ml
0.01
19
200
55
455
1.17
0.50
1.2
1.1
35.27
178.23
iu/ml
4.53
11
140
10
65
1.48
0.48
2.2
2.2
34.50
30.14
%
—
10
65
10
65
1.48
0.48
1.0
1.0
—
—
—
0
0
60
503
1.15
0.47
1.2
1.1
—
—
—
0
0
34
393
0.83
0.46
3.9
5.3
35.44
20.25
u/ml
0.22
34
388
180
1865
0.92
0.45
1.9
1.5
—
—
—
0
0
16
116
1.33
0.45
1.1
1.1
—
—
—
0
0
16
117
1.32
0.43
1.0
1.0
—
—
—
0
0
5
30
1.61
0.43
3.0
3.0
3.20
2.63
%
—
5
30
12
156
0.74
0.42
1.1
1.0
16.54
17.95
u/ml
—
7
107
5
31
1.55
0.42
1.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
190.71
—
0
7
0
16
0.00
0.41
0.0
1.2
—
7.25
—
0
8
132
1173
1.09
0.40
3.9
4.3
4.90
21.70
ug/l
1.50
102
920
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
8
58
1.33
0.40
4.2
6.4
—
—
—
0
0
0
18
0.00
0.39
0.0
1.8
—
4.25
—
0
8
91
796
1.10
0.39
1.7
1.7
15.75
8.40
u/ml
0.99
22
204
39
322
1.17
0.39
1.5
1.4
11.96
12.89
u/l
0.10
31
283
32
260
1.19
0.38
1.0
1.0
-1.10
-2.31
mmol/l
—
7
57
32
260
1.19
0.38
1.0
1.0
7.21
7.24
kpa
0.03
27
223
32
260
1.19
0.38
1.0
1.0
—
—
—
0
0
10
69
1.40
0.37
6.8
2.4
—
—
—
0
0
85
744
1.10
0.37
1.2
1.1
10.13
9.73
u/ml
0.05
50
430
21
164
1.24
0.36
1.6
1.7
6.51
6.07
mmol/l
0.38
14
128
625
6202
0.96
0.36
2.0
1.8
—
—
—
0
0
18
138
1.26
0.36
1.3
1.4
302103.85
161315.40
e6/l
0.30
13
96
28
227
1.19
0.35
1.1
1.1
—
—
—
0
0
40
335
1.15
0.35
2.3
2.5
157.38
108.71
ug/min
0.21
33
214
25
201
1.20
0.34
1.2
1.3
192.78
209.95
pmol/l
0.36
25
201
21
166
1.22
0.33
1.3
1.2
—
—
—
0
0
22
175
1.21
0.33
1.2
1.1
1557.59
1441.13
miu/ml
0.19
22
175
31
257
1.16
0.31
1.0
1.0
3.38
3.29
kpa
0.07
26
221
28
231
1.17
0.30
1.1
1.2
77.70
17.17
u/ml
0.39
19
183
634
5955
1.03
0.30
5.2
3.7
0.00
0.00
estimate
1.60
230
2166
58
505
1.11
0.30
11.4
9.4
—
—
—
0
0
115
1035
1.07
0.29
1.2
1.2
3.84
2.75
u/ml
0.32
81
680
12
90
1.29
0.29
1.3
1.2
—
—
—
0
0
12
90
1.29
0.29
1.3
1.2
—
—
—
0
0
12
90
1.29
0.29
1.3
1.2
—
—
—
0
0
359
3339
1.04
0.29
1.3
1.3
18.82
27.15
iu/ml
1.67
77
853
23
188
1.18
0.28
1.2
1.5
—
—
—
0
0
15
117
1.24
0.27
1.1
1.1
—
—
—
0
0
72
752
0.92
0.26
3.2
2.6
33.43
68.56
u/ml
1.13
66
718
78
695
1.08
0.26
1.5
1.5
50.91
77.50
titre
2.39
11
72
10
74
1.30
0.26
1.7
2.5
14.76
16.80
%
—
10
74
218
2011
1.05
0.26
2.6
2.8
0.72
0.74
ug/l
0.09
131
1123
9
70
1.24
0.25
4.4
6.9
5.18
4.94
kpa
—
9
70
711
6711
1.03
0.25
2.0
2.0
—
—
—
0
0
9
73
1.19
0.24
1.8
1.4
33.33
28.49
s
—
9
73
26
218
1.15
0.24
1.4
1.3
67.00
10.68
u/ml
0.73
16
170
298
2775
1.04
0.24
1.7
1.5
—
—
—
0
0
5
37
1.30
0.23
1.0
1.4
—
—
—
0
0
70
626
1.08
0.23
3.6
3.0
55.02
55.22
%
0.04
70
626
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
88
797
1.07
0.21
1.2
1.1
5.99
5.93
u/ml
0.01
58
496
0
12
0.00
0.21
0.0
1.0
—
0.05
—
0
12
0
12
0.00
0.21
0.0
1.3
—
0.18
—
0
12
0
12
0.00
0.21
0.0
1.2
—
51.33
—
0
12
58
517
1.08
0.21
1.7
1.6
0.25
0.39
nmol/l
1.32
51
408
0
13
0.00
0.20
0.0
1.0
—
17.35
—
0
13
0
13
0.00
0.20
0.0
1.0
—
20.17
—
0
6
6
46
1.26
0.20
1.2
1.8
—
—
—
0
0
11
86
1.23
0.20
1.9
2.3
8.89
8.38
mmol/l
0.18
11
86
0
14
0.00
0.20
0.0
7.4
—
—
—
0
0
25
213
1.13
0.20
2.7
2.3
14.58
3.14
u/ml
—
7
85
42
370
1.10
0.19
1.5
1.3
6.96
2.82
u/ml
0.47
23
216
7
56
1.20
0.18
1.0
1.2
—
—
—
0
0
197
1834
1.04
0.18
5.0
3.7
32.48
31.91
%
0.31
159
1290
8
66
1.17
0.16
1.5
1.9
—
—
—
0
0
8
66
1.17
0.16
1.1
1.3
—
—
—
0
0
14
116
1.16
0.15
1.2
2.2
—
—
—
0
0
9
76
1.14
0.15
1.4
2.8
—
—
—
0
0
41
368
1.07
0.14
1.3
1.1
—
—
—
0
0
40
413
0.93
0.13
3.5
3.1
22.81
27.37
mg/l
0.37
28
271
10
113
0.85
0.13
1.2
1.2
—
48.08
—
0
13
875
8344
1.02
0.13
5.1
3.4
0.17
0.03
estimate
0.54
204
1947
55
502
1.06
0.12
4.1
3.7
1042.19
2991.85
u/ml
0.47
47
433
95
948
0.96
0.11
1.6
1.5
1.32
1.26
mm
0.64
69
704
56
515
1.05
0.10
1.2
1.1
—
—
—
0
0
5
45
1.07
0.09
1.6
1.5
—
—
—
0
0
5
46
1.05
0.09
1.8
2.5
95.40
99.09
g/l
—
5
46
52
523
0.96
0.09
1.2
1.2
—
—
—
0
0
99
980
0.97
0.08
1.6
1.5
—
—
—
0
0
111
1043
1.03
0.08
1.2
1.2
1.29
1.18
u/ml
0.05
67
622
7
66
1.02
0.07
1.1
1.3
—
45.34
—
0
15
7
66
1.02
0.07
1.0
1.0
—
—
—
0
0
6
71
0.81
0.07
1.2
1.2
—
—
—
0
0
10
108
0.89
0.07
1.1
1.1
—
—
—
0
0
84
787
1.03
0.07
1.2
1.2
—
—
—
0
0
8
75
1.03
0.07
1.3
1.3
—
—
—
0
0
75
744
0.97
0.07
1.2
1.2
—
—
—
0
0
9
83
1.04
0.07
1.4
2.7
—
—
—
0
0
37
341
1.05
0.06
1.4
1.3
—
—
—
0
0
70
694
0.97
0.06
1.1
1.1
0.18
0.43
u/ml
1.44
35
294
23
235
0.94
0.06
1.3
1.1
—
—
—
0
0
217
2118
0.99
0.06
1.9
1.9
—
—
—
0
0
75
741
0.97
0.06
1.2
1.2
—
—
—
0
0
312
3035
0.99
0.05
1.3
1.3
11.88
8.52
u/ml
0.29
92
1120
13
115
1.09
0.05
1.6
1.2
—
—
—
0
0
101
988
0.98
0.03
1.6
1.6
—
—
—
0
0
759
7287
1.00
0.03
1.6
1.7
—
—
—
0
0
13
117
1.07
0.03
1.5
2.0
2.60
3.49
mg/l
1.14
13
111
548
5257
1.01
0.03
6.2
4.6
—
—
—
0
0
32
314
0.98
0.00
1.2
1.2
9.41
1.61
u/ml
0.42
17
163
11
109
0.97
0.00
2.5
3.3
—
—
—
0
0
13
129
0.97
0.00
1.7
1.3
64.08
76.97
umol/l
1.49
13
129
234
2253
1.00
0.00
1.5
1.4
—
—
—
0
0
22
214
0.99
0.00
1.4
1.2
—
—
—
0
0
11
106
1.00
0.00
1.3
1.2
2.64
0.99
u/ml
0.27
11
106
37
361
0.99
0.00
1.9
1.4
11.57
10.23
u/ml
0.07
19
190
111
1070
1.00
0.00
1.2
1.2
4.72
7.19
u/ml
1.02
75
726
200
1924
1.00
0.00
2.9
2.7
11623.15
7260.78
u/l
0.53
54
725
70
674
1.00
0.00
5.0
3.4
10.23
7.18
umol/l
1.12
55
545
18
171
1.01
0.00
1.9
1.7
—
—
—
0
0
22
212
1.00
0.00
1.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
6
58
1.00
0.00
2.8
2.1
3.58
1.96
ug/l
—
6
46
0
5
0.00
-0.00
0.0
7.0
—
6.78
—
0
5
5
56
0.86
-0.00
1.6
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
374.00
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
57
1.01
-0.00
2.7
2.2
4.85
3.43
ug/l
—
6
52
0
5
0.00
-0.00
0.0
1.0
—
2720.00
—
0
5
7
70
0.96
-0.00
1.3
1.6
0.00
0.00
estimate
—
7
70
0
7
0.00
-0.00
0.0
1.0
—
7301.71
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
48
1.00
-0.00
1.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint F5_SPEECH and mortality.

Females

Parameter HR [95% CI] p-value
F5_SPEECH 2.33 [1.63, 3.33] < 0.001
Birth year 0.997 [0.99, 1.01] 0.521

During the follow-up period (1.1.1998 — 31.12.2019), 456 out of 16064 females with F5_SPEECH died.

Males

Parameter HR [95% CI] p-value
F5_SPEECH 1.96 [1.3, 2.95] 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 439 out of 36866 males with F5_SPEECH died.

Mortality risk

Mortality risk for people of age

years, who have F5_SPEECH.

N-year risk Females Males
1 0.163% 0.335%
5 1.268% 2.075%
10 3.551% 5.315%
15 6.847% 10.057%
20 12.053% 16.402%

Relationships between endpoints

↥

Index endpoint: F5_SPEECH – Specific development disorders of speech and language

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data